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Summary 
Transcriptional regulators belonging to the PadR family contribute to resistance against 
antibiotics and small toxic compounds in many bacteria. The genome of the Gram-positive 
human pathogen Listeria monocytogenes contains 5 genes encoding proteins belonging to 
the PadR family. The exact regulons and biological functions of these PadR-like transcription 
factors remained elusive. 
Four genes encoding PadR-like transcription factors were inactivated in L. monocytogenes 
EGD-e in order to compare the transcriptome of the resulting strains to the wild type using 
RNA-sequencing. The RNA-sequencing data revealed that all four PadR-like transcription 
factors strongly repress a small set of genes comprising one or two transcriptional units. In 
most cases the repressors could be shown to be autoregulatory. When the PadR-like 
proteins are inactivated, the transcription of the target genes increases between 100- and 
500-fold. The strong repression under standard conditions suggests that it is beneficial for 
the bacteria to inactivate the target genes under most conditions, while increased 
transcription occurs only under very specific conditions. 
In order to identify conditions leading to the expression of genes controlled by PadR-like 
transcription factors, promoter-lacZ fusions were constructed using the most strongly 
repressed promoters. Using these reporters, a natural compound collection was screened for 
substances inducing transcription. This screen identified aurantimycin A as an inducer of 
LftR-controlled gene expression. The depsipeptide antibiotic aurantimycin A, produced by the 
soil bacterium Streptomyces aurantiacus, is very toxic for Gram-positive bacteria. 
Surprisingly, the MIC of aurantimycin against L. monocytogenes is much higher compared to 
other Gram-positive bacteria. The resistance depended on expression of the lieAB genes 
which is tightly regulated by LftR in interplay with LftS. The LieAB transporter was shown to 
protect L. monocytogenes from aurantimycin induced lysis. This is the first description of an 
aurantimycin resistance mechanism. The system discovered may play a vital role for the 
survival, spread and persistence of L. monocytogenes in the soil, where it may come into 
contact with the antibiotic producing bacterium S. aurantiacus.  
Genes controlled by another PadR-type transcription factor, LstR, were shown to be induced 
by the 16-membered macrolide antibiotic josamycin, but they were not involved in resistance 
against this antibiotic. One of the genes controlled by LstR, lmo0421, encodes a homolog to 
RodA or FtsW, which are involved in cell wall biosynthesis. Still, under the conditions 
investigated, Lmo0421 did not possess RodA or FtsW functionality, so its biological function 
remained unclear. 
The padR-like gene lmo0599 (lltR) was important for growth of L. monocytogenes at low 
temperatures. The inactivation of lmo0599 impaired the growth of L. monocytogenes at 6°C. 
It was also shown that this phenotype depended on the overexpression of the gene lmo0600 
in the absence of lltR. 
Taken together, the results suggest that the PadR-like transcription factors in L. 
monocytogenes act as repressors to control the expression of a very specific set of genes. 
These genes are mostly surface associated and become active under defined conditions 
only. They may play an important role in response to certain environmental stimuli and for 
survival in the environment. 
 
Zusammenfassung 
In vielen Bakterien regulieren PadR-typ Transkriptionsfaktoren Resistenz-mechanismen 
gegen toxische Substanzen oder Antibiotika. Im Genom des Gram-positiven Listeriose 
Erregers Listeria monocytogenes sind insgesamt fünf Gene enthalten, welche Proteine aus 
der PadR Proteinfamilie codieren. Die genauen Regulons, sowie die biologische Funktion 
dieser Transkriptionsfaktoren waren großteils unbekannt. 
Vier der fünf Gene, welche für Transkriptionsfaktoren vom PadR-Typ kodieren, wurden 
inaktiviert und die Transkriptome der entsprechenden Stämme mit dem Wildtyp verglichen. 
Die Daten zeigten, dass PadR-Typ-Faktoren eine kleine Zahl an Genen stark reprimieren. In 
den meisten Fällen waren die Repressoren auch selbstregulierend. Die Inaktivierung der 
Repressoren führte zu einer 100- bis nahezu 500-fachen Induktion der jeweiligen Zielgene. 
Diese starke Repression unter Standardbedingungen weist darauf hin, dass es vorteilhaft 
sein könnte, die Zielgene nur unter sehr spezifischen Bedingungen zu exprimieren, während 
unter anderen Bedingungen besser ist, dass die Gene nicht exprimiert werden. 
Mithilfe von Promoter-lacZ Fusionen der am stärksten reprimierten Gene wurde die 
Naturstoffsammlung des DZIF auf Substanzen, welche die Genexpression induzieren, 
untersucht. Diese Experimente zeigten, dass LftR-kontrollierte Gene von Aurantimycin A 
induziert werden. Aurantimycin A ist ein Depsipeptidantibiotikum, welches von dem 
Bodenbakterium Streptomyces aurantiacus produziert wird und welches für viele Gram-
positive Bakterien sehr giftig ist. Überraschenderweise war L. monocytogenes deutlich 
resistenter gegen das Antibiotikum als andere Bakterien, wie sich in einer hohen minimalen 
Hemmkonzentration zeigte. Diese Resistenz basierte auf der Expression der lieAB Gene, 
welche von LftR und LftS kontrolliert wird. Es wurde gezeigt, dass der LieAB Transporter L. 
monocytogenes vor Lyse durch Aurantimycin schützt. Dies ist die erste Beschreibung eines 
Resistenzmechanismus gegen Aurantimycin. Der entdeckte Mechanismus könnte eine 
wichtige Rolle für das Überleben und die Verbreitung von L. monocytogenes im Boden 
spielen, wenn es dort mit dem Aurantimycin-produzierenden Bakterium S. aurantiacus 
zusammentrifft.  
Andere Gene, welche von dem Transkriptionsfaktor LstR reguliert werden, wurden durch das 
Makrolidantibiotikum Josamycin induziert. Sie hatten jedoch keinen Einfluss auf die 
Resistenz gegenüber Josamycin. Ein von LstR kontrolliertes Gen, lmo0421, kodiert für ein 
Protein mit Homologie zu RodA oder FtsW, welche an der Zellwandbiosynthese beteiligt 
sind. Es konnte jedoch gezeigt werden, dass unter den getesteten Bedingungen Lmo0421 
die Funktion von RodA oder FtsW nicht übernehmen konnte. 
Das Gen lmo0599 (lltR) war wichtig für das Wachstum von L. monocytogenes bei niedrigen 
Temperaturen. Nach Inaktivierung von lmo0599 war Wachstum bei 6°C nur eingeschränkt 
möglich. Es wurde auch gezeigt, dass dieser Phänotyp von der Überexpression des Genes 
lmo0600 verursacht wurde. 
Zusammenfassend kann gesagt werden, dass die PadR-Typ-Transkriptionsfaktoren in L. 
monocytogenes die Expression einer kleinen Anzahl von Genen reprimieren. Diese Gene 
sind meinst membranassoziiert und werden nur unter bestimmten Bedingungen aktiviert. Es 
könnte sein, dass diese Gene eine wichtige Rolle für die Reaktion auf spezielle 
Umweltsignale und das Überleben in der Umwelt spielen. 
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Chapter 1
Introduction
1.1 Listeria monocytogenes
1.1.1 Historic descriptions of L. monocytogenes
In the modern scientific literature, the first encounters with bacteria that were most likely
Listeria date to the early 20th century. In 1924, Murray et al. observed a disease in rab-
bits in a breeding facility for laboratory animals. A characteristic feature of the disease
was large mononuclear leucocytosis. They succeeded in isolating a small gram-positive
bacillus from infected animals which they named Bacterium monocytogenes (Murray et
al. 1926). Soon afterwards, infections in humans caused by similar bacteria were also
reported (Nyfeldt 1929, Burn 1936). In 1933, Gill showed a connection between the fatal
”circling disease” in sheep and a small gram-positive bacillus, which he named Listerella
monocytogenes (Gill 1933). From that time on, many more cases of infection with Lis-
teria were reported in different animals causing meningitis, encephalitis, septicaemia or
abortion of pregnancy (Gray and Killinger 1966).
The early descriptions of Listeria already linked the disease now known as listeriosis to
the consumption of inadequate feed (Murray et al. 1926) and even today, L. monocyto-
genes gets the most attention for outbreaks of listeriosis caused by the consumption of
contaminated food (Pouillot et al. 2016, Angelo et al. 2017, Halbedel et al. 2019).
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1.1.2 Listeriosis - L. monocytogenes as a pathogen
Listeriosis is the disease caused by infection with bacteria from the genus Listeria. It
has been observed in a wide variety of animals for example sheep, pigs, cows, chickens,
birds and even fish or crustaceans (Fenlon 1999). L. monocytogenes is the main causative
agent of human listeriosis, while other species like L. seeligeri, L. innocua, or the animal
pathogen L. ivanovii rarely cause human disease (Rocourt et al. 1986, Perrin et al. 2003,
Guillet et al. 2010).
In healthy humans, listeriosis usually manifests in gastrointestinal symptoms like diar-
rhea, or flu-like symptoms such as fever and muscle aches (Ooi and Lorber 2005). How-
ever, immune suppressed persons, elderly people and pregnant woman are especially vul-
nerable to infections with L. monocytogenes (Silk et al. 2013). In these groups, the dis-
ease often manifests in more severe illnesses, for example meningitis, encephalitis, sep-
ticaemia or abortion of pregnancy and death from listeriosis is not uncommon (Slutsker
and Schuchat 1999, Charlier et al. 2017).
Infection sources range from fruit and vegetables over milk, meat products and fish to
soft cheeses or other ready-to-eat foods. (Schuchat et al. 1992, Dalton et al. 1997,
Swaminathan and Gerner-Smidt 2007, McCollum et al. 2013, Stephan et al. 2015). Heat-
ing above 70°C has been shown to reliably inactivate L. monocytogenes (Mackey and
Bratchell 1989), so a common characteristic of all foods often identified as infection
sources is that they are usually consumed without additional heating prior to consump-
tion. Foods that have been cooked during preparation can become re-contaminated at a
later stage of processing, causing disease when the bacteria are able to grow during stor-
age. Because of the severity of the disease in risk groups, outbreaks of L. monocytogenes
are a major public health concern (Valk et al. 2005, Mateus et al. 2013).
1.1.3 Morphology and physiology of L. monocytogenes
L. monocytogenes is a small gram-positive rod of approximately 1 µm in length (about
half the size of Bacillus subtilis, a closely related bacterium). It is motile by polar or
peritrichous flagella, but loses motility at higher temperatures (not motile at 37°C) (Gray
and Killinger 1966, Rocourt 1999). Its optimum growth temperature is around 37°C al-
though it can also grow at temperatures near freezing or up to around 45°C (Junttila et al.
1988, Annous et al. 1997). The genome of the L. monocytogenes reference strain EGD-e
is 2.944.528 base pairs in size with a GC content of 38 % (Glaser et al. 2001). L. mono-
cytogenes does not form spores, but is highly resistant to physical and chemical stresses
like low temperature, alkaline or acidic pH, high salt concentration and the presence of
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various disinfectants (Junttila et al. 1988, George et al. 1988, Best et al. 1990, Vasseur
et al. 1999).
For the role of L. monocytogenes as a food associated pathogen, its abilities to grow at
refrigeration temperatures, to replicate at acidic and alkaline pH as well as to multiply at
high salt concentrations are especially important, because such conditions are often used
to treat or conserve food for longer periods of time (Bucur et al. 2018). High tolerance
to adverse conditions set this pathogen apart from other bacteria. The mixture of unique
properties -like its ability to grow at low temperatures, in environments high in salt or
under acidic conditions- means that most methods of preservation (cooling, salting, pick-
ling) are inadequate to protect food from spoilage by L. monocytogenes. The major route
of infection is the ingestion of contaminated food. For this reason, it is also important to
know where the L. monocytogenes comes from and how it gets onto food.
1.1.4 L. monocytogenes in the environment - saprophyte or pathogen?
Bacteria belonging to the species L. monocytogenes seem to be widespread in the envi-
ronment, because they could be isolated from a variety of different sources like surface
and ground water, decaying plant matter, silage, or soil (Fenlon 1999). Contributing to its
ubiquitous occurrence in nature are its ability to utilize a variety of carbon sources (Pine
et al. 1989), swimming motility below 30°C (Gru¨ndling et al. 2004), and the capacity to
grow at low temperature as well as high osmolarity (Cole et al. 1990). Still, knowledge
on the life cycle and persistence in natural habitats is sparse and it is uncertain in which
niches L. monocytogenes actually replicates.
A common hypothesis is that soil and especially decaying vegetation is the primary habi-
tat of Listeria species (Vivant et al. 2019). Decaying plant matter seems to be one en-
vironmental niche where L. monocytogenes is able to grow (Donald et al. 1995, Fenlon
1999). The widespread presence of L. monocytogenes in the environment is one hint that
it may be a saprophytic organism. The observation that in the presence of plant sugars
like cellobiose virulence genes are not activated (Milenbachs et al. 2003) is supporting
this hypothesis. Additionally, L. monocytogenes is able to hydrolyse chitin, one of the
most common polymers in natural systems (Paspaliari et al. 2015). The hydrolysis of
chitin is up-regulated at low temperatures that are common in the environment while low
chitinase activity is observed at 37°C (Leisner et al. 2008). There are also hints that L.
monocytogenes might be part of the commensal microflora of the gut, because it could
be carried asymptomatically in the gastrointestinal tract by up to 10 % of the human
population (Farber and Peterkin 1991).
Although L. monocytogenes occurs ubiquitously in the environment and could be a part of
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the gut microflora in healthy persons, it also has the ability to actively invade eukaryotic
host cells (Pizarro-Cerda´ et al. 2012). After invasion, L. monocytogenes does not only
survive inside the host cell, but can actively replicate inside the cytoplasm (Joseph and
Goebel 2007). It is therefore classified as a facultative intracellular pathogen. Phosphory-
lated sugars present in the cytosol of host cells can also be utilized by L. monocytogenes
and these sugars do not repress virulence genes as is the case with plant-derived sugars
such as cellobiose (Chico-Calero et al. 2002). In healthy individuals, the immune sys-
tem generally limits the infection to gastrointestinal symptoms (Ooi and Lorber 2005).
In contrast, in immunocompromized persons infections with L. monocytogenes often be-
come systemic and lead to very serious outcomes including death. The adaptation of L.
monocytogenes to life in the environment as well as inside eukaryotic hosts has led to
the suggestion that this bacterium possesses two very different personalities (Gray et al.
2006).
The transition from saprophyte to pathogen is mainly controlled by the virulence reg-
ulator PrfA reacting to a variety of environmental signals (Freitag et al. 2009). Once
contaminated food is ingested, L. monocytogenes enters the gut and an infection cycle
starts upon contact of the bacterium with gut epithelial cells (Pentecost et al. 2006). The
infection cycle of L. monocytogenes is shown in figure 1.1. The bacterium triggers phago-
cytosis by the host cell through interaction of the internalins InlA or InlB with the host
cell receptors E-cadherin or Met, respectively (Mengaud et al. 1996, Shen et al. 2000).
The InlA mediated interaction with E-cadherin is especially important for the ability of L.
monocytogenes to cross the gut epithelial barrier (Lecuit et al. 2001, Ortega et al. 2017).
After entry into host cells, the resulting phagosome is lysed by the combined action of
listeriolysin (LLO) and the phospholipases PlcA and PlcB (Cossart et al. 1989, Smith
et al. 1995, Kanki et al. 2018). Once inside the cytoplasm, the bacterium starts to grow,
replicates and then moves actively by polymerizing host actin with the help of the actin-
assembly inducing protein ActA (Domann et al. 1992, Kocks et al. 1993, Southwick
2006). The active movement allows the bacterium to spread to neighbouring cells and to
repeat the infection cycle. This way of moving between host cells also allows L. mono-
cytogenes to breach all major anatomical infection barriers present in the human body
(for example the blood-brain barrier or the placental barrier) and to infect into the brain
or the foetus. (Gray and Killinger 1966, Berche 1995, Faralla et al. 2018, Ghosh et al.
2018). In this systemic stadium the disease is very difficult to treat and special antibiotic
treatment regimes need to be followed depending on the manifestation observed in the
patient (Jones and MacGowan 1995). An understanding of the mechanisms of antibiotic
treatment and antimicrobial resistance in Listeria is therefore essential.
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Figure 1.1: The infection cycle of L. monocytogenes. There are three
main stages in L. monocytogenes infections. First, the bacterium enters
the host cell cytoplasm. Initial attachment and phagocytosis are mediated
by the interaction of the bacterial internalins InlA and InlB with the host
cell receptors E-cadherin and Met, respectively. The phagosome is de-
stroyed after phagocytosis by the combined action of listeriolysin O, PlcA
and PlcB. In a second stage, the bacterium starts to grow and replicate in-
side the cytoplasm. L. monocytogenes can move actively inside of the host
cells by polymerizing host actin molecules with ActA. The third stage of
infection is the spread to adjacent host cells. Here, L. monocytogenes uses
the energy of actin polymerization to breach the cell membranes and then
re-initiates the escape from the newly formed vesicle.
5
1.2 Antibiotics
For people infected with bacteria, the most potent medicines that help to cure the patients
are antibiotics. Usually, antibiotics are small compounds that kill the bacteria or prevent
their growth without major negative impact on the patient. In order to be used in a clinical
setting, in vitro as well as in vivo effectiveness, a lack of toxicity for humans, and reason-
ably low cost are essential factors (Moellering 1981). Substances that fulfil these criteria
usually target structures that are specific for bacteria and do not occur in human cells. Of-
ten, the target structures are involved in the synthesis of DNA, RNA, proteins or the bac-
terial cell wall (Kohanski et al. 2010). Beginning with the famous discovery of penicillin
by Alexander Fleming in 1929 (Fleming 1929), many antibiotic substances (for example
gentamycin or vancomycin) have been isolated from natural sources, the most fertile of
which were soil dwelling Streptomyes species (Clardy et al. 2009). The treatment of Lis-
teriosis is commonly performed with penicillins in combination with gentamicin, because
resistance to these antibiotics is rarely reported (Morvan et al. 2010). However, treatment
with other antibiotics like vancomycin or macrolides might be necessary for particular
maifestation of the disease (Jones and MacGowan 1995).
1.2.1 Main target structures of antibiotics
Antibiotics often binds and inactivate or interfere with the biological function of a main
cellular target structure. Figure 1.2 shows cellular processes that are targets of different
antibiotics. For example, DNA-gyrase or topoisomerase complexes, essential for prokary-
otic DNA maintenance, are bound and misregulated by quinolone antibiotics (Aldred et
al. 2014). The bacterial RNA polymerase is inactivated by rifamycins and the cell mem-
brane compromised by polymyxins (Campbell et al. 2001, Trimble et al. 2016). Protein
biosynthesis at the bacterial ribosome is the target of many different antibiotics such as
tetracyclines and aminoglycosides, interfering with the 30S subunit, or macrolide antibi-
otics and chloramphenicol that target the 50S subunit of the bacterial ribosome (McCoy
et al. 2011). The β -lactams, for example penicillin, bind and inactivate proteins involved
in the synthesis of the cell wall, the so called penicillin binding proteins (PBPs) (Fre`re
et al. 1992). The disruption of those important cellular processes has varying effects on
the bacterial cell, but all result in the inhibition of growth. Generally, antibiotics are also
classified as bacteriostatic and bactericidal, depending on whether they impact bacterial
growth or kill the bacteria (Kohanski et al. 2010).
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Figure 1.2: Major points of action of common antibiotics. Schematic
showing structures or processes commonly targeted by antibiotics as well
as some antibiotics that interfere with them. Adapted after Kapoor et al.
2017
1.2.2 Antibiotic resistance mechanisms
Many different microorganisms naturally produce antibiotics. A large variety of antibioti-
cally active substances have been isolated from sources like fungi, plants and bacteria, but
most of the active compounds were isolated from streptomycetes (Korzybski et al. 1967).
It is likely that microorganisms produce antibiotics to gain an edge over competitors, but
antibiotics in nature could also be important for other purposes for example as signals to
communicate with other organisms (Clardy et al. 2009). Whatever their significance in
nature might be, as soon as substances inhibiting growth appeared, resistance mechanisms
should also have evolved. The co-evolution of antibiotic producers and their competitors
may have led to the diverse set of antibiotics and resistance mechanisms that are found
in nature today (Munita and Arias 2016). Some common ways to resist an antibiotic are
discussed below:
1. The spatial exclusion of the antibiotics,
2. The temporal exclusion of the antibiotics,
3. The modification of the antibiotic target structure,
4. The modification of the antibiotic, and
5. The efflux of the antibiotic
An obvious way to avoid any harmful effects caused by an antibiotic is to avoid or min-
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imize contact with the substance (spatial exclusion). Due to their size, microorganisms
are very limited in their capacity to move over long distances, but they can avoid con-
tact by separating themselves spatially. The most prominent examples for such behavior
are the formation of biofilms or capsules. Both mechanisms rely on the production of
an extracellular matrix as a barrier to prevent antibiotics from reaching the cell. The
polysaccharide capsule formed by some Klebsiella pneumoniae strains mediates resis-
tance to antimicrobial peptides (Campos et al. 2004) and biofilm formation is a serious
problem in staphylococcal infections (Stewart 2002, Høibya et al. 2010). Biofilms of
L. monocytogenes can also be the cause of recurrent contamination in the food industry,
because of their resistance against common disinfection agents (Pan et al. 2006).
Another way to cope with an antibiotic stress is to wait until it disappears (temporal ex-
clusion). Some bacteria are known to form dormant cell types such as persister cells
and spores that are metabolically inactive and thus resistant to antibiotic treatment (Lewis
2012). Biofilms also make use of this mechanism, because the nutrient limited conditions
inside of the biofilm slow bacterial growth thereby reducing the negative effects antibi-
otics have on the bacteria (Stewart 2002). Spores and persister cells are a major cause of
chronic or recurring infections with for example Clostridium or Staphylococcus species
(Wood et al. 2013, Tetz and Tetz 2017).
More direct responses that increase the resistance to an antibiotic are also possible. Most
antibiotics possess a single main cellular target structure and this target can be modified
in subtle ways that prevent binding of the antibiotic while retaining the biological func-
tion (target modification). Macrolides for example bind with high affinity to the bacterial
ribosome and interfere with protein synthesis (Mazzei et al. 1993, Kannan et al. 2014).
A commonly found macrolide resistance mechanism is the methylation of the ribosome
to prevent macrolide binding (Weisblum 1995). Cell wall modifications leading to van-
comycin resistance in S. aureus (Cui et al. 2006) and mutations in the β -subunit of the
RNA polymerase leading to rifampin resistance are further examples for this mechanism
(Alifano et al. 2015). Another way is to bypass the target completely by having another
structure taking over its function as found for example in methicillin resistant S. aureus
that acquired an exogenous, class B PBP (PBP2a) encoded by mecA (Wu et al. 2001).
In L. monocytogenes HflXr, a ribosome-splitting factor, confers protection against lin-
comycin and erythromycin probably by recycling stalled ribosomes (Duval et al. 2018).
Soon after the clinical use of penicillin became a standard treatment, resistances by
β -lactamase mediated cleavage of the antibiotic were described (Beigelman and Rantz
1950). Such enzymatic degradation or modification of antibiotics is a strategy used by
different bacteria to inactivate a wide range of antibiotics (Wright 2005). The same strat-
egy is also used by antibiotic producing organisms to protect themselves against the an-
tibiotics they produce. For example the antibiotic streptomycin is phosphorylated by its
producer Streptomyces griseus and the phosphorylated form does not interfere with pro-
tein biosynthesis (Sugiyama et al. 1981).
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Antibiotic efflux is another commonly employed resistance mechanism. This type of re-
sistance can be found in all domains of life and ranges from very specific transporters
that only act on specific substances to multi-drug efflux pumps that transport a wide va-
riety of compounds (Poole 2007, Du et al. 2018). There are five major classes of efflux
pumps in bacteria. These are the ATP-binding cassette (ABC) transporters, major facili-
tator superfamily (MFS) transporters, multidrug and toxic compounds extrusion (MATE)
transporters, small multidrug resistance (SMR) and resistance-nodulation-division (RND)
transporters (Du et al. 2018). The ABC-type transporters directly use the chemical en-
ergy stored in ATP to drive conformational changes that enable transport. All the others
classes use energy stored in electrochemical gradients across the membrane to power ac-
tive compound transport (Blanco et al. 2016, Du et al. 2018). Efflux pumps constantly
work against a gradient to keep the antibiotic concentration inside the cell low. For this
reason, there is an ongoing energetic cost associated with this type of resistance, although
it is not necessarily associated with a measurable fitness reduction (Alvarez-Ortega et
al. 2013). As an example, the resistance against tetracycline mediated by efflux pumps
is more common than other mechanisms like target modification or degradation of the
antibiotic (Roberts 2005). Efflux pumps also confer fluoroquinolone resistance to Pseu-
domonas aeruginosa or macrolide resistance to S. pneumoniae (Mef pumps) (Ambrose
et al. 2005, Aeschlimann 2012) and the MATE type transporter FepA mediates fluoro-
quinolone resistance in Listeria monocytogenes (Gue´rin et al. 2014).
1.3 PadR-like repressors
1.3.1 The PadR family of proteins
The family of PadR-like repressors got its name from the phenolic acid decarboxylase
repressor PadR. The name PadR was initially introduced to describe a repressor protein
regulating the expression of the phenolic acid decarboxylase gene padA in Pediococcus
pentosaceus (Barthelmebs et al. 2000b). It was shown that the PadR protein negatively
regulates the production of PadA, an enzyme that is responsible for the conversion of
toxic phenolic acids into less toxic substances (Barthelmebs et al. 2000b). In the presence
of phenolic acids, the repressor is inactivated and the phenolic acids are detoxified by
PadA (Gury et al. 2004).
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Infobox 1: PadR - PadR-like transcriptional regulator family
“Members of this family are transcriptional regulators that appear to be related to
the pfam01047 family. This family includes PadR, a protein that is involved in
negative regulation of phenolic acid metabolism.” a
ahttps://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=308908
In general, the structure of PadR-like proteins places them all in the HTH (Helix-Turn-
Helix) superfamily. Proteins of this superfamily are mostly transcription factors involved
in nucleic acid binding and the regulation of gene expression (Aravind et al. 2005). It has
been proposed that the overall length of the protein can serve to further classify PadR-like
proteins into two subfamilies (Huillet et al. 2006). Subfamily I contains a long C-terminus
forming a coiled coil dimerization domain separated from the DNA binding domain by
a linker (Silva et al. 2005), while subfamily II has a short C-terminal domain containing
only one dimerization helix (Fibriansah et al. 2012).
Infobox 2: HTH Superfamily - Helix-turn-helix domain proteins
“A large family of mostly alpha-helical protein domains with a characteristic fold;
most members function as sequence-specific DNA binding domains, such as in
transcription regulators. This superfamily also includes the winged helix-turn-helix
domains.” a
ahttps://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=cl21459
At the time of writing, the pfam database contained 19503 protein sequences belonging
to the PadR family (PF03551) distributed over 4480 different species. This species dis-
tribution can be visualized on pfam in a so called Sunburst graph, which can be seen in
Figure 1.3 (Pfam 2019).
Although PadR-like proteins have also been found in some Archaea, they are especially
common in members of the bacterial domain of life. It is also apparent from the sunburst
graph that the Gram-positive bacterial phyla Firmicutes and Actinobacteria represent the
biggest portion of the total PadR diversity (nearly 75 % of all the sequences). Members
of the Actinobacteria are an essential part of the global carbon cycle as they are major
degraders of plant biomass. They mainly live as saprophytes making up around 10 % of
soil microbioms or as symbionts associated with herbivorous animals (Lewin et al. 2016,
Trivedi et al. 2016). The Firmicutes on the other hand only make up a small portion of
soil microbiomes (around 2 %), while they can be found in abundance in manure or the
gastrointestinal track of animals and constitute a major part of the human gut microbiome
(Mao et al. 2015, Jandhyala et al. 2015, Trivedi et al. 2016, Rieke et al. 2018). It seems as
if both the Actinobacteria and the Firmicutes do not necessarily grow in the same niches,
but that they do co-exist in soil environments.
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Figure 1.3: Sunburst representation of PadR sequences on Pfam
(Pfam 2019). The sequences of PadR-like proteins in the Pfam database
grouped according to their phylogeny. As of June 2019 the tree comprised
19503 sequences across 4480 species, of which 4177 were Bacteria and
303 Archaea. Sequences from the Listeriaceae are highlighted red in the
upper left corner at around 11 o’clock. The red part on the right represents
archaeal protein sequences.
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1.3.2 PadR - the transcriptional regulator of phenolic acid decar-
boxylase
Initial research on PadR showed that it regulates the expression of the genes padA or
padC, encoding phenolic acid decarboxylases. These enzymes increase the tolerance of
bacteria to this class of compounds by degrading the toxic phenolic acids (Barthelmebs
et al. 2000a, Barthelmebs et al. 2000b, Tran et al. 2008). Under normal conditions PadR
binds to the padA promoter and prevents transcription of the gene (Gury et al. 2004). In
the presence of phenolic acids, like p-coumaric acid, the binding of PadR to its operator
does not occur (Gury et al. 2004). It thus seems that in response to phenolic acid stress,
decarboxylases that degrade the toxic compounds are specifically induced. The role of
the repressor PadR is to prevent the transcription of the decarboxylase genes when not
needed, while it is activated in the presence of inducing compounds.
The binding of B. subtilis PadR to the DNA is principally mediated by a winged helix-
turn-helix domain (Park et al. 2017). The beta-sheets of PadR also interact with the DNA,
but the interaction is mostly unspecific bonding to the phosphate backbone of the DNA
helix (Park et al. 2017). Binding of PadR to its operator prevents the transcription from
the padC promoter it controls (Nguyen et al. 2011). The operator sequence recognized
by PadR-like transcription factors is generally between 16 and 22 base pairs long and
consists of an inverted repeat and a variable spacer region (Gury et al. 2004, Agustian-
dari et al. 2008, Nguyen et al. 2011, Fibriansah et al. 2012). The ATGT/ACAT inverted
repeat has been suggested to be the canonical sequence for PadR-like repressors (Fibri-
ansah et al. 2012). The operator of B. subtilis consists of two similar sites one containing
the canonical ATGT-8N-ACAT repeat and overlapping the -10 promoter box, the other
with an imperfect repeat overlapping the transcription start site (Nguyen et al. 2011). In
B. cereus the protein bcPadR1 also recognizes a region overlapping the -10 box of the
promoter (Fibriansah et al. 2012). PadR-like repressors therefore seem to interfere with
transcription by blocking RNA polymerase from accessing the promoter region.
Transcription of PadR-controlled genes can be induced by addition of phenolic acids like
p-coumaric acid (Tran et al. 2008). This acid was crystallized in complex with PadR,
showing that a PadR monomer binds one molecule of the effector in a pocket between the
N-terminal and the C-terminal domains (Park et al. 2017). This binding seemed to be pre-
dominantly enthalpy-driven by mainly hydrophilic interactions. Upon effector binding,
conformational changes in the protein lead to a dissociation from the DNA. The mech-
anism of induction thus involves the thermodynamically favored binding of effector to
the protein, followed by structural re-arrangements that lead to the dissociation from the
DNA (Park et al. 2017). The promoter is then free to bind RNA polymerase and initiate
transcription of the phenolic acid decarboxylase.
Despite the diversity of PadR-like sequences, only a few proteins of the PadR family have
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been extensively studied. The biological functions assigned to proteins of this family
range from virulence gene control in Vibrio cholerae by AphA (Kovacikova et al. 2003),
over control of multi-drug-resistance pumps by LmrR in Lactococcus lactis (Agustiandari
et al. 2008), all the way to the regulation of circadian rhythms by Pex in Synechococcus
elongates (Takai et al. 2006). The next section will look at the PadR-like proteins that can
be found in L. monocytogenes.
1.4 PadR-like transcription factors in L. monocytogenes
According to the Pfam database, the genome of L. monocytogenes harbors five genes
belonging to the PadR family:
1. lmo0422 - renamed lstR (Zhang et al. 2005)
2. lmo0599 - renamed lltR (Hauf et al. 2019b)
3. lmo0719 - renamed lftR (Kaval et al. 2015)
4. lmo1213
5. lmo1408 - renamed ladR (Huillet et al. 2006)
The PadR-like protein Q734F6 from Bacillus cereus has been crystallized and its struc-
ture deduced from X-ray diffraction data (Fibriansah et al. 2012). Recently, the crystal
structure of LftR has also been determined (Lee et al. 2019). The overall structure of
LftR is nearly identical to Q734F6, so it seems likely that other PadR-like proteins have
a similar structural layout. Based on the crystallographic results, the secondary elements
of the other PadR-like proteins can be inferred. The N-terminal HTH domain involved
in DNA binding of transcription factors is followed by two beta-sheets and another helix
important for dimerization and substrate recognition (Fibriansah et al. 2012, Lee et al.
2019).
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Figure 1.4 shows a protein alignment of the five PadR-like proteins from Listeria mono-
cytogenes compared to PadR from B. subtilis and the PadR-like protein Q734F6 from B.
cereus with the secondary structural elements depicted at the bottom of the figure 1.4.
Amino acids strongly conserved among all the proteins (highlighted in black) can be
found in all of the helices and in the second beta-sheet. Such highly conserved amino
acids are likely to be important for the function of the proteins (Poteete et al. 1992). For
example the conserved Y–L–L (tyrosine–leucine–leucine) motive in the third helix (the
putative DNA binding helix of the HTH domain) could to be important for the interaction
with the DNA. Supporting this conjecture, it has been shown that the exchange of tyrosine
in the Y–L–L motif for an alanine or the deletion of the beta-wing (the two beta-sheets
shown in red in figure 1.4) abrogated DNA binding of LftR (Lee et al. 2019).
The C-terminal regions of the PadR-like proteins shown in figure 1.4 are either around 20
to 30 amino acids long or significantly longer (with over 100 amino acids). For example
B. subtilis PadR and LadR from L. monocytogenes have significantly longer C-terminal
domains than the other proteins placing them in the PadR subfamily I. All other PadR-like
proteins, representing the shorter sequences (lstR, lftR, lltR and lmo1213 in L. monocy-
togenes), belong to subfamily II. The next pages will briefly summarize the literature
knowledge about the PadR-like proteins of L. monocytogenes.
1.4.1 LadR regulates mdrL expression
Figure 1.5: Genomic context of L. monocytogenes ladR.
While screening a transposon library in L. monocytogenes LO28 a mutant that showed
altered hemolysis in the presence of cellobiose was identified (Huillet et al. 1999). Cel-
lobiose normally inhibits hemolysis by suppressing PrfA-mediated haemolysin A activa-
tion (Milenbachs et al. 2003). In the mutant, the transposon had inserted between the
genes lmo1408, called orfA, and lmo1409 (see figure 1.5). The lmo1409 gene shows sig-
nificant similarity to multidrug resistance transporters and was therefore re-named mdrL
(L for Listeria, Huillet et al. 1999). Lmo1408 (renamed LadR) was shown to repress
the transcription of mdrL under standard conditions (Huillet et al. 2006). Transcripts of
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the mdrL gene were detectable in the presence of the synthetic laser dye rhodamine 6G,
whereas no mdrL transcripts were observed in the absence of the inducer (Huillet et al.
2006). However, evidence for rhodamine 6G transport by MdrL is still outstanding.
The genes ladR and mdrL have been associated with resistance to disinfectants (Ro-
manova et al. 2006, Tamburro et al. 2015, Jiang et al. 2018). For example, mdrL is
over-expressed in L. monocytogenes exposed to sub-lethal benzalkonium concentrations
(Tamburro et al. 2015). MdrL was initially investigated as a potential exporter of benza-
lkonium (a disinfectant commonly used in the food industry), because it was one of two
described efflux pumps in L. monocytogenes at that time (Romanova et al. 2006). A di-
rect link between MdrL and benzalkonium resistance was also claimed (Jiang et al. 2018).
These authors could show an increased lag phase when mdrL was deleted, but the MIC
of benzalkonium was unaffected (Jiang et al. 2018). In another project, a transposon li-
brary was screened for mutants with an altered type I interferon response in macrophages
(Crimmins et al. 2008). This study found one mutant with a disrupted ladR gene. In this
ladR mutant the two genes mdrL and mdrM were induced 30-fold and 3-fold respectively
(Crimmins et al. 2008). They found a contribution of MdrM but not of MdrL to the inter-
feron response, so it seems likely that LadR exerts a weak repressive effect on mdrM that
caused this phenotype (Crimmins et al. 2008) while mdrL, the main target gene of LadR
repression, remains without a clearly defined function.
1.4.2 LstR - a lineage-specific thermal regulator
Figure 1.6: Genomic context of L. monocytogenes lstR.
A detailed examination of the genomes of the most common clinical serotypes of L. mono-
cytogenes led to the observation that strains belonging to lineage I lack an operon contain-
ing genes for the extra-cytoplasmic function sigma factor sigC (lmo0423), an unknown
gene coding for a protein of the PadR family (lmo0422, now called lstR), and a rodA/ftsW
paralog (lmo0421) (Zhang et al. 2003). At that time the operon was identified to be absent
in lineage I, the function of those genes (see figure 1.6) was completely unknown. Further
characterization of the operon led to the description of lstR (for lineage-specific thermal
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regulator) as being responsible for resistance to heat (Zhang et al. 2005). According to
these results, the sigma factor SigC is important for the temperature-dependent expres-
sion of the one operon and the RodA/FtsW paralog mediates the heat adaptive response
(Zhang et al. 2005). Other sigma factors of L. monocytogenes are the housekeeping sigma
factor SigA, SigB involved in the general stress response and virulence (Kazmierczak et
al. 2003), SigH involved in intracellular growth (Romeroa and Morikawa 2016) and SigL
involved in the response to various stressful conditions (Mattila et al. 2012).
Transcriptomic and proteomic studies of alternative sigma factors mutants of L. monocy-
togenes confirmed the auto-regulatory nature of this operon by proving the transcriptional
dependence of lmo0422/lmo0421 on SigC. No other genes were identified as being regu-
lated by SigC (Chaturongakul et al. 2011, Mujahid et al. 2013a). It has also been shown,
that stable L-forms of Listeria monocytogenes acquired a mutation in lmo0421 (Studer
et al. 2016). As L-form bacteria lack the cell wall, they are assumed to be stabilized by
mutations in cell wall synthesis genes. Therefore, the mutation of this RodA homolog
could be a hint that it indeed has a function in the synthesis of the cell wall like other
RodA proteins (Meeske et al. 2016, Emami et al. 2017).
1.4.3 LftR regulates the expression of the lieAB transporter genes
Figure 1.7: Genomic context of L. monocytogenes lftR.
LftR has been identified recently and named the listerial protein facilitating invasion and
transcriptional regulator (Kaval et al. 2015). It is encoded in a bicistronic operon to-
gether with lftS, a gene of unknown function (see figure 1.7). LftR negatively regulates
the expression of the operon lmo0979-lmo0980, coding for a putative ABC-type trans-
porter (Kaval et al. 2015). The tight regulation of the transporter is necessary for an
efficient invasion into HeLa cells (Kaval et al. 2015), again linking a transporter reg-
ulated by a protein of the PadR family to virulence as was the case for LadR and the
pump MdrL (Huillet et al. 2006). The exact role of the efflux pump did not become clear
though. The transporter genes lmo0979-0980 were renamed lieAB for listerial importer
of ethidium bromide as artificial substrate, because the pump imports ethidium bromide
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in an ATP-consuming manner (Kaval et al. 2015). The active import of a toxic substance
like ethidium bromide does not make any biological sense, though. Therefore, despite
these discoveries the biological function of the LieAB transporter and LftR still remained
hidden.
1.4.4 Lmo0599 and Lmo1213 - two uncharacterized PadR-like pro-
teins
Figure 1.8: Genomic context of L. monocytogenes lltR.
Beside the proteins described above, two uncharacterised PadR-like proteines are also en-
coded in the genome of L. monocytogenes. At the time of writing, no knowledge existed
about function of the two remaining PadR-like proteins Lmo0599 and Lmo1213. The
gene lmo0599 is located at the beginning of the three gene lmo0599-lmo0600-lmo0601
operon (see figure 1.8). Lmo0600 is a DUF1700 domain-containing potential transmem-
brane protein and Lmo0601 contains a DUF4097 domain showing some homology to
bacterial adhesins.
The gene lmo1213 encoding a putative PadR-like repressor forms a bicistronic operon
together with lmo1214 (see figure 1.9). The latter gene codes for a DUF2812 containing
protein without any known function.
Figure 1.9: Genomic context of L. monocytogenes lmo1213.
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1.5 Aims of this study
The genome of L. monocytogenes contains five genes that show significant homology to
the PadR family of transcriptional regulators. Three of these have been studied previously
(Zhang et al. 2005, Huillet et al. 2006, Kaval et al. 2015). Still, the biological role of these
proteins has not yet been clearly defined and knowledge about effector molecules exists
only for LadR (Huillet et al. 2006).
In general, PadR-like proteins seem to regulate gene expression in response to certain
environmental stimuli. In the course of this work, deletion mutants were constructed to
determine the regulon structure of the PadR-like proteins. Promoter-lacZ constructs are
made to screen for conditions or substances that induce the expression of the normally
repressed genes. Further, the interaction of LftR with promoters it controls was studied
to identify and validate the possible LftR-binding motif.
19

Chapter 2
Materials and Methods
2.1 Primers
During the course of this work a range of genetic manipulations were done. All oligonu-
cleotides used to generate the desired nucleic acid material are listed in the following
table (table 2.1). They were synthesized by Eurofins Genomics GmbH or Integrated
DNA Technologies, Inc. The lyophilized oligonucleotides were dissolved to 100 µM
in molecular biology grade water from Carl Roth GmbH + Co. KG.
Table 2.1: Primers used in this study.
Name Sequence Use
SaH032 CAGATCTATCGATGCATGCCATGGAGGAAAG
GAAGAGGAGAATTATG
lmo1408 deletion US FW
SaH033 AATTCAGAGGTGCTATTGTGTCGACAAAAAC
CGGCGAACTTAATATTCGC
lmo1408 deletion US RV
SaH034 ATTAAGTTCGCCGGTTTTTGTCGACACAATA
GCACCTCTGAATTTC
lmo1408 deletion DS FW
SaH035 CCTCGCGTCGGGCGATATCGGATCCGGCCGA
TATTTGAACAAATGG
lmo1408 deletion DS RV
SaH036 CTCGCGTCGGGCGATATCGGATCCCAGGGAG
ATAGCTACTAGGG
lmo0422 deletion DS FW
continues on next page
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SaH037 AGGAGGTTTAATCGTCGACATGAGTTCTTCT
ACATTTGAAG
lmo0422 deletion DS RV
SaH038 TGTAGAAGAACTCATGTCGACGATTAAACCT
CCTTTTTCATCTTATTC
lmo0422 deletion US FW
SaH039 CAGATCTATCGATGCATGCCATGGGTTAATC
ATGGTGGGCGTCG
lmo0422 deletion US RV
SaH052 GATCTATCGATGCATGCCATGGATGGAGGTT
AACCCGCAGTTC
lmo0599 in pMAD FW
SaH053 GCTTCTAGAATTCGAGCTCCCTTATTCATTT
ACTGCTTCCCCCTC
lmo0599 in pMAD RV
SaH058 CCGGTAGCAAGAGCAGCAGTAAAAGAAGA
GTACTGTTC
lmo0599: C145G,
T146C, T147A, A151G,
G152C, T145G, T155C
FW
SaH059 TTTTACTGCTGCTCTTGCTACCGGATAAATA
GCACCTTC
lmo0599: C145G,
T146C, T147A, A151G,
G152C, T145G, T155C
RV
SaH079 AGAACTAGTGGATCCCACGCTAATCTTGATG
AGAAATGCC
PlftR in pBP117 RV
SaH090 CGGGAAGCCCTGGGACG check insertion of pro-
moters in pBP117
SaH091 TGGCCTTCCTGTAGCCAGC check insertion of pro-
moters in pBP117
SaH099 GTTGTAAAACGACGGGGAATTCCATTTGAAT
ACAACCTTCTTTCC
PlieABin pBP117 RV
SaH109 CTAGAACTAGTGGATCCCGCATGTTCTTAGC
GACTGC
Plmo0422 in pBP117 FW
SaH110 GTAAAACGACGGGGAATTCCATTTAAGTTTC
ACCTTCTTCTGC
Plmo0422 in pBP117RV
SaH113 CTAGAACTAGTGGATCCCTATCTTGGGAATG
CTTATGAAC
Plmo1409 in pBP117 FW
SaH114 GTAAAACGACGGGGAATTCCATAATACAACT
ACACTTCCC
Plmo1409 in pBP117RV
SaH115 CTAGAACTAGTGGATCCCTCACGCATAAACT
TATCTCTCC
Plmo0599 in pBP117 FW
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SaH116 CGACGGGGAATTCCTGCAGCATGCTAACTCC
TCCATTCTG
Plmo0599 in pBP117RV
SaH170 CTAGAACTAGTGGATCCCTCAAACCGTCCGT
TCAG
PlieAB(193 bp) in pBP117
FW
SaH171 CTAGAACTAGTGGATCCCACAAAAGTCATTT
CAGATGA
PlieAB(152 bp) in pBP117
FW
SaH172 CTAGAACTAGTGGATCCCTGACTTTTTTATT
GACACATCC
PlieAB(122 bp) in pBP117
FW
SaH173 CTAGAACTAGTGGATCCCACTCGGTGTTACT
ATGTAG
PlieAB(97 bp) in pBP117
FW
SaH174 CTAGAACTAGTGGATCCCTGACTTTTTTATT
GACACTACCGCAACTCGGTGTTACTAT-
CAAGTAGTAATAAGTAATACAGAATACCG
PlieAB(122 bp): A-104T,
T-103A, G-82C, T-81A
FW
SaH175 CTATCGATGCATGCCATGGTCCATCTTCCTC
CTCCAG
lmo0422 in pMAD DS
FW
SaH176 GCACATGCAGCTGAAAACAAGAAAATCCTA
TC
lmo0422: T268G,
T269C, C274G, T275C,
C277G, T278C DS RV
SaH177 AGCTGCATGTGCCAGAATATAAAGCTGACC lmo0422: T268G,
T269C, C274G, T275C,
C277G, T278C US FW
SaH178 CTGCAGAAGCTTCTAGAATTCGACAGCGGA
AGATTTAACG
lmo0422 in pMAD US
RV
SaH179 CTATCGATGCATGCCATGGTGGCAAGGATGA
GGAGC
lmo0421 deletion DS FW
SaH180 CTTTATGAGTTAATTTAGTGTATAACCGACA
TG
lmo0421 deletion DS RV
SaH181 CACTAAATTAACTCATAAAGAAGCCTCCTC lmo0421 deletion US FW
SaH182 CGTGCTAGGTTTGAGAAG lmo0421 deletion US RV
SaH185 CCCATGGAAAAGGATCCATGGAGGTTAACC
CGCAGTTC
lmo0599 into pIMK3 FW
SaH186 CGAATTCCTGCAGCCCGGGTTATTCATTTAC
TGCTTCCCCCTC
lmo0599 into pIMK3 RV
SaH187 CTAGAACTAGTGGATCCCTTTTTTATTGACA
CATCCGCAACTCGGTGTTA CTATGTAGAT-
CATTTAAGTAATACAGAATACCGGTG
PlieAB(118 bp): T-78A,
A-77T, G-76C, T-75A,
A-74T, A-73T FW
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SaH188 GTAACACCGGTATTGACATAATGTTATTACT
ACTACATAGTAACACCG
PlieAB(122 bp) US RV:
bp-69...-61 GTAAT-
ACAG→ CATTATGTC
SaH189 CACTACTCAGTAAGTGGCCATAACTGTATTA
CTTATTACTACTACATAG
PlieAB(122 bp) US RV:
bp-60...-51 AATACCG-
GTG→ TTATGGCCAC
SaH190 ATTAAAACCCCACATGAGTCATTCACCGGTA
TTCTGTATTACTTATTAC
PlieAB(122 bp) US RV:
bp-50...-41 TTACT-
GAGTA → AATGACT-
CAT
SaH191 CTTCTTTCCATTTTTTATTTTTTGGGGTGTA
CTCAGTAACACCGGTATTC
PlieAB(122 bp) US
RV: bp-40...-31
GTGGGGTTTT →
CACCCCAAAA
SaH192 TACAACCTTCTTTCCTAAAAAATAAAAAACC
CCACTACTCAGTAACACC
PlieAB(122 bp) US
RV: bp-30...-21
AATAAAAAAT →
TTATTTTTTA
SaH208 CTTTAAGAAGGAGATATACATATGAAAGGAC
TTACCGAGTTACTC
lftR into pSH304 FW
SaH209 CGAACTGCGGGTGGCTCCATGGCGCTTGCC
CTCCTTTAAC
lftR into pSH304 RV
SaH210 CTTTAAGAAGGAGATATACATATGTTTAATT
GGTACAAAAAATACCG
lftS into pSH304 FW
SaH211 CGAACTGCGGGTGGCTCCATGGTTTAATCGA
ATCTCGCAATTTCTGACG
lftS into pSH304 RV
SaH212 CTATCGATGCATGCCATGGATGGAGGTTAAC
CCGCAGTTC
lmo0600 deletion US FW
SaH213 AGTGATGTTTATTCATTTACTGCTTCCCCCT lmo0600 deletion US RV
SaH214 TGAATAAACATCACTTAAGCAAAAAACT lmo0600 deletion DS FW
SaH215 CTGCAGAAGCTTCTAGAATTCTCATCTTCTT
CAGGCACCGT
lmo0600 deletion DS RV
SaH216 CTATCGATGCATGCCATGGTGACCTTGGTAA
GCCAGAAG
lmo0601 deletion US FW
SaH217 TTCGATTTTATGCATTTTTCCCGCCTCC lmo0601 deletion US RV
SaH218 TGCATAAAATCGAAAAATAAAAAATCAGTG
CGCT
lmo0601 deletion DS FW
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SaH219 CTGCAGAAGCTTCTAGAATTCAGCTCCGTGC
CAAGTCC
lmo0601 deletion DS RV
SaH227 CTGTATTTGTTATTACTACTACATAGTAACA
CC
PlieAB(122 bp): G-69C,
T-68A US RV
SaH228 GTAATAACAAATACAGAATACCGGTGT PlieAB(122 bp): G-69C,
T-68A DS FW
SaH229 TCTGTAAAACTTATTACTACTACATAGTAAC
ACC
PlieAB(122 bp): A-67T,
A-66T US RV
SaH230 TAATAAGTTTTACAGAATACCGGTGTTAC PlieAB(122 bp): A-67T,
A-66T DS FW
SaH231 GTATTCTGATTTACTTATTACTACTACATAG PlieAB(122 bp): T-65A,
A-64T US RV
SaH232 ATAAGTAAATCAGAATACCGGTGTTACTG PlieAB(122 bp): T-65A,
A-64T DS FW
SaH233 CGGTATTCACTATTACTTATTACTACTACAT
AG
PlieAB(122 bp): C-63G,
A-62T US RV
SaH234 AAGTAATAGTGAATACCGGTGTTACTGAG PlieAB(122 bp): C-63G,
A-62T DS FW
SaH235 ACCGGTATAGTGTATTACTTATTACTACTAC
A
PlieAB(122 bp): G-61C,
A-60T US RV
SaH236 GTAATACACTATACCGGTGTTACTGAGTAG PlieAB(122 bp): G-61C,
A-60T DS FW
SaH237 ACACCGGTTATCTGTATTACTTATTACTACT
AC
PlieAB(122 bp): A-59T, T-
58A US RV
SaH238 AATACAGATAACCGGTGTTACTGAGTAG PlieAB(122 bp): A-59T, T-
58A DS FW
SaH239 TAACACCGCAATTCTGTATTACTTATTACTA
C
PlieAB(122 bp): A-57T,
C-56G US RV
SaH240 TACAGAATTGCGGTGTTACTGAGTAGTGG PlieAB(122 bp): A-57T,
C-56G DS FW
SaH241 AGTAACACGCGTATTCTGTATTACTTATTAC
TAC
PlieAB(122 bp): C-55G,
G-54C US RV
SaH242 CAGAATACGCGTGTTACTGAGTAGTG PlieAB(122 bp): C-55G,
G-54C DS FW
SaH243 TCAGTAACTGCGGTATTCTGTATTACTTATT
ACTAC
PlieAB(122 bp): G-53C,
T-52A US RV
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SaH244 GAATACCGCAGTTACTGAGTAGTGGGGT PlieAB(122 bp): G-53C,
T-52A DS FW
SaH245 CAGTAAGACCGGTATTCTGTATTACTTATTA
C
PlieAB(122 bp): G-51C
US RV
SaH246 ACCGGTCTTACTGAGTAGTGGGGTTT PlieAB(122 bp): G-51C
DS FW
SaH253 CTATCGATGCATGCCATGGTCTCTGGCTTGT
TTTAACC
sigC deletion US FW
SaH254 TTAGGTACCGAATCGAACGACAGCGGAAG sigC deletion US RV
SaH255 TTCGGTACCTAAGAAAAAACTAGATGCAGT
AC
sigC deletion DS FW
SaH256 CTGCAGAAGCTTCTAGAATTCTGCAGAAGA
AGGTGAAAC
sigC deletion DS RV
SaH257 CTATCGATGCATGCCATGGTCGTGCTATGTT
TATTTGGGC
internal fragment for dis-
ruption of lmo1071 with
pMAD FW
SaH258 CTGCAGAAGCTTCTAGAATTCTTATTAACCC
ATACCAATCCCA
internal fragment for dis-
ruption of lmo1071 with
pMAD RV
SaH259 CTATCGATGCATGCCATGGTCTGCTTTCACC
CATTC
lmo2427-2428 deletion
US FW
SaH260 ATGGCCTCTTAAAATGAAAATACAGAAGTC lmo2427-2428 deletion
US RV
SaH261 CATTTTAAGAGGCCATTGTTTTCCGTC lmo2427-2428 deletion
DS FW
SaH262 CTGCAGAAGCTTCTAGAATTCTGATTTAGTG
GCGTATGG
lmo2427-2428 deletion
DS RV
SaH263 CTATCGATGCATGCCATGGTTATTACCCACC
GCTCCCAATC
internal fragment for dis-
ruption of lmo2688 with
pMAD FW
SaH264 CTGCAGAAGCTTCTAGAATTCACGAGTTATG
GTGTTGCTG
internal fragment for dis-
ruption of lmo2688 with
pMAD RV
SaH265 AAAGTAGGTTTGATGTCAACC PlftRS modification US
RV
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SaH266 CAAACCTACTTTCATATACTATATACTTGTA
CCTAGTAACAACTAGTAG
PlftRS: G-51C, T-50A, A-
49T, T-48A DS FW
SaH267 CAAACCTACTTTGTATTACTATTATGTTGTA
CCTAGTAACAACTAGTAG
PlftRS: A-41T, T-40A, A-
39T, C-38G DS FW
SaH268 CAAACCTACTTTGTATATGTATATACTTGTA
CCTAGTAACAACTAGTAG
PlftRS: T-47A, A-46T, C-
45G DS FW
SaH269 CTGCAGAAGCTTCTAGAATTCCCGGATTATT
TTATCGGTGTTC
internal fragment for dis-
ruption of lmo2687 with
pMAD FW
SaH270 CTATCGATGCATGCCATGGTTATTATCCCCG
AACCAACAGC
internal fragment for dis-
ruption of lmo2687 with
pMAD RV
SaH273 CTGTATATGTTATATGTACTACATAGTAACA
CCGAGTTGC
PlieAB(122 bp): G-76C,
T-75A, A-74T, G-69C, T-
68A, A-67T US RV
SaH274 GTAGTACATATAACATATACAGAATACCGGT
GTTACTG
PlieAB(122 bp): G-76C,
T-75A, A-74T, G-69C, T-
68A, A-67T DS FW
SaH276 CCGGTATTCTGTATTTGTTATTTGTACTACA
TAGTAACACC
PlieAB(122 bp): G-76C,
T-75A, G-69C, T-68A
US RV
SaH277 CCGGTATTCTGTATTTGTTAAAACTACTACA
TAGTAACACC
PlieAB(122 bp): A-74T,
A-73T, G-69C, T-68A
US RV
SaH278 CCGGTATTCTGTATTTGTATTTACTACTACA
TAGTAACACC
PlieAB(122 bp): T-72A,
A-71T, G-69C, T-68A
US RV
SaH279 CCGGTATTCTGTATTTGATATTACTACTACA
TAGTAACACC
PlieAB(122 bp): A-70T,
G-69C, T-68A US RV
SaH280 CAAATACAGAATACCGGTGT PlieAB(122 bp) modifica-
tion DS FW
SaH283 CTATCGATGCATGCCATGGGGTGCGGTCATA
TCTGGATG
lmo0420 deletion US FW
SaH284 CAAAATCTCGCTCTAATCATCTGTTTAAACT
CC
lmo0420 deletion US RV
SaH285 GATTAGAGCGAGATTTTGATCCGATCTTTGG
C
lmo0420 deletion DS FW
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SaH286 CTGCAGAAGCTTCTAGAATTCGGTTGGTTCG
GCAAGGG
lmo0420 deletion DS RV
SHW306 GAGTCAGTGAGCGAGGAAG binds p15A origin region
2.2 Plasmids
All plasmids used in this work can be found in the table below (table 2.2).
Table 2.2: Plasmids used in this study.
Name Genotype Construction
pBP117 lacZ neo (Hauf et al. 2019a)
pET11a bla PT 7 lacI Novagen
pIMK2 Phelp neo (Monk et al., 2008)
pIMK3 Phelp-lacO lacI neo (Monk et al., 2008)
pMAD bla erm bgaB (Arnaud et al., 2004)
pSAM1 bla erm ∆lmo1408 lmo1408 upstream
(SaH032, SaH033) and
downstream (SaH034,
SaH035) BamHI/NcoI in
pMAD
pSaH001 bla erm bgaB ∆lmo1408 BamHI/NcoI cut frag-
ment from pSAM1 into
pMAD
pSaH002 bla erm bgaB ∆lmo0422 lmo0422 upstream
(SaH036, SaH037) and
downstream (SaH038,
SaH039) BamHI/NcoI in
pMAD
pSaH003 bla erm bgaB ∆lmo0422 pSaH002 cut BamHI,
PCR purified and re-
ligated
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pSaH004 bla erm bgaB-lmo0599 lmo0599 (SaH052,
SaH053) EcoRI/NcoI
into pMAD
pSaH005 bla erm bgaB-lmo0599: C145G, T146C, T147A,
A151G, G152C, T145G, T155C
PCR around pSaH004
(SaH058, SaH059) and
DpnI digest
pSaH010 PlieAB(266 bp)-lacZ neo (Hauf et al. 2019a)
pSaH011 PlftRS(315 bp)-lacZ neo (Hauf et al. 2019a)
pSaH012 Plmo0423(370 bp)-lacZ neo 370 bp upstream of
lmo0423 (SaH109,
SaH110) BamHI/EcoRI
into pBP117
pSaH013 bla erm bgaB ∆sigB (lmo0895) (Hauf et al. 2019a)
pSaH014 Plmo1409(347 bp)-lacZ neo 347 bp upstream of
lmo1409 (SaH113,
SaH114) BamHI/EcoRI
into pBP117
pSaH015 Plmo0599(201 bp)-lacZ neo 201 bp upstream of
lmo0599 (SaH115,
SaH116) BamHI/EcoRI
into pBP117
pSaH018 PgpsB(237 bp)-lacZ neo (Hauf et al. 2019a)
pSaH019 PdivIVA(214 bp)-lacZ neo (Hauf et al. 2019a)
pSaH026 PlieAB(193 bp)-lacZ neo 193 bp upstream of
lieAB (SaH170, SaH099)
BamHI/EcoRI into
pBP117
pSaH027 PlieAB(152 bp)-lacZ neo 152 bp upstream of
lieAB (SaH171, SaH099)
BamHI/EcoRI into
pBP117
pSaH028 PlieAB(122 bp)-lacZ neo 122 bp upstream of
lieAB (SaH172, SaH099)
BamHI/EcoRI into
pBP117
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pSaH029 PlieAB(97 bp)-lacZ neo 97 bp upstream of lieAB
(SaH173, SaH099)
BamHI/EcoRI into
pBP117
pSaH030 PlieAB(122 bp): A-104T, T-103A, G-82C, T-81A-
lacZ neo
122 bp upstream of
lieAB (SaH174, SaH099)
BamHI/EcoRI into
pBP117
pSaH031 PlieAB(118 bp): T-78A, A-77T, G-76C, T-75A, A-
74T, A-73T-lacZ neo
118 bp upstream of
lieAB (SaH187, SaH099)
BamHI/EcoRI into
pBP117
pSaH032 bla erm bgaB ∆lmo0421 lmo0421 upstream
(SaH179, SaH180) and
downstream (SaH181,
SaH182) EcoRI/NcoI in
pMAD
pSaH033 bla erm bgaB-lmo0422: T268G, T269C, C274G,
T275C, C277G, T278C
upstream (SaH175,
SaH176) and down-
stream (SaH177,
SaH178) of lmo0422
DNA binding helix into
pMAD by OE-PCR
pSaH034 bla erm bgaB ∆lmo0421-lmo0422:T268G, T269C,
C274G, T275C, C277G, T278C
PCR around pSaH032
(SaH176, SaH177) and
DpnI digest
pSaH035 Phelp-lacO-lmo0599 lacI neo * BackBone SE-
QUENCE UNCERTAIN
lmo0599 (SaH185,
SaH186) into pIMK3 by
OE-PCR
pSaH036 bla erm bgaB-lftRS repair allel (Hauf et al. 2019a)
pSaH037 Phelp-lacO-lmo0599 lacI neo lmo0599 cut NcoI/SalI
from pSaH035 and lig-
ated into pSW25 cut
NcoI/SalI
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pSaH038 PlieAB(122 bp): bp-69...-61 GTAATACAG→CAT-
TATGTC -lacZ neo
PlieABupstream
(SHW306, SaH188) and
downstream (SaH091,
SaH195) fused by PCR
(SaH099, SaH172),
then BamHI/EcoRI into
pBP117
pSaH039 PlieAB(122 bp): bp-60...-51 AATACCGGTG →
TTATGGCCAC-lacZ neo
PlieABupstream
(SHW306, SaH189) and
downstream (SaH091,
SaH196) fused by PCR
(SaH099, SaH172),
then BamHI/EcoRI into
pBP117
pSaH040 PlieAB(122 bp): bp-50...-41 TTACTGAGTA →
AATGACTCAT -lacZ neo
PlieABupstream
(SHW306, SaH190) and
downstream (SaH091,
SaH197) fused by PCR
(SaH099, SaH172),
then BamHI/EcoRI into
pBP117
pSaH041 PlieAB(122 bp): bp-40...-31 GTGGGGTTTT →
CACCCCAAAA -lacZ neo
PlieABupstream
(SHW306, SaH191) and
downstream (SaH091,
SaH198) fused by PCR
(SaH099, SaH172),
then BamHI/EcoRI into
pBP117
pSaH042 PlieAB(122 bp): bp-30...-21 AATAAAAAAT →
TTATTTTTTA-lacZ neo
PlieABupstream
(SHW306, SaH192) and
downstream (SaH091,
SaH199) fused by PCR
(SaH099, SaH172),
then BamHI/EcoRI into
pBP117
pSaH043 bla PT 7 lacI lftR-strep lftR (SaH208, SaH209)
NdeI/SalI into pSH304
pSaH044 bla PT 7 lacI lftS-strep lftS (SaH210, SaH211)
NdeI/SalI into pSH304
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pSaH045 bla erm bgaB-lmo0599: C145G, T146C, T147A,
A151G, G152C, T145G, T155C ∆lmo0600
lmo0600 US (SaH212,
SaH213) and DS
(SaH214, SaH215) from
LMSH3 into pMAD by
OE-PCR
pSaH046 bla erm bgaB-lmo0599: C145G, T146C, T147A,
A151G, G152C, T145G, T155C ∆lmo0601
lmo0601 US (SaH216,
SaH217) and DS
(SaH218, SaH219) from
LMSH3 into pMAD by
OE-PCR
pSaH047 PlieAB(122 bp): G-69C, T-68A-lacZ neo PlieABUS (SHW306,
SaH227) and DS
(SaH091, SaH228) from
pSaH028 fused by PCR
(SHW306, SaH091),
then BamHI/EcoRI into
pBP117
pSaH048 PlieAB(122 bp): A-67T, A-66T-lacZ neo PlieABUS (SHW306,
SaH229) and DS
(SaH091, SaH230) from
pSaH028 fused by PCR
(SHW306, SaH091),
then BamHI/EcoRI into
pBP117
pSaH049 PlieAB(122 bp): T-65A, A-64T-lacZ neo PlieABUS (SHW306,
SaH231) and DS
(SaH091, SaH232) from
pSaH028 fused by PCR
(SHW306, SaH091),
then BamHI/EcoRI into
pBP117
pSaH050 PlieAB(122 bp): C-63G, A-62T-lacZ neo PlieABUS (SHW306,
SaH233) and DS
(SaH091, SaH234) from
pSaH028 fused by PCR
(SHW306, SaH091),
then BamHI/EcoRI into
pBP117
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pSaH051 PlieAB(122 bp): G-61C, A-60T-lacZ neo PlieABUS (SHW306,
SaH235) and DS
(SaH091, SaH236) from
pSaH028 fused by PCR
(SHW306, SaH091),
then BamHI/EcoRI into
pBP117
pSaH052 PlieAB(122 bp): A-59T, T-58A-lacZ neo PlieABUS (SHW306,
SaH237) and DS
(SaH091, SaH238) from
pSaH028 fused by PCR
(SHW306, SaH091),
then BamHI/EcoRI into
pBP117
pSaH053 PlieAB(122 bp): A-57T, C-56G-lacZ neo PlieABUS (SHW306,
SaH239) and DS
(SaH091, SaH240) from
pSaH028 fused by PCR
(SHW306, SaH091),
then BamHI/EcoRI into
pBP117
pSaH054 PlieAB(122 bp): C-55G, G-54C-lacZ neo PlieABUS (SHW306,
SaH241) and DS
(SaH091, SaH242) from
pSaH028 fused by PCR
(SHW306, SaH091),
then BamHI/EcoRI into
pBP117
pSaH055 PlieAB(122 bp): G-53C, T-52A-lacZ neo PlieABUS (SHW306,
SaH243) and DS
(SaH091, SaH244) from
pSaH028 fused by PCR
(SHW306, SaH091),
then BamHI/EcoRI into
pBP117
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pSaH056 PlieAB(122 bp): G-51C-lacZ neo PlieABUS (SHW306,
SaH245) and DS
(SaH091, SaH246) from
pSaH028 fused by PCR
(SHW306, SaH091),
then BamHI/EcoRI into
pBP117
pSaH062 bla erm bgaB ∆lmo2427-2428 lmo2427-2428 US
(SaH259, SaH260) and
DS (SaH261, SaH262)
into pMAD by OE-PCR
pSaH063 PlftRS(315 bp): G-51C, T-50A, A-49T, T-48A -lacZ
neo
PlftRS US (SaH079,
SaH265) and DS
(SaH108, SaH266)
fused by PCR (SaH079,
SaH108), then into
pBP117 by OE-PCR
pSaH064 PlftRS(315 bp): A-41T, T-40A, A-39T, C-38G-lacZ
neo
PlftRS (SaH079, SaH265)
and DS (SaH108,
SaH267) fused by PCR
(SaH079, SaH108), then
into pBP117 by OE-PCR
pSaH065 PlftRS(315 bp): T-47A, A-46T, C-45G-lacZ neo PlftRS (SaH079, SaH265)
and DS (SaH108,
SaH268) fused by PCR
(SaH079, SaH108), then
into pBP117 by OE-PCR
pSaH066 bla erm bgaB-lmo1071 bp:53-594-TAATAA lmo1071 fragment
(SaH257, SaH258) into
pMAD by OE-PCR
pSaH067 bla erm bgaB -lmo2687 bp:24-730-TAATAA lmo2687 fragment
(SaH269, SaH270) into
pMAD by OE-PCR
pSaH068 bla erm bgaB -lmo2688 bp:73-724-TAATAA lmo2688 fragment
(SaH263, SaH264) into
pMAD by OE-PCR
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pSaH069 bla erm bgaB-lmo0423: T117G, A121C, A122C sigC US (SaH253,
SaH254) and DS
(SaH255, SaH256) into
pMAD by OE-PCR
pSaH070 PlieAB(122 bp): G-76C, T-75A, A-74T, G-69C, T-
68A, A-67T-lacZ neo
PlieABUS (SaH172,
SaH273) and DS
(SaH099, SaH274) fused
by PCR (SaH172,
SaH099), then
BamHI/EcoRI into
pBP117
pSaH071 PlieAB(122 bp): G-76C, T-75A, G-69C, T-68A-
lacZ neo
PlieABUS (SaH172,
SaH276) and DS
(SaH099, SaH280) fused
by PCR (SaH172,
SaH099), then
BamHI/EcoRI into
pBP117
pSaH072 PlieAB(122 bp): A-74T, A-73T, G-69C, T-68A-lacZ
neo
PlieABUS (SaH172,
SaH277) and DS
(SaH099, SaH280) fused
by PCR (SaH172,
SaH099), then
BamHI/EcoRI into
pBP117
pSaH073 PlieAB(122 bp): T-72A, A-71T, G-69C, T-68A-lacZ
neo
PlieABUS (SaH172,
SaH278) and DS
(SaH099, SaH280) fused
by PCR (SaH172,
SaH099), then
BamHI/EcoRI into
pBP117
pSaH074 PlieAB(122 bp): A-70T, G-69C, T-68A-lacZ neo PlieABUS (SaH172,
SaH279 and DS
(SaH099, SaH280)
fused by PCR
(SaH172, SaH099),
then BamHI/EcoRI into
pBP117
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pSaH077 bla erm bgaB ∆lmo0420 lmo0420 upstream
(SaH283, SaH284) and
downstream (SaH285,
SaH286) into pMAD by
OE-PCR
pSaH078 PlieAB(120 bp): G-69C, T-68A, A-57T, C-56G-
lacZ neo
PlieABdownstream from
pSaH47 (SaH091,
SaH240) used as primer
with SHW306 to am-
plify modified operator
from pSaH047, then
BamHI/EcoRI into
pBP117
pSW25 Phelp-lacO-mreB lacI neo Sabrina Wamp (mreB
(SW53/SW54) cut
NcoI/SalI into pSH207
cut NotI/PstI)
pSH207 Phelp-lacO-spoIIIJ lacI neo BamHI/SalI spoIIIJ frag-
ment from pSH198 into
pIMK3
pSH198 Phel p-spoIIIJ neo Dr. Sven Halbedel
pSH304 bla PT 7 lacI-divIVA-strep Dr. Sven Halbedel
2.3 Bacterial strains
The standard host for cloning procedures like plasmid propagation and amplification was
Escherichia coli Top 10. All work with L. monocytogenes was done in the background of
strain EGD-e. Table 2.3 contains all other strains used.
Table 2.3: Bacterial strains used in this study.
Name Genotype Construction
LMKK26 ∆lftS (Kaval et al. 2015)
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LMKK31 ∆lftRS (Kaval et al. 2015)
LMKK42 ∆lftR rsbTC10T (Kaval et al. 2015)
LMS160 ∆lieAB (Kaval et al. 2015)
LMS168 ∆lftRS ∆lieAB (Kaval et al. 2015)
LMS169 ∆lftR ∆lieAB (Kaval et al. 2015)
LMSH001 ∆lmo1408 (ladR) pSaH001→ EGD-e
LMSH002 ∆lmo0422 (lstR) pSaH003→ EGD-e
LMSH003 lmo0599:L49A, R51A, L52A pSaH005→ EGD-e
LMSH005 attB::PlieAB(266 bp)-lacZ neo (Hauf et al. 2019a)
LMSH006 ∆lftR rsbTC10T attB::PlieAB(266 bp)-lacZ neo (Hauf et al. 2019a)
LMSH007 attB::Pl f tRS(315 bp)-lacZ neo (Hauf et al. 2019a)
LMSH008 ∆lftR rsbTC10T attB::Pl f tRS(315 bp)-lacZ neo (Hauf et al. 2019a)
LMSH009 ∆lmo0895 (sigB) (Hauf et al. 2019a)
LMSH010 attB::Plmo1409(347 bp)-lacZ neo pSaH014→ EGD-e
LMSH011 ∆lmo1408 (ladR) attB::Plmo1409(347 bp)-lacZ neo pSaH014→ LMSH001
LMSH012 attB::Plmo0423(315 bp)-lacZ neo pSaH012→ EGD-e
LMSH013 ∆lmo0422 (lstR) attB::Plmo0423(315 bp)-lacZ neo pSaH012→ LMSH002
LMSH014 attB::Plmo0599(201 bp)-lacZ neo pSaH015→ EGD-e
LMSH015 lmo0599:L49A, R51A, L52A attB::Plmo0599(201
bp)-lacZ neo
pSaH015→ LMSH003
LMSH016 attB::aphA3 int (Hauf et al. 2019a)
LMSH017 attB::PgpsB(237 bp)-lacZ neo (Hauf et al. 2019a)
LMSH018 attB::PdivIVA(214 bp)-lacZ neo (Hauf et al. 2019a)
LMSH024 ∆lmo0895 (sigB) attB::PlieAB(266 bp)-lacZ neo (Hauf et al. 2019a)
LMSH025 ∆lmo0895 (sigB) attB::Pl f tRS(315 bp)-lacZ neo (Hauf et al. 2019a)
LMSH026 ∆lftR (Hauf et al. 2019a)
LMSH027 ∆lftS attB::PlieAB(266 bp)-lacZ neo (Hauf et al. 2019a)
LMSH028 ∆lftS attB::Pl f tRS(315 bp)-lacZ neo pSaH011→ LMKK26
LMSH030 attB::PlieAB(193 bp)-lacZ neo pSaH026→ EGD-e
LMSH031 attB::PlieAB(152 bp)-lacZ neo pSaH027→ EGD-e
LMSH032 attB::PlieAB(122 bp)-lacZ neo pSaH028→ EGD-e
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LMSH033 attB::PlieAB(97 bp)-lacZ neo pSaH029→ EGD-e
LMSH034 ∆lftR attB::PlieAB(266 bp)-lacZ neo (Hauf et al. 2019a)
LMSH035 ∆lftR ∆lmo0979-0980 (Hauf et al. 2019a)
LMSH036 attB::PlieAB(122 bp):A-104T, T-103A, G-82C, T-
81A -lacZ neo
pSaH030→ EGD-e
LMSH037 ∆lftS attB::PlieAB(122 bp):A-104T,T-103A,G-
82C,T-81A -lacZ neo
pSaH030→ LMKK26
LMSH038 attB::PlieAB(118 bp):T-78A,A-77T,G-76C,T-
75A,A-74T,A-73T-lacZ neo
pSaH031→ EGD-e
LMSH039 lmo0422:T268G, T269C, C274G, T275C, C277G,
T278C
pSaH033→ EGD-e
LMSH040 ∆lmo0421, lmo0422:T268G, T269C, C274G,
T275C, C277G, T278C
pSaH034→ LMSH39
LMSH042 lmo0599:L49A, R51A, L52A attB::Phel p-lacO-
lmo0599 lacI neo
pSaH0037→ LMSH3
LMSH043 lftS revertant (Hauf et al. 2019a)
LMSH044 attB::PlieAB(122 bp):bp-69...-61 GTAATACAG→
CATTATGTC-lacZ neo
pSaH038→ EGD-e
LMSH045 attB::PlieAB(122 bp):bp-60...-51 AATACCGGTG
→ TTATGGCCAC-lacZ neo
pSaH039→ EGD-e
LMSH046 attB::PlieAB(122 bp):bp-50...-41 TTACTGAGTA
→ AATGACTCAT-lacZ neo
pSaH040→ EGD-e
LMSH047 attB::PlieAB(122 bp):bp-40...-31 GTGGGGTTTT
→ CACCCCAAAA-lacZ neo
pSaH041→ EGD-e
LMSH048 attB::PlieAB(122 bp):bp-30...-21 AATAAAAAAT
→ TTATTTTTTA-lacZ neo
pSaH042→ EGD-e
LMSH049 lftS revertant attB::PlieAB(266 bp)-lacZ neo (Hauf et al. 2019a)
LMSH050 lmo0599:L49A, R51A, L52A, ∆lmo0600 pSaH045→ LMSH3
LMSH051 lmo0599:L49A, R51A, L52A, ∆lmo0601 pSaH046→ LMSH3
LMSH052 attB::PlieAB(122 bp):G-69C, T-68A-lacZ neo pSaH047→ EGD-e
LMSH053 attB::PlieAB(122 bp):A-67T, A-66T-lacZ neo pSaH048→ EGD-e
LMSH054 attB::PlieAB(122 bp):T-65A, A-64T-lacZ neo pSaH049→ EGD-e
LMSH055 attB::PlieAB(122 bp):C-63G, A-62T-lacZ neo pSaH050→ EGD-e
LMSH056 attB::PlieAB(122 bp):G-61C, A-60T-lacZ neo pSaH051→ EGD-e
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LMSH057 attB::PlieAB(122 bp):A-59T, T-58A-lacZ neo pSaH052→ EGD-e
LMSH058 attB::PlieAB(122 bp):A-57T, C-56G-lacZ neo pSaH053→ EGD-e
LMSH059 attB::PlieAB(122 bp):C-55G, G-54C-lacZ neo pSaH054→ EGD-e
LMSH060 attB::PlieAB(122 bp):G-53C, T-52A-lacZ neo pSaH055→ EGD-e
LMSH061 attB::PlieAB(122 bp):G-51C-lacZ neo pSaH056→ EGD-e
LMSH063 lmo0422:T268G, T269C, C274G, T275C, C277G,
T278C attB::Plmo0423(315 bp)-lacZ neo
pSaH012→ LMSH39
LMSH064 ∆lftRS attB::PlieAB(266 bp)-lacZ neo (Hauf et al. 2019a)
LMSH065 ∆lieAB attB::PlieAB(266 bp)-lacZ neo (Hauf et al. 2019a)
LMSH066 ∆lftS ∆lieAB (Hauf et al. 2019a)
LMSH067 ∆lmo2427-2428 pSaH062→ EGD-e
LMSH068 ∆lmo2427-2428 lmo0422:T268G, T269C, C274G,
T275C, C277G, T278C
pSaH062→ LMSH39
LMSH069 attB::Pl f tRS(315 bp):G-51C, T-50A, A-49T, T-48A
-lacZ neo
pSaH063→ EGD-e
LMSH070 attB::Pl f tRS(315 bp):A-41T, T-40A, A-39T, C-
38G-lacZ neo
pSaH064→ EGD-e
LMSH071 attB::Pl f tRS(315 bp):T-47A, A-46T, C-45G-lacZ
neo
pSaH065→ EGD-e
LMSH072 lmo1071::pSaH066 pSaH066→ EGD-e
LMSH073 lmo2687::pSaH067 pSaH067→ EGD-e
LMSH074 lmo2688::pSaH068 pSaH068→ EGD-e
LMSH075 lmo0422:T268G, T269C, C274G, T275C, C277G,
T278C lmo1071::pSaH66
pSaH066→ LMSH39
LMSH076 lmo0422:T268G, T269C, C274G, T275C, C277G,
T278C lmo2687::pSaH067
pSaH067→ LMSH39
LMSH077 lmo0422:T268G, T269C, C274G, T275C, C277G,
T278C lmo2688::pSaH068
pSaH068→ LMSH39
LMSH078 ∆lmo2427-2428 lmo1071::pSaH066 pSaH066→ LMSH67
LMSH079 ∆lmo2427-2428 lmo2687::pSaH067 pSaH067→ LMSH67
LMSH080 ∆lmo2427-2428 lmo2688::pSaH068 pSaH068→ LMSH67
LMSH081 ∆lmo2427-2428 lmo0422:T268G, T269C, C274G,
T275C, C277G, T278C lmo1071::pSaH066
pSaH066→ LMSH68
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LMSH082 ∆lmo2427-2428 lmo0422:T268G, T269C, C274G,
T275C, C277G, T278C lmo2687::pSaH067
pSaH067→ LMSH68
LMSH083 ∆lmo2427-2428 lmo0422:T268G, T269C, C274G,
T275C, C277G, T278C lmo2688::pSaH068
pSaH068→ LMSH68
LMSH088 ∆lmo0421 pSaH032→ EGD-e
LMSH089 lmo0423:T117G, A121C, A122C pSaH069→ EGD-e
LMSH090 lmo0423:T117G, A121C, A122C
lmo0422:T268G, T269C, C274G, T275C,
C277G, T278C
pSaH069→ LMSH39
LMSH091 attB::PlieAB(120 bp):G-76C, T-75A, A-74T, G-
69C, T-68A, A-67T-lacZ neo
pSaH070→ EGD-e
LMSH092 attB::PlieAB(120 bp):G-76C, T-75A, G-69C, T-
68A-lacZ neo
pSaH071→ EGD-e
LMSH093 attB::PlieAB(120 bp):A-74T, A-73T, G-69C, T-
68A-lacZ neo
pSaH072→ EGD-e
LMSH094 attB::PlieAB(120 bp):T-72A, A-71T, G-69C, T-
68A-lacZ neo
pSaH073→ EGD-e
LMSH095 attB::PlieAB(120 bp):A-70T, G-69C, T-68A-lacZ
neo
pSaH074→ EGD-e
LMSH096 lmo0423:T117G, A121C, A122C
attB::Plmo0423(315 bp)-lacZ neo
pSaH012→ LMSH089
LMSH097 lmo0423:T117G, A121C, A122C
lmo0422:T268G, T269C, C274G, T275C,
C277G, T278C attB::Plmo0423(315 bp)-lacZ neo
pSaH012→ LMSH090
LMSH098 ∆lftR attB::PlieAB(122 bp)-lacZ neo pSaH028→ LMSH26
LMSH100 ∆lftR attB::Pl f tRS(315 bp)-lacZ neo pSaH011→ LMSH26
LMSH101 ∆lftR attB::PlieAB(122 bp) G-69C, T-68A-lacZ neo pSaH047→ LMSH26
LMSH102 ∆lftR attB::Pl f tRS(315 bp):A-41T, T-40A, A-39T,
C-38G-lacZ neo
pSaH064→ LMSH26
LMSH104 lmo0599:L49A, R51A, L52A A640221G, PlltR -35
box mutation
LMSH3 cold growth
suppressor
LMSH105 lmo0599:L49A, R51A, L52A A640869 deletion,
Lmo0600 frame shift
LMSH3 cold growth
suppressor
LMSH106 lmo0599:L49A, R51A, L52A A640758C,
Lmo0600 Q45P
LMSH3 cold growth
suppressor
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LMSH107 lmo0599:L49A, R51A, L52A A640221G, PlltR -35
box mutation
LMSH3 cold growth
suppressor
LMSH108 lmo0599:L49A, R51A, L52A A640869 deletion,
Lmo0600 frame shift
LMSH3 cold growth
suppressor
LMSH109 lmo0599:L49A, R51A, L52A G640611T,
Lmo0600 RBS mutation, LltR E104D
LMSH3 cold growth
suppressor
LMSH110 lmo0599:L49A, R51A, L52A, ∆lmo0601
C640782A, Lmo0600 P53Q
LMSH51 cold growth
suppressor
LMSH111 lmo0599:L49A, R51A, L52A, ∆lmo0601
C640871T, Lmo0600 Q83*
LMSH51 cold growth
suppressor
LMSH112 lmo0599:L49A, R51A, L52A, ∆lmo0601
C640757T, Lmo0600 Q45*
LMSH51 cold growth
suppressor
LMSH113 lmo0599:L49A, R51A, L52A, ∆lmo0601
G640346T, LltR C16F
LMSH51 cold growth
suppressor
LMSH114 lmo0599:L49A, R51A, L52A, ∆lmo0601 133 bp
insertion in lmo0600, Lmo0600 frame shift
LMSH51 cold growth
suppressor
LMSH115 lmo0599:L49A, R51A, L52A, ∆lmo0601
C640757T, Lmo0600 Q45*
LMSH51 cold growth
suppressor
LMSH116 lmo0599:L49A, R51A, L52A, ∆lmo0601 8 bp in-
sertion in lmo0600, Lmo0600 frame shift
LMSH51 cold growth
suppressor
LMSH117 lmo0599:L49A, R51A, L52A, ∆lmo0601
G640731A, Lmo0600 G36E
LMSH51 cold growth
suppressor
LMSH118 ∆lmo0420 pSaH077→ EGD-e
LMSH119 ∆lmo0420 ∆lmo2427-2428 pSaH062→ LMSH88
LMSH120 attB::PlieAB(120 bp):G-69C, T-68A, A-57T, C-
56G-lacZ neo
pSaH078→ EGD-e
LMSH121 G750063A, LftR G27S aurantimycin-resistant
suppressor
LMSH122 A750155 deletion, LftR frame shift aurantimycin-resistant
suppressor
LMSH123 G749972T, PlftR RBS mutation aurantimycin-resistant
suppressor
LMSH124 G750063A, LftR G27S aurantimycin-resistant
suppressor
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LMSH125 A750080 deletion, LftR frame shift aurantimycin-resistant
suppressor
LMSH126 A750155 deletion, LftR frame shift aurantimycin-resistant
suppressor
LMSH127 A750080 deletion, LftR frame shift aurantimycin-resistant
suppressor
LMSH128 G749973T, PlftR RBS mutation aurantimycin-resistant
suppressor
LMSH129 C750039T, LftR premature stop aurantimycin-resistant
suppressor
LMSH130 A750182 deletion, LftR frame shift aurantimycin-resistant
suppressor
LMSH131 A750155 deletion, LftR frame shift aurantimycin-resistant
suppressor
LMSH132 C750121T, LftR T46M aurantimycin-resistant
suppressor
LMSH133 C750062A, LftR premature stop aurantimycin-resistant
suppressor
LMSH134 A insertion after A750155, LftR frame shift aurantimycin-resistant
suppressor
LMSH135 A750080 deletion, LftR frame shift aurantimycin-resistant
suppressor
LMSH136 A749939G, PlftR -10 box mutation aurantimycin-resistant
suppressor
LMSH137 T750252 deletion, LftR frame shift aurantimycin-resistant
suppressor
LMSH138 A750155 deletion, LftR frame shift aurantimycin-resistant
suppressor
LMSH139 A750155 deletion, LftR frame shift aurantimycin-resistant
suppressor
LMSH140 A750155 deletion, LftR frame shift aurantimycin-resistant
suppressor
LMSH141 ∆lftS G750193A, LftR G70D LMKK26 aurantimycin
suppressor
LMSH142 ∆lftS C750141T, LftR R53C LMKK26 aurantimycin
suppressor
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LMSH143 ∆lftS C750141T, LftR R53C LMKK26 aurantimycin
suppressor
LMSH144 ∆lftS C750141T, LftR R53C LMKK26 aurantimycin
suppressor
LMSH145 ∆lftS C749998T, LftR T5I LMKK26 aurantimycin
suppressor
LMSH146 ∆lftS G750237T, LftR premature stop LMKK26 aurantimycin
suppressor
LMSH147 ∆lftS C750141T, LftR R53C LMKK26 aurantimycin
suppressor
LMSH148 ∆lftS C750141T, LftR R53C LMKK26 aurantimycin
suppressor
LMSH149 ∆lftS T750252 deletion, LftR frame shift LMKK26 aurantimycin
suppressor
LMSH150 ∆lftS G750253A, LftR premature stop LMKK26 aurantimycin
suppressor
LMSH151 ∆lftS G750165T, LftR premature stop LMKK26 aurantimycin
suppressor
LMSH152 ∆lftS T750252 deletion, LftR frame shift LMKK26 aurantimycin
suppressor
LMSH153 ∆lftS T750252 deletion, LftR frame shift LMKK26 aurantimycin
suppressor
LMSH154 ∆lftS G750237T, LftR premature stop LMKK26 aurantimycin
suppressor
LMSH155 ∆lftS C750141T, LftR R53C LMKK26 aurantimycin
suppressor
LMSH156 ∆lftS C750141T, LftR R53C LMKK26 aurantimycin
suppressor
LMSH157 ∆lftS T750252 deletion, LftR frame shift LMKK26 aurantimycin
suppressor
LMSH158 ∆lftS T750252 deletion, LftR frame shift LMKK26 aurantimycin
suppressor
LMSH159 ∆lftS C750141T, LftR R53C LMKK26 aurantimycin
suppressor
LMSH160 ∆lftS C750141T, LftR R53C LMKK26 aurantimycin
suppressor
continues on next page
43
LMSH162 ∆lftR attB::PlieAB(120 bp):G-69C, T-68A, A-57T,
C-56G-lacZ neo
pSaH078→ LMSH26
LMSH163 attB::PlieAB(122 bp):A-57T, C-56G-lacZ neo pSaH053→ LMSH26
2.4 DNA based work
Molecular cloning was done in silico with Geneious and Clone Manager software and
oligonucleotides were designed using these software products. Oligonucleotides were or-
dered from Eurofin Genomics GmbH or Integrated DNA Technologies Inc. in lyophilized
form and dissolved to 100 µM in molecular biology grade water from Carl Roth GmbH
+ Co. KG.
2.4.1 Preparation of genomic DNA
Genomic DNA to was extracted from overnight cultures. For use as a PCR template, 1 ml
of the culture was harvested by centrifugation in a 2 ml microcentrifuge tube and the cells
were resuspended in water. Around 300 mg glass beads (1 mm diameter) were then added
to the suspension and the samples lysed at 30 Hz for 5 minutes using the TissueLyser II
from QIAGEN. After lysis, the suspension was centrifuged at 13,000 x g for 2 minutes
and the supernatant used immediately as a PCR template.
When high quality DNA was needed, a chloroform-phenol extraction was performed. For
this purpose, 1 ml of an overnight culture was harvested, the cell pellet re-suspended in
400 µl of TES buffer before addition of lysozyme (10 mg/ml). The mixture was incu-
bated at 37C for 60 minutes to lyse the cells. Afterwards, 40 µl 20 % SDS and 400
µl phenol:chloroform:isoamyl alcohol mix (25:24:1) were added and mixed vigorously.
Centrifugation at 13,000 x g for 4 minutes separated phases and the upper phase was
transferred into a new 1.5 ml microcentrifuge tube. Another extraction with 500 µl chlo-
roform was performed before the DNA was precipitated from the aqueous phase by the
addition of 1 ml of 100 % ethanol. The DNA was pelleted by centrifugation, washed with
70 % ethanol, air-dried and re-suspended in 100 µl molecular biology grade water.
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2.4.2 PCR
Standard PCR
Standard PCR reactions for molecular cloning were done using Phusion®-High Fidelity
DNA Polymerase in HF Buffer. Colony and check PCR reactions used Taq Polymerase
in ThermoPol Buffer. Both enzymes were produced by New England Biolabs, Inc. De-
oxynucleotides were ordered as a premix of 10 mM dATP, dCTP, dGTP and dTTP from
Thermo Fisher Scientific. The annealing temperature was varied depending on primer
melting temperature, but was 58°C for most reactions. The make-up of the PCR reactions
and the standard PCR protocols for both polymerases can be found in table 2.4 and 2.5.
Table 2.4: Composition and PCR protocol for Taq PCR reactions.
Taq Polymerase PCR ThermoPol buffer 1 x
dNTPs 0.4 mM
Primer 0.4 µM
Taq polymerase 0.02 U/µl
Template less than 1 µg
Taq PCR Protocol
Initial denaturation 95°C 5 min
30 cycles of:
Denaturation 95°C 5 sec
Annealing 58°C 5 sec
Extension 68°C 30 sec/kb
Pause 16°C ∞
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Table 2.5: Composition and PCR protocol for Phusion PCR reactions.
Phusion polymerase PCR HF buffer 1 x
dNTPs 0.4 mM
Primer 0.4 µM
Phusion polymerase 0.02 U/µl
Template less than 1 µg
Phusion PCR protocol
Initial denaturation 95°C 5 min
30 cycles of:
Denaturation 95°C 5 sec
Annealing 58°C 5 sec
Extension 72°C 30 sec/kb
Final extension 72°C 1 min
Pause 16°C ∞
Overlap extension PCR - OE-PCR
To join two DNA fragments using PCR or to insert a fragment into a plasmid the primers
were designed in a way that an overlapping region between the two fragments or between
the fragment and the plasmid backbone had a melting temperature of around 45°C. Single
fragments to be joined were produced in a first round of PCR. The two fragments were
used as template in a second PCR using only the outer primers to join them together.
To insert a DNA fragment into a plasmid, the plasmid was cut near the intended site of
insertion using a restriction endonuclease. The plasmid and insert were then added as
template to a PCR reaction without primers. The standard protocol used to insert DNA
fragments into pMAD or pIMK derivatives can be found in table 2.6. 1 µl of DpnI was
added to a 30 µl PCR reaction after cycling and the mix was incubated at 37°C for at least
one hour. Afterwards the PCR mix (5 µl) was transformed into E. coli Top 10.
Table 2.6: PCR protocol for insertion of fragments into a plasmid.
PCR protocol
Initial denaturation 95°C 15 min
30 cycles of:
Denaturation 95°C 30 sec
Annealing 45°C 30 sec
Extension 72°C 14 min
Final extension 72°C 14 min
Pause 16°C ∞
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Colony PCR
Using a sterile toothpick, material from a single colony was transferred into a well of
an 8-well strip as well as onto a new agar plate. For L. monocytogenes, the 8-well strip
was closed and placed in a microwave for 2 minutes at 900 W. For E. coli the microwave
treatment was omitted. 20 µl PCR mix was then added and the PCR performed according
to the standard protocol after an incubation for 15 minutes at 95°C.
To confirm genome modifications in L. monocytogenes, an 0.5 ml aliquot from an over
night culture was pelleted in a 2 ml microcentrifuge tube and the supernatant was dis-
carded. Around 500 mg 0.1 mm diameter glass beads and 750 ml sterile water were
added. The samples were then placed in the Qiagen TissueLyser II and shaken for 5 min-
utes at 30 Hz. Afterwards samples were centrifuged for 2 minutes at 13,000 x g and 5 µl
of the supernatant was used as template for a standard PCR reaction of 25 µl total volume.
2.4.3 Agarose gel electrophoresis
To check the product purity and size of PCR reactions or of plasmid digests, samples
were loaded onto agarose gels containing 1 % agarose in 1x TAE buffer. Small gels (6
cm) were run at a constant voltage of 100 V and big gels (15 cm) at 150 V until a sufficient
separation of the DNA fragments was achieved. For size comparison the GeneRuler 1 kb
DNA Ladder from Thermo Fisher Scientific was used. After electrophoresis the DNA was
stained by incubating the gels in 400 ml TAE containing 4 drops of a 5 mg/ml ethidium
bromide solution for around 15 minutes. The stained DNA was visualized using a Gel
Doc™XR+ Gel Documentation System from Bio-Rad Laboratories Inc.
50x TAE buffer Tris 2 M
sterilized by filtration acetic acid 1 M
EDTA 50 mM
pH was adjusted to 8.3 with
acetic acid. For use, the buffer
was diluted to 1x.
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2.4.4 DNA purification
To purify the DNA produced after PCR or endonuclease digest, the NucleoSpin®Gel and
PCR Clean-up Kit from MACHEREY-NAGEL GmbH Co. KG was used. In most cases
Buffer NTI was diluted 1:1 with ddH2O in order to prevent purification of small fragments
like primers. Otherwise the manufactures protocol was followed. Elution was done with
about half the original samples volume of molecular biology grade water.
2.4.5 Plasmid purification
Plasmid harboring E. coli were grown over night in 4 ml LB containing the appropriate
antibiotic. Cells were harvested by centrifugation and the plasmid extracted with the QI-
Aprep Spin Miniprep Kit from QIAGEN GmbH following the manufacturer’s protocol.
Molecular biology grade water (100 µl) was used to elute the plasmid from the column.
2.4.6 Endonuclease digestion
To check plasmids for the presence of inserts of a defined size, to create compatible ends
for cloning, to linearize plasmids or to simply check for the presence of a restriction site,
DNA was cut with endonucleases. One volume of DNA was mixed with the appropri-
ate amount of enzyme and restriction buffer, as recommended by the enzyme manufac-
turer. The digest was incubated at the temperature recommended by the manufacturer
for one hour. After the digest, the fragments produced were visualized by agarose gel
electrophoresis or purified and used for cloning or PCR. All enzymes and buffers were
ordered from New England Biolabs, Inc.
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2.4.7 Ligation
Ligation of DNA fragments was done over night in 20 µl volume with T4 DNA Ligase
from New England Biolabs. The Ligation mix was prepared following the manufactures
protocol and placed in a lukewarm water bath. The water bath was covered with a lid and
placed at 6°C over night. The ligation mix (5 µl) was transformed into competent E. coli
the next day.
2.4.8 Sanger sequencing
Sanger sequencing was employed in order to confirm the DNA sequences of PCR prod-
ucts or plasmids. The composition of a sequencing reaction and the cycling conditions
used are listed in table 2.8 and table 2.9 respectively. The BigDye™reagents were ordered
from Thermo Fisher Scientific.
Table 2.8: Composition of a Sanger sequencing reaction. * The DNA
amount used was varied with size of the product to be sequenced.
Composition DNA* 1000 bp PCR product 20 ng
or plasmid 200 ng
Primer (10µM) 0.5 µl
BigDye 3.1 0.5 µl
5x ABI buffer 2 µl
water ad 10 µl
Table 2.9: PCR protocol for Sanger sequencing. * The annealing tem-
perature was varied according to primer melting temperature.
PCR protocol
Initial denaturation 96°C 2 min
25 cycles of:
Denaturation 96°C 10 sec
Annealing* 45-60°C 5 sec
Extension 60°C 4 min
Hold 4°C ∞
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2.5 RNA based work
2.5.1 Cultivation
For RNA extraction, over-night cultures were diluted to an OD600 of 0.05 and grown to
mid-exponential phase (3 hours) at 37°C using a shaking frequency of 250 rpm. This
pre-culture with all cells in the same growth stage was used to inoculate pre-warmed
medium (37°C) at an OD600 of 0.05. Once the culture reached an OD600 of 0.5 ± 0.05
a volume of 25 ml was mixed with 25 ml of ice-cold killing buffer and incubated on
ice for 5 min. Cells were harvested by centrifugation at 10,000 x g and 4°C for 5 min.
After re-suspension of the cell pellet in 1 ml killing buffer, the cells were transferred to a
microcentrifuge tube, spun down at 13,000 x g for 30 sec and stored at -80°C until RNA
extraction.
Killing Buffer Tris/HCl pH 7.5 20 mM
sterilized by filtration MgCl2 5 mM
NaN3 20 mM
2.5.2 RNA extraction
RNA isolation was performed using the phenol/chloroform protocol adapted from Vo¨lker
et al. 1994. Here, the cell pellet was re-suspended in 1 ml lysis buffer I and incubated
on ice for 5 min with 100 µg/ml lysozyme. Meanwhile, 300 µl lysis buffer III were
prepared and pre-heated to 95°C in a 2 ml microcentrifuge tube. The cell suspension
was centrifuged at 5000 x g and 4°C for 5 minutes. The pellet was re-suspended in lysis
buffer II. The suspension in buffer II was added to pre-heated buffer III and incubated at
95°C for exactly 5 min. After this incubation 600 µl phenol:chloroform:isoamylalcohol
mixture (25:24:1) was added and shaken at room temperature at 700 rpm for 5 min. The
mixture was centrifuged at 13,000 x g for 5 min to separate the phases and the upper
aqueous phase was transferred to a new 1.5 ml microcentrifuge tube containing 600 µl
phenol:chloroform:isoamylalcohol mixture. After repeating the phenol/chloroform ex-
traction once, the aqueous phase was transferred to a tube containing 600 µl chloro-
form:isoamylalcohol (25:1). After shaking vigorously, the mixture was centrifuged as
before and a second chloroform purification step was performed. The remaining upper
aqueous phase was then transferred to an RNase-free plastic tube. Nucleic acids were
precipitated over night at -20°C using 1.5 volumes of 100 % ethanol and 0.1 volumes of
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3 M sodium acetate (pH 5.2). After precipitation nucleic acids were pelleted by centrifu-
gation at 13,000 x g and 4°C for 15 minutes. The pellet was washed once with 500 µl 70
% ethanol. After washing and another round of centrifugation at 13,000 x g and 4°C for
15 minutes the supernatant was removed completely and the pellet was left to dry at room
temperature under a laminar flow hood. Dry pellets were dissolved in 100 µl RNAse-free
water and kept on ice or stored at -80°C.
Lysis Buffer I Sucrose 25 %
sterilized by filtration Tris/HCl pH 8.0 20 mM
NaN3 0.25 mM
Lysis Buffer II NaCl 200 mM
sterilized by filtration EDTA 3 mM
Lysis Buffer III NaCl 200 mM
sterilized by filtration EDTA 3 mM
SDS 1 %
2.5.3 RNA quantification
RNA concentration was measured using the Qubit RNA BR Assay Kit and the Qubit
Fluorometer from Thermo Fisher Scientific following the manufacturer’s instructions.
Shortly, the Qubit RNA BR Reagent was diluted 1:200 in Qubit RNA BR Buffer and 198
µl mixed with 2 µl RNA sample. For the standards 190 µl working solution and 10 µl
standard were used. After mixing the samples were incubated at room temperature for 2
minutes and then measured.
2.5.4 RNA gel electrophoresis
For RNA electrophoresis gels, 1.5 % agarose was dissolved in 1x MOPS buffer and 6 %
formaldehyde was added once the mix cooled to 60°C. RNA was thawed on ice and 4
µg of RNA were diluted in 10µl RNase-free water plus 10 µl RNA loading dye. The
mix was then incubated at 65°C for 10 minutes, before being cooled on ice for 5 minutes,
loaded onto the gel and run in 1x MOPS buffer at 120 V for 1.5 hours.
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10x MOPS Buffer MOPS 200 mM
sodium acetate 50 mM
EDTA 10 mM
RNA Loading Dye Formamide 65 %
Formaldehyde 12 %
10x MOPS 20 %
Sucrose 2 %
Bromophenol 0.2 %
Xylene cyanol 0.2 %
2.5.5 Northern blotting
RNA separated in a formaldehyde agarose gel was fragmented for 2 minutes using UV il-
lumination. The gel was then placed onto a positively charged nylon membrane and RNA
blotted onto the membrane using a vacuum blotter at 55 mbar. For the first 10 minutes
of blotting the gel was covered with RNA hydrolysis solution. The hydrolysis solution
was then replaced with 0.1 M Tris-HCl solution at pH 7.4 for 5 minutes to neutralize the
hydrolysis solution. The Tris solution was then removed and 20x SSPE was added for
blotting. Blotting was done for 2.5 hours while 20x SSPE buffer was replenished when
the amount on top of the gel markedly decreased. After blotting the membrane was air
dried and RNA cross-linked via UV illumination for 2 minutes. To visualize rRNA the
membrane was then stained with methylene blue solution for 5 minutes and de-stained
three times with sterile water for 3 minutes. The methylene blue stained rRNA served
as a loading control. Membranes were air-dried after de-staining and stored until mRNA
detection.
RNA Hydrolysis Solution NaOH 50 mM
NaCl 10 mM
20x SSPE NaCl 3 M
NaH2PO4 200 mM
EDTA 20 mM
Methylene Blue Solution methylene blue 100 mg
3M sodium acetate pH 5.2 13.2 ml
glacial acetic acid 2 ml
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2.5.6 Detection of specific mRNA transcripts
RNA probes
Specific RNA transcripts were detected using DIG-labelled, single stranded RNA probes
around 800 bp in length (or less for smaller target genes). For this purpose, an 800 bp
fragment of the gene to be detected was amplified with PCR. The primer annealing at the
3’ end of the gene also contained the T7 polymerase promoter. The PCR product was pu-
rified and the RNA probe complementary to the mRNA transcript that should be detected
was synthesized using the DIG Northern Starter Kit and T7 Polymerase form Roche Di-
agnostics GmbH. A 10-fold dilution series of the RNA probes (until 10−5) was spotted (1
µl) onto nylon membrane and immobilized by UV cross linking. The efficiency of probe
synthesis was evaluated following the detection procedure described in the DIG Northern
Starter Kit manual. Good quality probes gave a detectable signal even if diluted 100,000-
fold.
mRNA detection
Nylon membranes with cross-linked RNA were placed in a tight sealing tube and 1 ml
hybridization buffer was added per 5 cm2 of membrane. The membrane was rotating
continuously during pre-hybridized at 68°C for one hour. 15 µl of the DIG labelled RNA
probes were added to 5 ml hybridization buffer and the mix was incubated at 95°C for
10 minutes, cooled on ice for 2 minutes and then stored at room temperature until use.
The pre-hybridization solution was discarded and the RNA probes were added to the
membrane while taking care that the membrane did not fall dry. Hybridization with RNA
probe was performed at 68°C over night with continuous rotation. On the next day, RNA
probes were collected and frozen at -20°C for re-use. The membrane was washed twice
at room temperature (5 minutes) with 1 ml 2x SSC + 0.1 % SDS per 2 cm2 of membrane.
Two more washes were performed at 68°C with 0.2x SSC + 0.1 % SDS. Afterwards, the
detection of the RNA probe bound to the blot followed the detection procedure outlines
in the DIG Northern Starter Kit manual.
20x SSC NaCl 3 M
pH 7 NaCitrate 0.3 M
Hybridization Buffer SSC 5 x
N-Lauroylsarcosin-Na 0.1 %
SDS 7 %
Blocking Solution 1 %
Formamide 50 %
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2.5.7 RNA sequencing
RNA quality control
The RNA extracted was confirmed to be of high quality and not degraded before preparing
sequencing libraries. To this end, a quality check on the Agilent 2100 Bioanalyzer System
using the RNA 6000 Nano Kit following the manufacturer’s instructions was performed.
Shortly, fresh RNA 6000 Nano gel matrix was prepared (stable for about one month) and
9 µl thereof were dispensed into the matrix well. The matrix was pushed into the chip
by applying pressure using the syringe with the plunger placed at 1 cm. The 9 µl matrix
was also added to the two wells at the top right. Afterwards, 5 µl marker were added to
all remaining wells, followed by 1 µl of the ladder or RNA sample. After mixing on the
IKA vortexer for 1 minute, samples were immediately run on the Bioanalyzer. Only RNA
with intact rRNA peaks was used for DNA digestion and rRNA removal.
DNA digest
Contaminating DNA was removed from RNA samples using the RNAse-Free DNase Set
from Qiagen starting with 10 µg of total RNA calculated according to Qubit measurement
results. The necessary amount of RNA sample was brought to a final volume of 87.5 µl
using RNase-free water. Then, 10 µl Buffer RDD and 2.5 µl DNase I were added. After
mixing the samples were incubated at room temperature for 10 minutes. After the DNA
digest, the absence of residual DNA was tested by the amplification of a fragment of L.
monocytogenes genomic DNA in 30 PCR cycles. The PCR reaction was separated on
an agarose gel and PCR products visualized using ethidium bromide staining. Samples
yielding a detectable PCR product indicating residual DNA were discarded.
Purification and removal of small RNAs
RNA was then purified using RNA Clean & Concentrator-5 from Zymo Research. Here,
only large RNAs >200 nt were purified as specified in the manufacturer’s protocol.
Shortly, RNA Binding Buffer was diluted with pure ethanol to a final concentration of
50 %. 200 µl of the resulting buffer was added to the DNase digest and transferred to
a spin column. After centrifugation at 10,000 x g for 30 seconds, 400 µl of RNA Prep
Buffer were added, centrifuged as before and the flow through was discarded. The col-
umn was washed twice with RNA Wash Buffer (first 700 µl, then 400 µl). Once the final
wash buffer had been discarded, the columns were dried by centrifugation at 10,000 x
g for 2 minutes. RNA was eluted with 15 µl RNase-free water. After DNA digest and
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purification, quality and quantity of the RNA were again determined, before proceeding
to the removal of the rRNA.
rRNA removal
rRNA was removed using the Ribo-Zero®rRNA Removal Kit from Illumina using ap-
proximately 3 µg of purified RNA as the input. First, the magnetic beads were washed by
adding 225 µl bead solution to a plastic tube, placing it on the magnetic stand for 2 min-
utes, discarding the supernatant, re-suspending the beads in 225 µl RNase-free water and
then repeating the washing procedure once more. After the second wash, the beads were
re-suspended in 65 µl Magnetic Bead Resuspension Solution, adding 1 µl RiboGuard
RNase Inhibitor. RNA sample was then mixed with 4 µl Ribo-Zero Reaction Buffer and
as much RNase-free water as necessary to get a final volume of 30 µl. To the 30 µl,
10 µl Ribo-Zero Removal Solution was added and the samples incubated for 10 minutes
at 68°C followed by 5 minutes at room temperature. The 40 µl RNA sample were then
added to the 65 µl magnetic beads prepared before and mixed immediately. After all
samples were incubated for at least 5 minutes at room temperature, they were placed at
50°C for 10 minutes. Then, they were put on the magnetic stand for 1 minute and 85
µl of the supernatant transferred to an RNase-free plastic tube. The remaining RNA was
precipitated by adding 95 µl RNase-free water, 18 µl 3 M sodium acetate, 2 µl 10 mg/ml
glycogen stock, 600 µl pure ethanol and incubating over night at -20°C. On the next day,
samples were centrifuged at 10,000 x g and 4°C for at least 30 minutes and washed twice
with freshly prepared 70 % ethanol. Each wash was followed by a 5 minute centrifugation
at 10,000 x g and 4°C. After the ethanol had been removed, the samples were completely
dried under a laminar flow hood.
Library preparation
For Illumina library preparation the TruSeq®Stranded mRNA Kit was used. The protocol
(TruSeq®) started with the addition of 19.5 µl Fragment Prime Finish Mix to the RNA
pellet obtained after rRNA removal and precipitation (see above). The samples were then
transferred to PCR tubes and incubated at 98°C for 8 minutes, before being cooled to 4°C.
A 17 µl aliquot of the sample was transferred to a new PCR tube. First Strand Synthesis
Act D mix was prepared by adding 1 µl Superscript II to 9 µl First Strand Synthesis Act
D stock. An 8 µl aliquot of the First Strand Synthesis Act D mix was added to the 17
µl RNA sample. The first strand was synthesized by incubation at 25°C for 10 minutes
followed by 42°C for 15 minutes, 70°C for 15 minutes and 4°C hold. The second strand
was synthesized by first adding 5 µl Resuspension Buffer to each sample and then adding
20 µl Second Strand Marking Mix. The mixture was incubated at 16°C for 1 hour. A 50
µl aliquot of the transcribed DNA was added to a new plastic tube and purified by adding
90 µl AMPure XP beads. The mix was incubated for 15 minutes at room temperature and
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then placed on a magnetic stand for 5 minutes. Of the supernatant 135 µl was removed
and 200 µl 80 % ethanol added. Following a 30 second incubation, all supernatant was
removed and 80 % ethanol added again. Once the last ethanol had been removed, the
samples were left to dry (until cracks in the pellet appeared). To dissolve the DNA,
17.5 µl Resuspension Buffer was added. The beads were re-suspended and then pelleted
again on the magnetic stand. Of the supernatant 15 µl were transferred to a new PCR
tube. Then, 2.5 µl Resuspension Buffer and 12.5 µl A-Tailing Mix were added. The
samples were then incubated at 37°C for 30 minutes, followed by 70°C for 5 minutes
and 4°C on hold. Afterwards, 2.5 µl Resuspension Buffer, 2.5 µl Ligation Mix and 2.5
µl of the desired adapter were added. The mix was incubated for 10 minutes at 30°C,
before 5 µl Stop Ligation Buffer were added. Now, the samples were purified two times
using AMPure XP beads again. To the 42.5 µl sample 42 µl AMPure XP beads were
added. The mix was incubated for 15 minutes at room temperature and then placed on a
magnetic stand for 5 minutes. Of the supernatant 79.5 µl was removed and 200 µl 80 %
ethanol added. Following a 30 second incubation, all supernatant was removed and 80 %
ethanol added again. Once the last ethanol had been removed, the samples were left to dry
(until cracks in the pellet appeared). To dissolve the library fragments, the beads were re-
suspended in 52.5 µl Resuspension Buffer and then pelleted again on the magnetic stand.
Of the supernatant, 50 µl was transferred to a new plastic tube and 50 µl AMPure XP
beads added again. The mix was incubated for 15 minutes at room temperature and then
placed on a magnetic stand for 5 minutes. Of the supernatant 95 µl was removed and 200
µl 80 % ethanol added. Following a 30 second incubation, all supernatant was removed
and 80 % ethanol added again. Once the last ethanol had been removed, the samples
were left to dry (until cracks in the pellet appeared). To dissolve the library fragments,
the beads were re-suspended in 22.5 µl Resuspension Buffer and then pelleted again on
the magnetic stand. Of the supernatant, 20 µl was amplified by PCR. For this purpose,
5 µl Primer Cocktail and 25 µl PCR Master Mix were added to the 20 µl samples. A
PCR for 12 to 15 cycles, depending on initial RNA input, was sufficient to have a good
concentration of the final library.
Table 2.15: PCR protocol for the library amplification PCR.
PCR Protocol
Initial denaturation 98°C 30 sec
12-15 cycles of:
Denaturation 98°C 10 sec
Annealing 60°C 30 sec
extension 72°C 30 sec
Final extension 72°C 5 min
Pause 4°C ∞
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After the PCR, the library was purified using 50 µl AMPure XP beads. After incubation
for 15 minutes at room temperature, the mix was placed on a magnetic stand for 5 minutes.
Of the supernatant 95 µl was removed and 200 µl 80 % ethanol added. Following a 30
second incubation, all supernatant was removed and 80 % ethanol added again. Once
the last ethanol had been removed, the samples were left to dry (until cracks in the pellet
appeared). To dissolve the library fragments, the beads were re-suspended in 32.5 µl
Resuspension Buffer and then pelleted again on the magnetic stand. Of the supernatant,
30 µl was transferred to a new plastic tube and stored at -20°C until further analysis.
Library quality control
The quality of the produced DNA libraries was assessed using the Agilent 2100 Bioan-
alyzer System with the DNA 120000 Kit. After preparation of the chip according to the
manufacturer’s instruction 1 µl of the library was loaded and analysed. The presence of
the typical library peak with a size of approximately 300 base pairs indicated a good qual-
ity library. The library concentration was determined using the Qubit dsDNA HS Assay.
Here, the Qubit dsDNA HS Reagent was diluted 1:200 in Qubit dsDNA HS Buffer. Of the
working solution 190 µl were transferred to plastic tubes and 10 µl standard or sample
added. After mixing, the samples were incubated at room temperature for 2 minutes and
then measured. Common library yields were around 200 nM.
Sequencing
Sequencing of the libraries was performed on the Illumina Miseq in paired-end mode (2
times 76 bp) with v3 chemistry. The pooling of 4-5 samples per run gave a sufficient cov-
erage to estimate differential expression. Pooling was performed according to Illuminas
“TruSeq Library Prep Pooling Guide”.
Transcriptomic analysis
The quality of the sequencing data was assessed using fastqc and quantification of mRNA
transcripts against the L. monocytogenes EGD-e cDNA (EMBL-EBI 2018) downloaded
via the ensemblgenomes ftp server (Kersey et al. 2018) and was done using the Salmon0.8.2
software (Patro et al. 2017). The differential expression ratio was determined as the ra-
tion of average expression from three biological replicates in the mutant compared to
the wild type. Transcript counts from three biological replicates were Log2-transformed
(to normalize for strongly deviating expression across the replicates) and used to calcu-
late P values using Students t-test. The following criteria were used to select genes with
significant differential expression:
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• an expression level of at least 10 TPM
• a P value less than 0.01
• an absolute differential expression factor of more than 2
2.6 Protein based work
2.6.1 Protein over-expression and purification
Proteins were overproduced in E. coli BL21 cells carrying a plasmid with an IPTG in-
ducible version of the protein of interest linked to a Strep-Tag®. The required antibiotic
was always added to the cultures to prevent loss of the plasmid. An over night culture was
used to inoculate 500 ml medium at an OD600 of 0.05. After reaching an OD600 of 0.5 at
37°C, protein expression was induced by addition of 1 mM IPTG. 2 hours after induction,
the culture was harvested by centrifugation and the cells were re-suspended in ZAP buffer
(12 ml) containing 1 mM PMSF. Cells were sonified at 40 % power output on ice (three
times 30 seconds). Afterwards the cell suspension was passed three times through the
EmulsiFlex C3 from Avestin Europe GmbH. Cell debris was removed by centrifugation
for 30 minutes at 10,000 g.
The strep-tag®containing protein was then purified from the lysate using 1 ml strep-
tactin®superflow from IBA GmbH in chromatography columns from Bio-Rad Laborato-
ries GmbH. Strep-tactin®was added to the columns and equilibrated with 2 ml Buffer W.
Afterwards, the cell lysate was added to bind the tagged protein. Unbound proteins were
removed by washing 5 times with Buffer W. The specifically bound protein was eluted in
6 fractions with 0.5 ml Buffer E and stored at -20°C.
ZAP Buffer Tris-HCl pH7.5 50 mM
NaCl 200 mM
EDTA 20 mM
Buffer W Tris-HCl pH8.0 100 mM
NaCl 150 mM
EDTA 1 mM
Buffer E Tris-HCl pH8.0 100 mM
NaCl 150 mM
Desthiobiotin 2.5 mM
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2.6.2 Isolation of cellular proteins
20 ml medium were inoculated at an OD600 of 0.05 with cells from an over night cul-
ture. They were grown until the desired growth phase was reached. Cells were usually
harvested (centrifugation at 6,000 g, 4°C, 10 minutes) in late exponential phase around
an OD600 of 1. The cell pellet was washed once in ZAP buffer and re-suspended in 1 ml
ZAP supplemented with 1 mM PMSF to inhibit protein degradation by proteases. The
cell suspension was then transferred to a 15 ml tube and sonicated on ice for 10 minutes at
40 % power output. The lysate was transferred into a microcentrifuge tube and cell debris
was removed by centrifugation at 13,000 x g for one minute at 4°C. The supernatant was
transferred into a new microcentrifuge tube and the centrifugation repeated. The solution
obtained after this second centrifugation was considered to be the total cellular protein
extract.
2.6.3 Quantification of protein concentrations
To determine the protein concentration of solutions, Roti®-Nanoquant solution by Carl
Roth GmbH + Co. KG was used following the manufacturer’s instructions.
2.6.4 ONPG β -galactosidase assay
To quantify β -galactosidase activity in L. monocytogenes, the respective strains were
grown over night and then re-inoculated at on OD600 of 0.05 into 5 ml fresh BHI broth
containing inducer substances where applicable. The culture was incubated at 37°C
(250rpm) for around 3 hours or until reaching an OD600 of 0.5 ± 0.1. Cells were har-
vested by centrifugation at 6500 x g for 5 minutes, re-suspended in 600 µl ddH2O and
transferred to a 2 ml micro centrifuge tube. Cells were pelleted at 13000 x g speed for 30
seconds and re-suspended in 1200 µl Z-Buffer. Afterwards, the samples were lysed by
sonification at 40 % power output for 10 minutes. Debris was removed from the lysates
by centrifugation at 13000 x g for 2 min. The protein concentration was then determined
using 50 µl sample aliquots and 950 µl Roti®-Nanoquant working solution. Otherwise
the manufacturer’s instructions were followed. 1000 µl of Z-Buffer and of the samples
(diluted where necessary due to high β -galactosidase activity) were transferred to a new
2 ml micro centrifuge tube and incubated at 30°C for 10 min. 200 µl of a 4 mg/ml ONPG
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solution (dissolved in Z-Buffer without 2-mercaptoethanol) were then added to all sam-
ples and a timer started. Once the first sample turned distinctly yellow, the reaction was
stopped by addition of 500 µl 1M NaCO3, the time noted and the sample OD600 at 420
nm measured against the Z-Buffer blank. β -galactosidase activity in Miller Units (MU)
was calculated according to equation 2.1.
5x Z-Buffer Na2HPO4 60 mM
NaH2PO4 40 mM
KCl 10 mM
MgSO4 1 mM
The pH was adjusted to 7 with NaOH (10 M) and the buffer sterilized by autoclaving.
Before use, it was diluted to 1x and 0.15 % (v/v) 2-mercaptoethanol were added.
1MU = 1000∗ OD420
t ∗ cprotein (2.1)
t = time in [minutes]
cprotein = Protein concentration [µg/µl]
2.7 Microbiology
2.7.1 Cultivation
Bacteria were grown on agar plates and stored at 6°C for up to one month. For longer
periods, bacteria were stored at -80°C in 25% glycerol. Standard cultivation of all bac-
terial strains was done at 37°C and 250 rpm for liquid cultures. As a standard measure
of growth, the optical density (OD) of liquid cultures at 600 nm was measured using a
Beckman Coulter DU 720 Spectrophotometer.
Media and antibiotics
E. coli was cultivated on LB medium or agar (1.5 % agar) using ampicillin (100 µg/ml)
or kanamycin (50 µg/ml) to select clones carrying resistance genes.
L. monocytogeneswas cultivated in BHI medium or agar (1.5 % agar) using erythromycin
(5 µg/ml) or kanamycin (50 µg/ml) to select clones carrying resistance genes.
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X-Gal was added to the medium at 100 µg/ml to monitor for β -galactosidase activity.
IPTG was used at a final concentration of 1 mM to induce expression from the lac opera-
tor.
2.7.2 Genetic engineering
Manipulation of E. coli
To prepare chemically competent E. coli cells, an over night culture was diluted 1:100 in
40 ml fresh medium and grown for 3 hours at 37°C with shaking at 250 rpm. Cells were
then collected by centrifugation (5,000 x g for 10 minutes at 4°C), re-suspended in 12.5
ml ice-cold 0.1 M CaCl2 and incubated on ice for at least 30 minutes. The cells were
then pelleted at 5,000 x g for 5 minutes at 4°C and re-suspended in 1 ml 0.1 M CaCl2.
Glycerol was added to a final concentration of 8 % and aliquots were stored at - 80°C
until use.
Chemically competent cells were thawed on ice and 100 µl of this cell suspension were
added to a microcentrifuge tube containing DNA to be transformed (e.g. one µl plasmid
DNA or 5 µl PCR reaction or ligation). Cells and DNA were mixed by flicking the tube
and then incubated on ice for at least 30 minutes. The cells were then heat shocked for
one minute at 42°C in a water bath and immediately afterwards placed on ice again for at
least 3 minutes. Room temperature LB was added to the cells after the incubation on ice
and the tubes were placed at 37°C with shaking at 250 rpm. After one hour at 37°C, the
cells were pelleted at 13,000 x g for 1 minute and plated on LB containing the necessary
antibiotic(s) and X-Gal when needed.
Manipulation of L. monocytogenes
In order to prepare L. monocytogenes for electroporation, an over night culture was di-
luted 1:50 in 40 ml BHI and grown for 3 hours at 37°C with shaking at 250 rpm. Then,
ampicillin was added at a final concentration of 100 µg/ml and the cells were incubated
for another 2 hours at 37°C with shaking at 250 rpm. Cells were harvested by centrifuga-
tion at 6,500 x g for 5 minutes and washed twice in 15 ml SGWB. After the last wash step,
the cells were re-suspended in 10 ml SGWB and lysozyme was added (final concentration
of 10 µg/ml). The cells were incubated for 20 to 30 minutes at 37°C with shaking at 250
rpm and then pelleted a last time (at 5,000 x g for 10 minutes) before being re-suspended
in 1 ml SGWB and stored at -80°C until use.
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SGWB Glycerol 50 %
sterilized by filtration Sucrose 500 mM
pH was adjusted to 7 with 100 m M NaOH.
80 µl electrocompetent L. monocytogenes suspension was added to a microcentrifuge
tube containing approximately 1 µg precipitated plasmid DNA and mixed shortly by
pipetting. 75 µl of the cells were then transferred to a 2 mm electroporation cuvette and
pulsed at 25 µF, 200 Ω and 2,400 V. Afterwards, 1 ml of room temperature BHI was
added and the cells incubated for 1 hour at 37°C for pIMK derivatives or for 1.5 hours
at 30°C for pMAD derivatives before being plated on BHI agar containing the necessary
antibiotics and X-Gal or IPTG when necessary.
To modify genome sections in L. monocytogenes the vector pMAD was used (Arnaud
et al. 2004). After transformation with a vector carrying a 300 to 800 bp sized region of
homology to the genome of L. monocytogenes, transformants were grown at 30°C for 3
days on plates containing erythromycin and X-Gal. Single colonies were then streaked
onto new erythromycin, X-Gal plates and incubated at 42°C for two days to integrate the
plasmid into the genome. 3 to 5 single, blue colonies were then used to inoculate 3 ml
BHI and incubated at 30°C for 2 hours and 42°C for 4 hours afterwards before a dilution
series to 10−5 was plated on BHI + X-Gal plates. After 2 days at 42°C, white colonies
were picked, checked for the desired modification by PCR and transferred to a new BHI
+ X-Gal and a BHI + X-Gal + erythromycin plate at 37°C. Once loss of plasmid was
proven by inability to grow on erythromycin and white color of the colonies, clones with
the desired modification -according to PCR results- were streaked to single colonies, one
colony used to inoculate an over night culture for permanent storage and material from
this final culture was also used to proof the desired modifications and loss of plasmid by
PCR.
2.7.3 Disc diffusion assay
The growth inhibition of different substances was tested by measuring the zone of inhi-
bition around a filter disc soaked with a solution of the inhibitor. To do so, fresh BHI
agar plates were inoculated with material from an over night culture by dipping a sterile
collection swap into the culture and streaking the material onto the surface of the agar
plate in three directions. Plates were shortly dried after being inoculated. During the
drying period, Whatman™ paper disc 6 mm in diameter were prepared with the rough
side facing down. Then 10 µl of a solution of the substance to be tested were spotted
onto the discs, which were then placed (rough side down) onto the prepared agar plates in
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triplicate. The diameter of the inhibition zone was measured after over night incubation
at 37°C.
2.7.4 Growth curves
Manual Growth Curves
For manual measurement of bacterial growth, 20 ml medium were inoculated at an OD600
of 0.05 and incubated at the specified temperature. For cultivations at 30, 37 and 42°C
samples were shaken at 250 rpm in New Brunswick™Innova®42 or 43 incubators and
OD600 measured every hour in a Beckman Coulter DU 720 Spectrophotometer. Cultiva-
tion at 6°C was performed statically and the OD measured every 24 hours after vortexing
of the samples.
Automatic Growth Curves
Automatic OD measurement during the course of batch growth was performed using
the Multiskan Sky or Multiskan Go Microplate Spectrophotometer from Thermo Fisher
Scientific. A 96 well plate containing 100 µl medium (including inhibitory substances
of twice the concentration to be tested where applicable) was prepared and cells from an
over night culture were diluted in fresh medium to an OD600 of 0.1. 100 µl of this dilution
was added to the 100 µl medium prepared in the 96 well plate. The plate was incubated
at 37°C with shaking at high frequency for 10 seconds followed by a pause of 20 to 50
seconds. OD600 was read every 5 or 15 minutes for 24 hours.
2.7.5 Lysozyme mediated lysis
In order to determine the susceptibility to lysozyme, an over night culture was used to
inoculate a 20 ml culture. The cells were grown from OD600 0.05 to mid-exponential
phase and then harvested at 6,000 x g for 5 minutes. The pellet was re-suspended in
the volume of 50 mM Tris-HCl, pH 8.0 necessary to get an OD600 of 0.8. From the re-
suspension 6 ml was transferred to a new tube and 2.5 µg/ml lysozyme were added. The
mix was incubated at 37°C with shaking at 250 rpm while measuring the OD600 every 15
minutes.
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2.7.6 Agar plate based screen for lacZ induction
To screen substances for the induction of promoter-lacZ fusions 1 volume of BHI broth
was mixed with 1/1000 volume of an over night culture of the bacteria and 1/500 volume
of X-Gal stock solution (50 mg/ml). To this mix 1 volume hot molten 1.5 % BHI Agar
was added, shortly but vigorously mixed and the plates poured immediately afterwards.
After solidification of the plates, 1 µl of a solution of the substance to be tested (usually
1 mM concentration) was spotted onto the surface and left to dry. After drying, the plates
were incubated over night at 37°C and inspected for blue coloration indicating induction
of the promoter-lacZ fusion. A total of 681 substances tested (at 1 mM in DMSO) were
part of the DZIF (German Centre for Infection Research) Natural Compound Library.
It contained secondary metabolites from streptomycetes (340 substances), myxobacteria
(253 substances) and fungi (88 substances), collected during screens at the University of
Tu¨bingen, the HIPS (Helmholtz Institute for Pharmaceutical Research Saarland) and the
HZI (Helmholtz Centre for Infection Research). The compounds were stored at 10 mM
in DMSO and dispensed as 1 mM solutions into 96 well plates using the STARlet liquid
handling system (Hamilton Robotics). The substances were randomized and encrypted
by a barcode system for non-biased screening.
2.7.7 MIC determination - broth dilution
To determine the MIC, BHI medium containing twice the concentration of antibiotic to
be tested was prepared and 100 µl aliquots thereof added to a 96 well flat bottom plate.
All antibiotics were tested in geometric dilution series spanning the expected MIC range.
Strains were grown over night and then diluted to OD600 0.1 before 100 µl of this inocu-
lum was added to the antibiotic containing medium prepared in the 96 well plate. Plates
were either incubated at 37°C in the Multiskan Sky or Multiskan Go Microplate Spec-
trophotometer from Thermo Fisher Scientific with automatic OD600 measurement (see
Automatic Growth Curves) or incubated statically at 37°C for 18 to 24 hours, followed
by OD600 measurement in a Tecan Sunrise Plate reader. MIC was determined to be the
highest concentration of the antibiotic where the OD did not increase more than two-fold
after 24 hours.
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2.7.8 Lysis by aurantimycin
20 ml BHI broth were inoculated at an OD600 of 0.05 and incubated at 37°C with shaking
at 250 rpm until an OD600 of 0.5 ± 0.1 was reached. After harvest by centrifugation,
the cells were re-suspended in enough 50 mM Tris pH 8.0 for the OD600 to be around 2.
100 µl of this cell suspension were added to a 96 well plate containing 100 µl 50 mM
Tris pH 8.0 with aurantimycin A (at a final concentration of 2 mg/ml), where applicable.
To energize the cells, 2.5 g/l glucose was added when indicated. The lysis of cells was
monitored at 37°C by measuring OD600 in 5 minute intervals using the Multiskan Go
Microplate Spectrophotometer from Thermo Fisher Scientific.
2.7.9 Selection of aurantimycin-resistant suppressors
To select for aurantimycin-resistant suppressor mutants, the wild type and the ∆lftS mu-
tant were each inoculated into 40 wells of a 96 well plate and grown in the Multiskan
Go Microplate Spectrophotometer at 37°C for 24 hours. The medium contained a fi-
nal aurantimycin concentration of 750 ng/ml. For each strain, cells from 20 different
wells were then streaked to single colonies on BHI agar. Single colonies were picked,
grown over night in liquid culture. An aliquot of the liquid culture was stored at -80°C.
Aurantimycin-resistance of the suppressors was confirmed by monitoring the OD600 in a
MIC assay (see section on MIC determination - broth dilution) using the Multiskan Go
Microplate Spectrophotometer from Thermo Fisher Scientific.
2.7.10 Selection of lltR* cold growth suppressors
∆lltR and and lltR* ∆lmo0601 strains grown on BHI agar at 6°C for at least 3 months
formed big colonies on a background of weak growth. These big colonies were picked
and streaked to single colonies, before being grown in liquid BHI at 37°C. An aliquot of
the liquid culture was preserved at -80°C. The growth phenotype at 6°C was confirmed
on BHI agar using the parental strains as controls.
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2.7.11 Scanning or transmission electron microscopy
Electron microscopy was performed by Lars Mo¨ller and Gudrun Holland at the RKI in
Berlin. Strains were grown to mid-exponential phase under standard conditions. A 10 ml
culture was harvested at 4629 x g for 2 minutes and re-suspended in 1 ml fixative (2.5
% glutaraldehyde and 1 % formaldehyde in 0.05 M HEPES buffer). After a two hour
incubation at room temperature, the samples were stored at 4°C until analysis.
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Chapter 3
Results
3.1 The regulons of the PadR-like repressors as deter-
mined by RNA sequencing
The first step in determining the function of the PadR-like repressors in L. monocyto-
genes was to determine the genes they regulate. In order to characterize the regulons of
the PadR-like transcription factors, mutants in each individual PadR-like repressor were
constructed using the pMAD plasmid system (Arnaud et al. 2004). The clean deletion
mutant for lftR was constructed perviously (Kaval et al. 2015). Clean deletion mutants
for ladR (∆lmo1408, strain LMSH1) and lstR (∆lmo0422, strain LMSH2) were obtained,
but all attempts to delete lltR (lmo0599) failed, because the plasmids were unstable in
E. coli (data not shown). As a result, instead of generating a deletion mutant, the lltR
gene was cloned into pMAD and three conserved amino acids in the DNA binding helix
mutated. The mutations introduced were L49A, R51A, L52A and the resulting strain was
named LMSH3. It will be referred to as the lltR* mutant. The conserved lysine in posi-
tion 49 (see figure 1.4) has previously been shown to be very important for DNA binding,
so the mutation of this amino acid alone should be sufficient to abrogate DNA binding by
LltR (Park et al. 2017).
The transcriptomes of the mutants and the wild type were determined using RNA se-
quencing. This technique allows the quantification of mRNA transcripts so that the tran-
script abundances in the mutants can be compared to the wild type. All strains were
grown under standard conditions until the mid-exponential phase, quenched in ice-cold
buffer and then harvested by centrifugation. The RNA was extracted using a chloroform-
phenol based method, because this protocol was easily scalable to obtain large amounts
of high quality RNA. The large RNA amounts obtained (around 50 µg per 25 ml bac-
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terial culture) might not be needed for RNA sequencing, but are essential for Northern
blotting procedures. Other column-based extraction procedures gave significantly lower
yields. Residual DNA and RNAs smaller than 200 nucleotides were removed to enrich
the mRNA transcripts. Further, the bacterial rRNA was removed by hybridization to ho-
mologous sequences immobilized on magnetic beads. The RNA library was prepared
from the enriched mRNA following the Illumina protocol (see methods section).
To identify the ideal sequencing depth for listerial samples, the number of samples per
Illumina MiSeq run was gradually increased in the RNA sequencing experiments. Table
3.1 lists the sequencing runs, samples analysed and the amount of data obtained in each
experiment.
Table 3.1: RNA sequencing runs. Information on the RNA sequencing
runs, the samples analysed and the number of raw reads obtained.
Sequencing Samples Analysed Million Reads Total Reads
Run per sample per run
Run 1 EGD-e replicate 1 22.2 39.0 M
LMKK42 (∆lftR rsbTC10T) replicate 1 16.8
Run 2 EGD-e replicate 2 11.2 38.4 M
LMKK42 (∆lftR rsbTC10T) replicate 2 10.4
EGD-e replicate 3 10.7
LMKK42 (∆lftR rsbTC10T) replicate 3 6.08
Run 3 EGD-e replicate 4 8.01 29.3 M
LMSH1 (∆ladR) replicate 1 9.27
LMSH2 (∆lstR) replicate 1 6.08
LMSH3 (lltR*) replicate 1 5.91
Run 4 EGD-e replicate 5 2.48 23.2 M
LMSH1 (∆ladR) replicate 2 3.18
LMSH2 (∆lstR) replicate 2 2.85
LMSH3 (lltR*) replicate 2 3.21
EGD-e replicate 6 3.02
LMSH1 (∆ladR) replicate 3 3.04
LMSH2 (∆lstR) replicate 3 2.67
LMSH3 (lltR*) replicate 3 2.73
Eight parallel samples were analysed in run number 4, still yielding sufficient sequencing
reads to reliably detect differential gene expression. Therefore, up to 8 samples could be
analysed in one run.
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3.1.1 RNA sequencing data exploration
and cut-off definition for weakly expressed genes
The genes significantly regulated should be identified by comparing mutant transcript
counts to those of the wild type. After initial quality checks for Illumina sequencing data
(not shown), the number of transcripts (TPM - transcripts per million sequenced bases) for
all annotated L. monocytogenes genes was quantified using the quasi-mapping approach
implemented in the software Salmon (Patro et al. 2017). Other quantification methods
like mapping of the reads (using Geneious, Star or bowtie), followed by quantifications
and differential expression analysis (using again Geneious or edgeR) or analysis using
Rockhopper were not chosen after an initial assessment (data not shown), because they
required more computing power while yielding the same results or results that were more
difficult to interpret due to the implemented statistics.
Genes that are regulated by the PadR-like repressors should be expressed at a higher
level in the mutants lacking these transcription factors. To gain a first impression of the
transcriptomic changes, the number of transcripts detected in the mutant (TPM values)
can be plotted against the TPM values of the wild type (see top row in figure 3.1). The
three replicates are represented by black, red and blue points, respectively. These plots
revealed that the data are highly skewed. Some strongly expressed genes dominate the
plot, while most genes have a relatively low expression level and cluster in the lower
left part of the plots (see figure 3.1 upper row). For the ∆lftR and ∆lstR mutants, some
genes seem to be differentially expressed, because much higher TPM values are detected
in the mutant than in the wild type as indicated by the cluster of points located above the
diagonal.
Logarithmic transformation is one way to reduce the skewness of the data (Zwiener et al.
2014). Log transformation of the x axis spreads the genes more evenly across the plot
(see figure 3.1 middle row). In these plots, genes with higher expression in the mutant
separate more clearly from the the other genes that are expressed at identical levels in the
mutant and the wild type. Still, genes that are strongly expressed in the wild type (right
margin of the plots) show a high variation in expression between different replicates.
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Figure 3.1: TPM/TMP plots comparing padR mutants and the wild-
type. Plotting of the transcript number (TPM) detected for each gene
in the ∆lftR (LMKK42), ∆ladR (LMSH1), ∆lstR (LMSH2) and lltR*
(LMSH3) mutants (y axis) versus the transcript number in the wild type
(x axis). The three replicates are shown in black, red and blue color. The
gray shaded area indicates points excluded from analysis, because they lie
below the minimum 10 TPM cut-off. Note that the axis scales vary from
all linear (top), over x axis logarithmic (middle), to both axes logarithmic
(bottom).
The remaining skewness can be removed by also scaling the y axis logarithmically. The
resulting double logarithmic graphs for the RNA-sequencing data show clusters of genes
that are up-regulated in all three replicates (black, red and blue points are present in the
cluster) for all four repressors (see figure 3.1 bottom row). The log transformation was
therefore also used in further analysis. From the ∆ladR plot it can also be seen, that the
differences between replicates increase significantly for genes with low expression levels
(increasing spread of the points on the bottom left). This random variation is the reason,
why weakly expressed genes are usually excluded from RNA sequencing analysis (Łabaj
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and Kreil 2016). In this work a cut-off value of 10 TPM was chosen for further analysis.
This cut-off is shown by the lines in the plots on the bottom. Points falling into this
bottom left region, highlighted in gray, fail to meet the cut-off criterion and are excluded
from the analysis.
A standard measure for differentially expressed genes is the differential expression ratio.
This ratio is shown in figure 3.2 for all mutant/wild type combinations. The graphs show
the differential expression ratios for all genes in each of the three replicates. The area
shaded gray indicates the zone in which genes failed to meet the minimum 2-fold differ-
ence between mutant and wild type and/or the minimum detection level of 10 TPM (see
previous section). For all PadR-type repressors, a small cluster of genes that are highly
up-regulated (around 100-fold) in all three replicates (presence of black, red and blue
points) can be seen around the middle of the x axis. This data suggests that these genes
are specifically negatively regulated by the respective repressor. Genes up- or down-
regulated in only one replicate can for example be found in the case of the wt/∆lftR (red
dots) or the wt/∆ladR comparison (black dots, figure 3.2). Such effects cannot be based
on the proteins investigated and represent outliers, because they were found in only one
replicate.
When comparing the wt/∆lftR plot to the others, a striking difference is a cloud of down-
regulated genes that was not found for the other regulators (see figure 3.2). The next
sections will take a closer look at the up and down-regulated genes for each repressor
by also looking at statistically significant differences. The statistical significance was
determined using a t-test on the log transformed count data from the three replicates (see
Materials and Methods).
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Figure 3.2: Differential expression ratios comparing padR mutants
and the wild type. for all genes in the ∆lftR (LMKK42), ∆ladR
(LMSH1), ∆lstR (LMSH2) and lltR* (LMSH3) mutants. The genes were
ordered according to the average expression in the wild type. The three
replicates are indicated by black, red and blue points. The black lines in-
dicate the threshold to be crossed for genes to be considered up- or down-
regulated based on a minimum 2-fold ratio between mutant and wild type,
as well as a minimum count of 10 TPM.
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3.1.2 Genes differentially expressed in the ∆lftR mutant
Instead of only looking at genes that were strongly regulated, all genes that can be said to
be statistically significantly regulated were determined next. As a measure of statistical
significance, P-values comparing wild type and mutant expression levels were calculated
using Student’s t-test. The statistical significance level was chosen to be 1 %. The ∆lftR
mutant (LMKK42) did show the most complex regulatory pattern of all the transcriptomes
examined. In total, there were 8 up-regulated (see table 3.2) and 16 down-regulated genes
(see table 3.3). Among the up-regulated genes, the strongest difference was found for the
lmo0979-0980 (lieAB) operon. It can be seen from table 3.2 that this operon was nearly
500-fold higher expressed in the mutant than in the wild type. The gene lftS, part of the
lftRS operon, was also strongly up-regulated (150-fold). The lftRS operon thus seems to
be autoregulatory. Compared to the strong regulation of lieAB and lftRS the other up-
regulated genes were only weakly influenced by the deletion of lftR. Noticeably, lmo0981
and lmo0982, two genes immediately downstream of lieAB were also up-regulated 7- and
4-fold, respectively.
Table 3.2: Genes up-regulated in the ∆lftR mutant (LMKK42).
Locus Induction Standard P-value Function
Ratio Deviation
lmo0979 466 173 2.8E-04 ABC-type transporter
ATPase subunit LieA
lmo0980 454 139 4.7E-04 ABC-type transporter
membrane subunit LieB
lmo0719 187 32.1 2.9E-07 hypothetical protein LftS
lmo0981 7.15 2.04 6.5E-03 transporter
lmo0982 4.46 1.15 7.1E-03 peptidase
lmo2678 2.75 0.55 1.4E-03 XRE family
transcription regulator
lmo2679 2.69 0.45 1.7E-03 histidine kinase
lmo2834 2.15 0.20 9.8E-05 oxidoreductase
Down-regulated genes were also observed in the ∆lftR mutant. All of the down-regulated
genes (see table 3.3) are under the transcriptional control of the alternative sigma factor
SigB (Hain et al. 2008, Oliver et al. 2009 or Mujahid et al. 2013b). The shared control of
all these genes by SigB suggests an interaction of LftR-controlled genes with SigB or the
SigB activation pathway.
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Table 3.3: Genes down-regulated in the ∆lftR mutant (LMKK42).
Locus Induction Standard P-value Function
Ratio Deviation
lmo0434 0.42 0.037 7.1E-03 InlB
lmo0670 0.12 0.098 6.2E-03 hypothetical protein
lmo1427 0.11 0.030 6.5E-03 OpuCB
lmo1425 0.10 0.018 2.1E-03 OpuCD
lmo1426 0.10 0.006 1.6E-03 OpuCC
lmo1428 0.08 0.021 4.1E-03 OpuCA
lmo0669 0.08 0.030 5.8E-03 oxidoreductase
lmo0602 0.07 0.018 2.1E-03 transcription regulator
lmo2748 0.07 0.013 4.1E-03 hypothetical protein
lmo0937 0.06 0.021 9.3E-03 hypothetical protein
lmo2230 0.05 0.017 9.5E-03 arsenate reductase
lmo2213 0.04 0.020 9.5E-03 hypothetical protein
lmo0994 0.04 0.025 8.3E-03 hypothetical protein
lmo0263 0.04 0.027 8.9E-03 InlH
lmo0596 0.04 0.015 4.3E-03 hypothetical protein
lmo0913 0.03 0.023 8.9E-03 aldehyde dehydrogenase
The ∆lftR mutant was investigated for SigB-controlled phenotypes, because all of the
down-regulated genes were controlled by SigB. SigB-dependent phenotypes include chiti-
nase activity and day light dependent coordination of swarming (Larsen et al. 2010, Tien-
suu et al. 2013). Different strain backgrounds (∆lftR, ∆lftS, ∆lftRS, ∆lieAB, ∆lftR ∆lieAB)
revealed that only the ∆lftR (LMKK42) and ∆lftR∆lieAB (LMS169) strains showed SigB-
dependent phenotypes (data not shown). Both of these strains over-express lftS, therefore
the SigB phenotype might be caused by LftS. Ectopic production of LftS on the other
hand did not produce any of the SigB-associated phenotypes (data not shown). These
phenotypes could also not be complemented by re-introduction of lftR in those mutants
(data not shown). Lokking for other possible causes of the phenotypes it became ob-
vious, that both mutants showing SigB-controlled phenotypes (∆lftR and ∆lftR ∆lieAB)
shared the same genetic background. The ∆lftR ∆lieAB strain LMS169 was constructed
by deleting lieAB in the ∆lftR mutant LMKK42 (Kaval et al. 2015).
For these reasons, a another explanation for the observed behaviour was that a second mu-
tation had occurred in sigB or any gene necessary for SigB activation. Close examination
of the RNA sequencing data revealed a mutation in rsbT, a gene necessary for activation
of SigB. This mutation introduced a premature stop codon in the rsbT transcript, which
likely prematurely halted the translation process. For the ∆lftR strain LMKK42, the pres-
ence of a C to T transition at base pair 10 of the rsbT gene was confirmed by genome
re-sequencing. The mutation found converts the fourth codon of rsbT from CAA, coding
for the amino acid glutamine, to TAA, a stop codon (see figure 3.3). The resulting RsbT
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protein thus is shortened from 136 amino acids to 3 amino acids and will in all likelihood
have lost its functionality.
Figure 3.3: Genomic context of the rsbT mutation observed in the
strain LMKK42 (∆lftR). The C to T transition converts a CAA codon
coding for glutamine to TAA, a stop codon ending translation. The re-
sulting protein is thus shortened from 136 to three amino acids and most
likely inactive.
RsbT inactivation causes a SigB null phenotype (Chaturongakul and Boor 2004), thus
explaining the down-regulation of SigB-dependent genes observed in the ∆lftR and ∆lftR
∆lieAB mutants. A new ∆lftR mutant was subsequently constructed and readily obtained
without second site mutations as confirmed by genome sequencing (data not shown).
It must therefore be concluded that SigB had been inadvertently disrupted during the
construction of the original ∆lftR mutant, a phenomenon that is not uncommon in L.
monocytogenes (Quereda et al. 2013). Since this phenotype depends on SigB activity
(Tiensuu et al. 2013), the abberant daylight-dependent coordination of swarming in strain
LMKK42 (Kaval et al. 2015) must also be caused by the mutation in rsbT.
3.1.3 Genes differentially expressed in the ∆ladR mutant
Three genes were found to be significantly up-regulated in the ∆ladR mutant (LMSH1)
(see table 3.4). The mdrL gene encoding a multi-drug efflux pump was the main regula-
tory target of LadR, with an induction ratio of over 150-fold, supporting the results of a
previous study on this repressor (Huillet et al. 2006). Two more genes were also signif-
icantly up-regulated in the ∆ladR mutant. These were lmo1618, encoding the transcrip-
tional regulator MarR, and lmo1617, encoding the efflux pump MdrM. The mdrM gene
is known to be approximately 3-fold induced in a ∆ladR mutant (Crimmins et al. 2008)
and forms an operon with marR (Toledo-Arana et al. 2009). Both genes can therefore be
assumed to be transcribed together. The RNA sequencing data on the ∆ladR mutant thus
confirmed previous knowledge.
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Table 3.4: Genes up-regulated in the ∆ladR mutant (LMSH1).
Locus Induction Standard P-value Function
Ratio Deviation
lmo1409 154 44 3.6E-4 MdrL
multi-drug-transporter
lmo1618 4.3 0.4 3.3E-4 MarR family
transcription regulator
lmo1617 2.6 0.8 9.4E-3 MdrM
multi-drug-transporter
3.1.4 Genes differentially expressed in the ∆lstR mutant
In the ∆lstR mutant (LMSH2), several genes were differentially regulated. A summary of
the up-regulated genes in the ∆lstR mutant is given in table 3.5. The genes with the high-
est induction rations around 140-fold were lmo0421 (encoding a protein homologous to
RodA and FtsW) and lmo0423 (sigC). These highly up-regulated genes were already ob-
served in the plots of the raw TPM values (see figure 3.1). The genes sigC-lstR-lmo0421
form one operon (Toledo-Arana et al. 2009) that is negatively regulated by LstR (autoreg-
ulatory). Two other strongly up-regulated genes in the ∆lstR mutant are located directly
downstream of the sigC-lstR-lmo0421 operon. Improper termination of transcription af-
ter lmo0421 could be a reason for this observation. Weak induction was observed for the
genes lmo2773 and lmo2050, but the 2-fold induction levels are of minor interest when
compared to the 140-fold induction of the sigC-lstR-lmo0421 operon.
Table 3.5: Genes up-regulated in the ∆lstR mutant (LMSH2).
Locus Induction Standard P-value Function
Ratio Deviation
lmo0421 145 11.3 2.6E-5 RodA homologue
lmo0423 139 19.3 8.6E-7 RNA polymerase
factor sigma C
lmo0420 55 10.2 1.1E-4 hypothetical protein
lmo0419 7 1.47 3.5E-3 hypothetical protein
lmo2773 2.4 0.53 3.5E-3 hypothetical protein
lmo2050 2.3 0.35 3.7E-3 excinuclease ABC
subunit A
Looking at the transcripts with the strand-specific analysis software Rockhopper showed
that in the ∆lstR mutant anti-sense RNA transcripts mapped to lmo0420, a gene oriented
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Figure 3.4: LstR-based control of the sigC-lstR-lmo0421 operon in the
wild type and in the absence LstR. Panel A: In the wild type, few mRNA
transcripts are made from PsigC. The amount of LstR produced is suffi-
cient to repress activity of PsigC to a basal level. Panel B: The repressor
LstR is no longer present in the ∆lstR mutant and PsigC becomes hyper-
active producing many mRNA transcripts. Some of these transcripts are
not properly terminated after lmo0421, the last gene of the operon, lead-
ing to transcription of the neighbouring region including lmo0420 and
lmo0419.
in opposite direction to the sigC-lstR-lmo0421 operon. The complete de-repression of
this autoregulatory operon is probably leading to incomplete termination of transcription
after lmo0421. For this reason, long transcripts spanning the entire region from sigC until
lmo0419 are produced (see figure 3.4).
It is possible that the anti-sense RNA binds to the lmo0420 mRNA and prevent its trans-
lation. From a proteomic perspective, the quantity of the Lmo0420 protein should be
reduced in the mutant, possibly affecting the ability of this protein to accurately fulfil its
function. The gene lmo0419 is oriented in the same direction as the sigC-lstR-lmo0421
operon. It should therefore be up-regulated in the ∆lstR mutant and the Lmo0419 protein
amount should be increased. The exact influence on the proteome of the ∆lstR mutant
needs to be investigated in further experiments. Two other genes (lmo2773 and lmo2050)
are up-regulated by a factor of slightly above two. This is barely above the 2-fold cut-off
used for significant differences (see chapter Materials and Methods).
There were also four genes down-regulated in the ∆lstR mutant (see table 3.6). The puta-
tive role of LstR as a transcriptional repressor suggested that the deletion mutant should
over-express the genes regulated by the repressor. Finding down-regulated genes was
therefore somewhat surprising and could be a hint for secondary effects. These might be
caused by the altered transcription profiles of up-regulated genes (see table 3.5). For ex-
ample, the up-regulated genes could themselves be transcription factors that interfere with
the expression of other genes, leading to their down-regulation. Interestingly, lmo0416
and lmo0417 are located in close vicinity of the sigC-lstR-lmo0421 operon, so a direct
influence may also be possible.
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In summary, it seems that the PadR-like repressor LstR is responsible for the repression
of its own operon sigC-lstR-lmo0421. Other genes were detected as being deferentially
expressed, but this might be due to secondary effects caused by the complete disruption
of regulation of the sigC-lstR-lmo0421 operon. One effect of the complete de-repression
seems to be an incomplete termination of transcription after the operon (see figure 3.4).
Table 3.6: Genes down-regulated in the ∆lstR mutant (LMSH2).
Locus Induction Standard P-value Function
Ratio Deviation
lmo1597 0.47 0.042 8.3E-3 hypothetical protein
lmo0416 0.46 0.011 1.7E-3 transcriptional
regulator
lmo0417 0.43 0.164 8.4E-3 hypothetical protein
lmo1839 0.22 0.057 7.4E-3 PyrP
3.1.5 Genes differentially expressed in the lltR* mutant
In the strain LMSH3 the DNA binding site of LltR (Lmo0599) has been modified by the
introduction of three amino acid exchanges (L49A, R51A, L52A) replacing the larger
original amino acids with the small alanine residue. This should result in a phenotype
similar to a lmo0599 deletion mutant, because mutation of the conserved lysine in position
49 abrogated DNA binding in another PadR protein (Park et al. 2017). As expected, a set
of up-regulated genes was observed when comparing the transcriptome of this mutant to
the wild type. The RNA sequencing results are presented in table 3.7.
Table 3.7: Genes up-regulated in the lltR* mutant (LMSH3).
Locus Induction Standard P-value Function
Ratio Deviation
lmo0599 151 50 4.4E-5 PadR-like repressor LltR
lmo0600 118 34 1.2E-4 hypothetical protein
lmo0601 107 24 4.8E-5 hypothetical protein
lmo0602 12.7 9.2 1.1E-3 transcription regulator
lmo0954 3.78 1.06 2.5E-3 hypothetical protein
lmo2487 3.13 0.66 7.3E-3 hypothetical protein
lmo0955 2.64 0.62 2.7E-3 hypothetical protein
lmo1637 2.51 0.25 3.4E-4 hypothetical protein
lmo0047 2.44 0.43 2.9E-3 hypothetical protein
lmo1636 2.39 0.37 4.3E-3 ABC-Transporter
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Most of the genes listed in table 3.7 are close to the threshold for significant differen-
tial expression (2-fold). Only the four genes at the top of the table, including the lltR-
lmo0600-lmo0601 operon and lmo0602, are highly over-expressed in the lltR* mutant.
The lltR* operon is over 100-fold up-regulated and the next most strongly regulated gene,
lmo0602, is located immediately downstream of this operon. These results clearly show
that LltR, like LstR in the previous section, is mainly regulating the expression of its
own operon. As was the case with the lstR operon, incomplete termination might cause
over-expression of downstream genes.
3.1.6 Confirmation of the RNA sequencing results by measuring pro-
moter activity in a β -galactosidase assay
To validate the results obtained with RNA sequencing, the activities of the promoters most
strongly repressed by LftR, LadR, LstR and LltR were quantified using β -galactosidase
measurements. For this purpose, the promoters of lieA, mdrL, sigC and lltR were fused
to a promoter-less lacZ gene present on a plasmid. Initially, a 300 bp region upstream of
the respective start codon should be cloned for all promoters, in order to include any reg-
ulatory elements that might be present in the upstream region. This was not possible for
the lltR promoter, because the resulting plasmids were unstable in E. coli. The sequence
had to be shortened to 201 bp to get a stable construct.
The plasmids carrying the promoter-lacZ fusions were then transformed into the wild
type and the mutants lacking the cognate PadR-like repressor. A single copy of the pIMK
based plasmids was integrated into the genome (Monk et al. 2008). The cells were then
grown to mid-exponential phase and the LacZ activity (the amount of LacZ produced)
was measured in an ONPG-based assay. The lltR, lstR and lieA promoters showed a
measurable, but low activity in the wild type under the growth conditions used (see figure
3.5). In the mutant strains lacking the cognate PadR-like repressor the β -galactosidase
activity was significantly higher (see figure 3.5). This confirmed the RNA sequencing
data by showing on a protein activity level the up-regulation of:
• PmdrL in the absence of ladR by 17-fold,
• PlltR in the lltR* mutant by 53-fold,
• PsigC in the absence of lstR by 77-fold, and of
• PlieA in the absence of lftR by 422-fold.
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Figure 3.5: Confirmation of the RNA-sequencing results using a
promoter-lacZ-based β -galactosidase assay. β -galactosidase activity of
the mdrL, lltR, lstR and lieA promoters in the wild type (strains LMSH10,
LMSH14, LMSH12 and LMSH5) and the mutants lacking the cognate
PadR-type repressor (strains LMSH11, LMSH15, LMSH13, LMSH6).
Cells were grown in BHI at 37°C until mid-exponential phase, harvested
and then lysed by sonification. The activity of promoter-less lacZ is
shown as a negative control. Three replicates were measured and the av-
erage is shown with standard deviation. Asterisks indicate the statistical
significance (t-test) with P<0.05 *, P<0.01 **, P<0.001 ***
The RNA sequencing data also suggested that LftR represses transcription of its own
operon lftRS. We wondered, if the transcripts of lftS could also be shown directly by
Northern blotting. For this purpose, RNA extracts from the wild type and the ∆lftR mutant
strain LMKK42 (carrying the rsbTC10T mutation inactivating SigB) were prepared. Using
an RNA probe complementary to the lftS transcript, it could be shown that lftRS (0.7 kb)
is weakly transcribed in the wild type. In contrast, a strong signal for a 0.4 kb transcript
(lftS only) was detected in the ∆lftRrsbTC10T background (see figure 3.6). Importantly,
no signal was detected in the lftS (LMKK26) and lftRS (LMKK31) mutants showing the
specificity of the method. Finally, the deletion of sigB (LMSH9) did not affect the signal
intensity of the lftRS transcript. This precludes an influence of the rsbTC10T mutation on
the expression of lftRS. The Northern blot thus confirmed the RNA sequencing data.
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Figure 3.6: Direct detection of lftS transcripts. Northern blot showing
the de-repression of lftS in the ∆lftR rsbTC10T background, confirming
lftR autoregulation. An lftS specific RNA probe detected a abundant lftS
transcripts in the absence of the lftR (∆lftR rsbTC10T lane). RNA from
strains LMKK26 (∆lftS), LMKK31 (∆lftRS) and LMSH9 (∆sigB) were
included as controls, proving the specificity of RNA-probe interaction by
the absence of a signal in the ∆lftS strain and low transcription of the
longer lftRS operon in the presence of lftR.
The RNA sequencing data showed that all four repressors strongly inhibit the transcription
of a small set of genes (one to four genes or one to two operons) and seem to be auto-
regulatory. The latter could not be shown for LadR, because we used a ∆ladR mutant and
this gene is not part of an operon. Some weak but significant regulation of other genes
was observed. In the case of LadR, this observation fits perfectly to previously published
data (Crimmins et al. 2008).
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3.2 Determination of conditions leading to the induction
of genes controlled by PadR-like transcription fac-
tors
PadR-like transcription factors often activate genes in response to environmental signals,
like the presence of toxic compounds (antibiotics or phenolic acids) or other stresses, for
example heat (Zhang et al. 2005, Agustiandari et al. 2008, Nguyen et al. 2011, Heravi
et al. 2015). One aim of this study was to identify conditions leading to the expression of
genes controlled by the PadR-like repressors. In order to be able to screen different condi-
tions and substances for induction, promoter-lacZ fusions were constructed as described
in the previous section. It has been shown that these constructs are nearly inactive in
the wildtype, but are strongly up-regulated in the respective repressor mutants (see figure
3.5).
Wild type cells carrying the reporter constructs PmdrL-lacZ, PlltR-lacZ, PsigC-lacZ and
PlieA-lacZ (LMSH10, LMSH14, LMSH12 and LMSH05) were mixed with liquid BHI
agar containing X-Gal as a chromogenic substrate for LacZ to pour plates. Concentrated
solutions of different substances were spotted on top of the plates and the plate were in-
cubated at 37°C over night. Under standard conditions no LacZ is produced, because
the promoters are inactive (see figure 3.5). The plate therefore stays color-less. Under
inducing conditions however, LacZ should be produced and catalyse X-Gal conversion to
a deeply blue reactant. Using this method, around 750 different chemical substances and
conditions such as cold, heat and pH were screened. 681 substances were compounds
from the DZIF natural substance collection (Herrmann et al. 2017) consisting of sec-
ondary metabolites from streptomycetes (340 substances), myxobacteria (253 substances)
and fungi (88 substances). A total of 67 commercially available substances or physical
conditions were also tested for induction of some promoter-lacZ constructs. These are
listed in table 3.8. Most compounds were dissolved in water or DMSO and saturated
solutions spotted on agar.
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Table 3.8: Substances and conditions screened beside the DZIF Nat-
ural Compound Collection. A ”plus” sign signifies ”induction”, a ”mi-
nus” sign signifies ”no induction”, a ”u” signifies ”unspecific induction”
for all reporter strains and ”n.d.” signifies ”not determined”
Substance Plmo0979
induction
Plmo0423
induction
Plmo0599
induction
Plmo1409
induction
Rhodamine 6G + - - -
Rhodamine B + n.d. n.d. n.d.
Ethidium bromide - - - -
Heat 42°C - - - -
Heat 48°C - - - -
Cold 6°C - - - -
Penicillin G - - - -
Phosphomycin - - - -
Bacitracin - - - -
Vancomycin u u u u
Benzalkonium - - - -
Vanillin - - - -
tert-Butylhydroquinone - - - -
Nalidixic acid - - - -
Erythromycin - + - -
Cycloserin - - - -
Cravacrol - - - -
Chloramphenicol - - - -
Acriflavine - - - -
Tetracycline - - - -
Gigasept - - - -
Grotanat u u u u
Lysozyme - - - -
Ethanol - - - -
continues on next page
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DMSO - - - -
NaOH 10 M - - - -
HCl 37 % u u u u
EDTA 0.5 M - - - -
KCl - - - -
Spectinomycin - - - -
Ampicillin - - - -
Triton X-100 - - - -
SDS - - - -
Deoxycholate - - - -
H2O2 - - - -
Kanamycin - - - -
Daunomycin - - - -
Chromomycin - - - -
Josamycin - + - -
Rifampicin - - - -
Tylosin - + - -
Moenomycin n.d. - - -
Bile salts n.d. - - -
Streptomycin n.d. - n.d. n.d.
Cellobiose n.d. - n.d. n.d.
Sucrose n.d. - n.d. n.d.
Trehalose n.d. - n.d. n.d.
Rhamnose n.d. - n.d. n.d.
Maltose n.d. - n.d. n.d.
Spiramycin n.d. - n.d. n.d.
Acridine orange - n.d. n.d. n.d.
Riboflavin - n.d. n.d. n.d.
Tryptophane - n.d. n.d. n.d.
Folic acid - n.d. n.d. n.d.
Imidazol - n.d. n.d. n.d.
continues on next page
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4-Hydroxybenzoate - n.d. n.d. n.d.
Salycilate - n.d. n.d. n.d.
Pyrogallol - n.d. n.d. n.d.
Indol - n.d. n.d. n.d.
Humic acid - n.d. n.d. n.d.
Emodin - n.d. n.d. n.d.
Methylene blue - n.d. n.d. n.d.
Congo red - n.d. n.d. n.d.
Nile red - n.d. n.d. n.d.
Fluorescein - n.d. n.d. n.d.
FeCl2 - n.d. n.d. n.d.
ZnCl2 - n.d. n.d. n.d.
NaN3 - n.d. n.d. n.d.
Menadione - n.d. n.d. n.d.
3.2.1 Conditions leading to the activation of LftR-controlled genes
It was known that LftR controls the transcription of the ABC-type transporter genes lieAB
and that this transporter imports ethidium bromide into the cells (Kaval et al. 2015), but
ethidium bromide did not . Conditions leading to the transcription of lieAB were un-
known. Using the PlieA-lacZ (LMSH05) reporter strain we screened for conditions lead-
ing to the activation of lieAB transcription. For the screening LMSH5 was grown in BHI
agar containing X-Gal as a chromogenic substrate. Different chemicals were spotted on
top of such agar plates. An induction of PlieA would lead to the production of LacZ which
in turn would convert X-Gal producing a deep blue end product that can easily seen by
eye.
During these screens, it could be shown that LftR-controlled genes are activated by dyes
of the rhodamine family (rhodamine B and rhodamine 6G were tested). A blue ring
corresponding to the zone of induction is visible around the region where the dye was
applied (see figure 3.7). On the other hand, a strain carrying a promoter-less lacZ re-
porter did not produce a color change indicating that the activity observed depends on
PlieA. Ethidium bromide, which had been shown to be an artificial substrate of the LieAB
transporter (Kaval et al. 2015), did also not induce expression from PlieA. This proved
that ethidium bromide is indeed an artificial substrate that is accidentally being imported
85
by LieAB. Identical results were obtained when using strain LMSH7 carrying the PlftR-
lacZ reporter, confirming the regulation of both the PlieA and PlftR promoters by LftR (see
figure 3.7).
Figure 3.7: Rhodamine dyes induce LftR-regulated transcription. A
volume of 2 µl of the dyes rhodamine 6G, rhodamine B and ethidium bro-
mide (all at 5 mg/ml) was spotted on agar plates containing strain LMSH5
(PlieA-lacZ reporter) or strain LMSH7 (PlftR-lacZ reporter). After over
night incubation at 37°C both strains showed a color change on the plates
containing X-Gal as a chromogenic substrate in the presence of the rho-
damine dyes. Strain LMSH16 carrying promoter-less lacZ did not show
a color change indicating specificity of the induction to the lieA and lftR
promoters. The artificial LieAB substrate ethidium bromide also does not
induce reporter activity.
Rhodamine dyes induce the transcription from both of the LftR-controlled promoters,
but it was not known how strong this induction was or in what concentration range the
induction occurred. In order to quantify the induction observed with rhodamine 6G the
strains LMSH5 (PlieA-lacZ) and LMSH7 (PlftR-lacZ) were inoculated at an OD600 of 0.05
into BHI medium containing increasing concentrations of rhodamine 6G and grown until
mid-exponential phase at 37°C. After lysis by sonification, the LacZ activity was mea-
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sured in using ONPG as a substrate. The maximal de-repression of the the lieA promoter
was achieved at a rhodamine 6G concentration of 0.5 µg/ml (see figure 3.8). At this con-
centration the lieA promoter was induced 13.5-fold while the lftR promoter was induced
6.6-fold (see figure 3.8).
As a control for maximal de-repression, the activity of the PlieA-lacZ (LMSH6) and PlftR-
lacZ reporter (LMSH8) was also measured in the ∆lftR rsbTC10T mutant background
lacking LftR. Compared to the strains LMSH6 and LMSH7 the induction by rhodamine
6G was only at 3.4 % (PlieA) or 6.2 % (PlftR) of the maximal capacity. It is important to
note the different expression levels from the lftR and lieA promoters in the absence of an
inducer. The expression level of lftRS is more than twice as high as that of lieAB. The
higher expression might be needed to guarantee the proper regulation of lieAB. Panel B
of figure 3.8 shows the structure of the dye and the induction of the PlieA-lacZ reporter on
agar containing X-Gal, when 2 µl rhodamine 6G (2.5 mg/ml) were spotted.
Rhodamine dyes are inducing expression of LftR-controlled genes, but they are of artifi-
cial origin (Cooksey 2016) and therefore unlikely to play any role in natural settings. It
must be assumed that they are not the natural effectors of LftR. In order to identify po-
tential naturally occurring effectors, a screening of the DZIF natural substance collection
was initiated. Again, strain LMSH5 carrying the PlieA-lacZ reporter was poured into BHI
agar containing X-Gal. A volume of 1 µl of the substances from the natural compound
collection were spotted onto the agar surface and left to dry before incubation over night
at 37°. This screen revealed aurantimycin A as a potent, naturally occurring inducer of
LftR-controlled gene expression (see figure 3.9, panel B). No other substances inducing
transcription were found in the DZIF collection.
To quantify the strength of induction at given aurantimycin concentrations, strain LMSH5
(PlieA-lacZ) was again inoculated at an OD600 of 0.05 into BHI medium containing in-
creasing concentrations of the antibiotic and grown to mid-exponential phase at 37°C.
Quantification of the resulting β -galactosidase activity revealed that aurantimycin induces
gene expression from the lieA promoter in a dose dependent manner, but at much lower
concentrations than rhodamine 6G (see figure 3.9, panel A). The structure of aurantimycin
A and the induction it causes in the agar based assay are also shown for reference (see
figure 3.9, panel B).
87
Figure 3.8: Quantification of the dose-dependent induction of PlieA by
rhodamine 6G. Panel A: In liquid culture, the β -galactosidase induced
in strains LMSH5 (PlieA-lacZ reporter) and LMSH7 (PlftR-lacZ reporter)
depends on the rhodamine 6G concentration. The strains were grown
at 37°C in BHI containing the indicated concentrations of rhodamine
6G. The strains LMSH6 (∆lftR rsbTC10T PlieA-lacZ) and LMSH8 (∆lftR
rsbTC10T PlftR-lacZ) were used as controls for maximal de-repression.
Three replicates were measured and the average is shown with standard
deviation. Asterisks indicate the statistical significance (t-test): P<0.01
*, P<0.001 **. Panel B: Induction of the PlieA-lacZ reporter by 2 µl rho-
damine 6G (2.5 mg/ml) on agar plates containing X-Gal after over night
incubation and structure of rhodamine 6G.
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Figure 3.9: Quantification of the dose-dependent induction of PlieA
by aurantimycin A. Panel A: In liquid culture, aurantimycin induced
β -galactosidase in strain LMSH5 (PlieA-lacZ reporter) in a concentration-
dependent manner. The cells were grown at 37°C in BHI containing the
indicated concentrations of aurantimycin. Strain LMSH16 (promoter-less
lacZ) and LMSH34 (∆lftR PlieA-lacZ) served as controls. Three replicates
were measured and the average is shown with standard deviation. Aster-
isks indicate the statistical significance (t-test): P<0.01 *, P<0.001 **.
Panel B: Induction of the PlieA-lacZ reporter by 2 µl aurantimycin A (2.5
mg/ml) on agar plates containing X-Gal after over night incubation and
structure of aurantimycin A.
3.2.2 Induction of LftR-controlled genes depends on LftS
The PadR-like transcriptional regulator LftR is encoded in an operon together with a
second protein of unidentified function named LftS. The lftRS operon is induced in the
presence of rhodamine dyes or aurantimycin A (see figure 3.7, figure 3.8 and figure 3.9).
To test whether lftS plays a role in the regulation of PlieA or PlftR, the induction by rho-
damine 6G and aurantimycin A was tested in a ∆lftS mutant background. To this end, the
PlieA-lacZ reporter was introduced into the ∆lftS mutant strain LMKK26 and into strain
LMSH43 constructed by re-introducing lftS into LMKK26, yielding the strains LMSH27
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and LMSH49 (labelled lftS+). Spotting of 2 µl of rhodamine 6G and aurantimycin A
(both at 2.5 mg/ml) onto plates containing the reporter strains and X-Gal showed that
PlieA-lacZ reporter construct gave the expected color signal in the wild type after over
night incubation at 37°C (see figure 3.10). In the absence of lftS, there was no induc-
tion of the promoters. To show that this effect depends only on lftS, the lftS gene was
re-introduced and the resulting lftS+ strain did again show the expected color change,
indicating that lftS is essential for the induction (see figure 3.10).
Figure 3.10: Effect of lftS on PlieA induction. Induction of the PlieA-
lacZ reporter in the agar based assay depends on the presence of lftS. A
volume of 2 µl of 2.5 mg/ml rhodamine 6G or aurantimycin A was spotted
on BHI agar plates with X-gal. The plates also contained strains LMSH5
(PlieA-lacZ [labelled wt]), LMSH27 (∆lftS PlieA-lacZ [labelled ∆lftS]) or
LMSH49 (lftS reverted PlieA-lacZ [labelled lftS+]) and were incubated
over night at 37°C.
To determine whether the induction in the ∆lftS background was low or completely pre-
vented, the β -galactosidase activity of the PlieA-lacZ reporter construct in strain LMSH27
(∆lftS) was quantified. The cells were grown at 37°C in BHI medium containing increas-
ing aurantimycin A concentrations until reaching mid-exponential phase. Strain LMSH16
(promoter-less lacZ) and strain LMSH34 (∆lftR PlieA-lacZ) were used as controls. In the
absence of lftS, the activity of the lieA promoter is essentially abolished, no matter at
which aurantimycin A concentration the strain was grown (see figure 3.11). The results
proved that lftS is absolutely essential for the induction observed in the wild type (see
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figure 3.9).
Figure 3.11: Quantification of the effect of lftS on PlieA induc-
tion. The β -galactosidase activity of strain LMSH27 (∆lftS) was quan-
tified using the ONPG assay. The cells were grown at 37°C in BHI
medium containing increasing aurantimycin concentrations until reach-
ing mid-exponential phase. The strains LMSH16 (promoter-less lacZ)
and LMSH34 (∆lftR PlieA-lacZ) are shown as controls for inactive and
active lacZ transcription.
The observation that lftS is essential for the induction of LftR-controlled genes could
mean that either LftS acts as an independent activator of transcription for those promoters
or that LftS acts through LftR by relieving the LftR-dependent repression in the presence
of effector molecules. To determine which is the case, the β -galactosidase activity of the
PlieA-lacZ reporter was measured for the wild type, the ∆lftS, ∆lftR and ∆lftRS mutants in
the presence or absence of 50 ng/ml aurantimycin. Previously published results indicated,
that the ABC transporter BceAB is required for the control of expression of the bceAB
genes in B. subtilis (Bernard et al. 2007). To test if the lieAB genes also play a role in the
induction process, the ∆lieAB mutant was included in the experiment.
The results clearly showed, that there is no activity in the ∆lftS mutant (see figure 3.12).
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The identical promoter activity of the ∆lftR and ∆lftRS mutants implied that LftS does
not have an effect on the promoter activity in absence of lftR (see figure 3.12). This
indicates that LftS is not an independent activator, but acts through LftR. The ∆lieAB
mutant behaved like the wild type ruling out the possibility that the transporter LieAB is
involved in gene regulation. Therefore, LftR is the dominant factor for repression of the
lieAB genes and LftS acts on LftR to activate transcription in the presence of effector.
Figure 3.12: Effect of other genes in the LftR regulon on PlieA in-
duction. Aurantimycin A induced β -galactosidase activity in lftRS and
lieAB mutants. Strains LMSH5 (PlieA-lacZ), LMSH27 (∆lftS PlieA-lacZ),
LMSH34 (∆lftR PlieA-lacZ), LMSH64 (∆lftRS PlieA-lacZ) and LMSH65
(∆lieAB PlieA-lacZ) were grown without antibiotic or in the presence of
50 ng/ml aurantimycin A until reaching mid-exponential phase. After
cell lysis, the β -galactosidase activity was measured in the ONPG assay.
The average values and standard deviation of three replicates are shown.
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3.2.3 Conditions leading to the activation of LstR-controlled genes
It was previously published that the PadR-like transcription factor LstR controls the tran-
scription of the sigC-lstR-lmo0421 operon and that the operon is activated by heat (Zhang
et al. 2005). Using a PsigC-lacZ (LMSH12) reporter strain in the wild type, it was tried
to show the induction of PsigC by heat, but under the conditions used no induction could
be seen (data not shown). To test whether some secondary metabolite induces expression
from PsigC, the DZIF natural compound collection was screened as described in the sec-
tion about the LftR-controlled genes. During this screen, a slight induction of the PsigC-
lacZ reporter was observed when the strain was exposed to the macrolide antibiotics nid-
damycin B (producer: Streptomyces) and josamycin (producer: Streptomyces). An even
weaker induction, close to the detection limit, could be seen for chromomycin A3 (pro-
ducer: Streptomyces) and streptovaricin (producer: Streptomyces). Using commercially
available material, it could be confirmed that josamycin is a strong inducer of the lstR
operon (see figure 3.13). The library screen further indicated that chromomycin induces
the lstR operon, but this result could not be reproduced with commercially available chro-
momycin (see figure 3.13). The other compounds were not commercially available at the
time of the experiments, so the induction could not be verified.
Because the sigC operon was induced by two different macrolide antibiotics, it was tested
if other members of this class of antibiotics also induce the expression from the sigC pro-
moter. Erythromyin and tylosin are commonly used drugs (EMA 1997, Principi and
Esposito 1999) that were also tested for induction of the lstR operon. Both compounds
induced β -galactosidase activity in the PsigC-lacZ reporter strain (see figure 3.13). The
strongest induction was observed with the 16-membered macrolides josamycin and ty-
losin. Erythromycin repeatedly induced the reporter but the induction level was very
low compared to josamycin (see figure 3.13). This indicates a targeted inactivation of
LstR by macrolides or via an intra-cellular response that is triggered by the exposure to
macrolides. The concentrations of the macrolide antibiotics was varied in this experiment,
because of the widely differing antibacterial activites against L. monocytogenes.
Interestingly, longer incubation at 37°C (for example over 48 hours) increased the signal
intensity significantly for all macrolides (data not shown). Macrolide antibiotics inhibit
bacterial protein biosynthesis by binding to the 50S subunit of the ribosome (Champ-
ney and Burdine 1995). The antibiotics that induce the sigC-lstR-lmo0421 operon are
therefore interfering with the ability of the bacteria to synthesize new proteins. It still
remains unclear why the operon should be activated under such conditions. It could be
possible that conditions inhibiting cell wall synthesis (for example antibiotics targeting
RodA/FtsW function) induce the production of a resistance-conferring RodA/FtsW par-
alog, because LstR controls expression of the RodA/FtsW paralog Lmo0421. Contrary
to this idea, all of the cell wall targeting antibiotics tested (see table 3.8) did not show
induction of the PsigC-lacZ reporter (data not shown).
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Figure 3.13: Induction of PsigC by macrolide antibiotics. The PsigC
reporter strain LMSH12 was poured into BHI agar plates containing X-
gal. Antibiotic solutions (2 µl) were spotted on top of the agar and the
plates incubated over night at 37°C. The β -galactosidase activity resulting
from the induction of the PsigC-lacZ reporter construct can be seen by the
blue color developing around a zone of complete growth inhibition.
3.2.4 Activity of the lstR-sigC-lmo0421 operon depends on SigC
The lstR-sigC-lmo0421 operon contains sigC and lstR, two proteins that are probably in-
volved in the regulation of transcription from the sigC promoter (Zhang et al. 2005). In
order to elucidate the role of SigC and LstR in the regulation of the lstR-sigC-lmo0421
operon, a sigC* mutant (LMSH89) containing a pre-mature stop condon and an lstR*
mutant (LMSH39) with amino acid exchanges in the DNA binding helix (L90A, L92A,
L93A), as well as a sigC* lstR* double mutant (LMSH90) were constructed. Intro-
duction of the PsigC-lacZ reporter into these backgrounds yielded the reporter strains
LMSH96 (sigC* PsigC-lacZ), LMSH63 (lstR* PsigC-lacZ), LMSH97 (sigC* lstR* PsigC-
lacZ), which were used together with strain LMSH12 (PsigC-lacZ), LMSH13 (∆lstR PsigC-
lacZ) and LMSH16 (lacZ) as controls for the following experiments. All strains were in-
oculated into BHI at an OD600 of 0.05 and grown at 37°C until reaching mid-exponential
phase, harvested and lysed by sonification.
Quantification of the β -galactosidase activity in the above mentioned reporter strains
showed that all promoter activity was abolished in the sigC* background (see figure 3.14,
panel A). SigC therefore seems to be essential for transcription from the sigC promoter.
This is in agreement with results from Zhang et al. who observed that the expression of
the lstR operon depends in part on SigC (Zhang et al. 2005).
SigC was also shown to be essential under inducing conditions. Induction by josamycin
did not occur in the sigC* mutant. Even in the sigC* lstR* double mutant the promoter
was inactive, therefore promoter activity depended on an intact sigC gene (see figure 3.14
panel B). In the lstR* single mutant the PsigC promoter was constitutively active. This can
be seen in the high β -galactosidase activity in the ONPG assay (see figure 3.14, panel A)
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or the strong blue background coloration in the agar based experiment (see figure 3.14,
panel B). Taken together these observations suggest that SigC is actively promoting tran-
scription of its own operon under the conditions studied and the transcriptional control is
based on negative regulation by LstR. Importantly, the ∆lstR and lstR* mutants produced
identical results in the β -galactosidase assay, indicating that the mutations introduced in
the lstR* mutant completely abolish the binding of the repressor to the DNA.
Figure 3.14: Effect of sigC on transcription and induction of the
sigC-lstR-lmo0421 operon. The expression from the sigC-lstR-lmo0421
operon depends on SigC. Panel A: The strains LMSH96 (sigC* PsigC-
lacZ), LMSH63 (lstR* PsigC-lacZ), LMSH97 (sigC* lstR* PsigC-lacZ),
together with strain LMSH12 (PsigC-lacZ), LMSH13 (∆lstR PsigC-lacZ)
and LMSH16 (promoter-less lacZ) as controls, were grown in BHI at
37°C until mid-exponential phase and β -galactosidase activity quantified
after sonification. The average values of three independent experiments
are shown with standard deviation. Asterisks indicate the statistical sig-
nificance (t-test): P<0.01 *, P<0.001 **. Panel B: The same strains
grown in BHI agar at 37°C over night with 2 µl of a josamycin solution
(1 mg/ml) spotted on top of the agar.
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3.3 The genes of the LftR regulon contribute to aurantimycin-
resistance
It has been shown in the previous sections that LftR regulates the expression of the lieAB
permease genes and of its own operon lftRS. These genes were expressed in the presence
of rhodamine 6G (see figure 3.7), which is likely to be an artificial substrate, because it
does not occur naturally (Cooksey 2016). On the other hand, the depsipeptide antibiotic
aurantimycin A (Graefe et al. 1995) is a naturally occurring inducer of LftR-dependent
gene expression (see figure 3.9). If the LieAB efflux pump is purposefully induced in the
presence of aurantimycin, but not by rhodamine 6G, then it should convey some kind of
benefit to the cell when exposed to the former substance, but not to the latter. To test if the
cells become resistant, MICs were determined for the wild type and ∆lftR, ∆lftS, ∆lieAB
and ∆lftR∆lieAB mutants.
As can be seen from table 3.9, the ∆lftR mutant is 2 times as resistant against aurantimycin
as the wild type or ∆lftS mutant. In contrast, mutants missing the lieAB transporter genes
are much more sensitive to aurantimycin A. However, there is no such effect on resis-
tance against rhodamine 6G (see table 3.9). This supports the hypothesis that LieAB
contributes to resistance against aurantimycin A but not against rhodamine 6G. More-
over, these results are in good agreement with the hypothesis of LftR acting as a repressor
of lieAB transcription. Thus, LftR seems to react to the same compound that is detoxified
by LieAB.
Table 3.9: Aurantimycin A and rhodamine 6G MIC values. MIC
values for the wild type and strains lacking genes of the lftRS and/or
lieAB operons when exposed to aurantimycin A or rhodamine 6G. The
strains used were LMKK26 (∆lftS), LMSH26 (∆lftR), LMS160 (∆lieAB)
and LMSH35 (∆lftR ∆lieAB). Three independent experiments were per-
formed and the average is shown. Deviation between the replicates was
minimal to not existent (data not shown).
Genotype MIC MIC
aurantimycin A [µg/ml] rhodamine 6G [µg/ml]
wild type 1.25 2
∆lftS 1.25 2
∆lftR 2.5 2
∆lieAB 0.156 2
∆lftR ∆lieAB 0.156 2
Mutants lacking the lieAB genes showed a strongly reduced MIC towards aurantimycin
(see table 3.9). This was an indication for active transport of the antibiotic by LieAB.
It was known that aurantimycin is forming pores in biological membranes (Grigoriev et
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al. 1995). Pores in the membrane usually lead to rapid cell lysis and death. To observe
if aurantimycin causes cell lysis, the wild type, ∆lftR and ∆lftR ∆lieAB mutants were
incubated in buffer with or without aurantimycin. The OD of the cell suspensions was
monitored during incubation at 37°C.
It can be clearly seen in figure 3.15 that all strains do significantly lyse in buffer containing
aurantimycin (see figure 3.15, panel B), but not in plain buffer (see figure 3.15, panel
A). Aurantimycin therefore causes cell lysis, but no differences between the wild type
and the ∆lftR (over-producing LieAB) and ∆lftR ∆lieAB (lacking LieAB) mutants could
be observed. The LieAB transporter belongs to the ABC-type (ATP binding cassette)
of transporters and thus requires energy in the form of ATP to be active (Kaval et al.
2015). Therefore, the effect of glucose addition to the lysis buffer was also investigated
(see figure 3.15, panel C). Under energizing conditions, the cells lacking lftR, and thus
over-producing LieAB, are more resistant towards aurantimycin-induced lysis than the
wild type or the ∆lieAB (lacking LieAB) mutant. This observation proves that the energy
dependent transport of aurantimycin by LieAB protects the cells from lysis.
Figure 3.15: Aurantimycin A mediated lysis of L. monocytogenes.
Wild type cells and the ∆lftR (LMSH26) and ∆lftR ∆lieAB (LMSH35) mu-
tants were grown to mid-exponential phase, harvested and re-suspended
in Tris-buffer. The addition of aurantimycin A to the buffer causes sig-
nificant cell lysis (panel B) when compared to plain buffer (panel A).
The ∆lftR mutant overexpressing lieAB is significantly more resistant to
aurantimycin-induced lysis, once glucose is added as an energy source
(panel C).
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3.3.1 Identification of spontaneous aurantimycin-resistant suppres-
sor mutants
It has been shown that the ∆lftS mutant cannot induce lieAB expression upon exposure
to aurantimycin (see figure 3.11). Nevertheless, the ∆lftS mutant has the same MIC as
the wild type that can induce the transcription of the resistance genes (see table 3.9).
This apparent contradiction led us to examine the growth kinetics of the wild type and the
∆lftS (LMKK26), ∆lieAB (LMS160) and ∆lftS ∆lieAB (LMSH66) mutants in the presence
of aurantimycin. For this purpose, the strains were initially grown to mid-exponential
phase in the presence of sub-inhibitory aurantimycin concentrations (100 ng/ml). The
aurantimycin-adapted cells were used to inoculate new growth curves using medium with
different antibiotic concentrations. The influence differing antibiotic concentrations have
on the kinetics of growth gives more detailed information than the end point determination
of MIC values.
It can be seen in figure 3.16 that the stains ∆lieAB and ∆lftS ∆lieAB do not grow at the
aurantimycin concentrations tested. The wildtype on the other hand shows a gradually
increasing lag phase when exposed to increasing aurantimycin concentrations. This can
be expected, when increasing concentrations of the antibiotic lead to the lysis of a succes-
sively greater part of the cells. Interestingly, the ∆lftS mutant did not behave like the wild
type in this experiment, although it had an identical MIC. In the absence of aurantimycin,
the ∆lftS mutant grew like all other strains tested, but in the presence of aurantimycin
growth was only detectable after around 15 hours of incubation at 37°C, regardless of
the antibiotic concentration applied. The growth is lieAB-dependent, because the ∆lftS
∆lieAB mutant completely failed to grow in the presence of aurantimycin.
The increased lag phase in medium containing aurantimycin could imply that fewer cells
form the initially viable inoculum, so it takes longer until growth is detectable (Hoffmann
et al. 2018). This would make sense, because aurantimycin supposedly kills the cells
by disrupting their plasma membrane (see figure 3.15). Antibiotics acting by inhibiting
growth would have an impact on the growth rate of bacteria (Frenkel et al. 2018). In such
a case, the growth curves would have a lower slope. For the ∆lftS strain, growth in the
presence of aurantimycin was only detected after around 15 hours of incubation, regard-
less of the antibiotic concentration applied. For strains missing the ABC-type transporter
LieAB no growth is observable in the presence of the aurantimycin concentrations tested.
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Figure 3.16: Growth at different aurantimycin A concentrations.
Growth of the wild type and strains LMKK26 (∆lftS), LMS160 (∆lieAB)
and LMSH66 (∆lftS ∆lieAB) at 37°C in BHI with aurantimycin A con-
centrations as indicated. To activate lieAB expression, all strains were ini-
tially grown at a sub-inhibitory aurantimycin concentration of 100 ng/ml
to mid-exponential phase before starting the experimental culture whose
OD600 is shown. Average values and standard deviations of three inde-
pendent experiments are depicted.
The strange growth behaviour of the ∆lftS mutant could imply that some cells resistant
to aurantimycin have grown to a detectable OD600 after around 15 hours. To test this
assumption, wild type and ∆lftS cells grown in the presence of 625 ng/ml aurantimycin
were used to re-inoculate a new culture (see figure 3.17). The OD600 of this culture was
monitored to quantify the growth behaviour. For comparison, growth of the wild type and
the ∆lftS mutant, pre-grown at the sub-inhibitory concentration of 100 ng/ml in order to
induce lieAB expression, were also monitored.
Figure 3.17 shows that the cultures pre-grown at sub-inhibitory concentrations of au-
rantimycin A showed an increased lag phase, while the cells re-inoculated from a culture
containing 625 ng/ml aurantimycin (sufficient to cause lysis) did not exhibit any lag phase
except at 1250 ng/ml. At this high concentration the wild type and ∆lftS cells pre-grown
at sub-inhibitory concentrations were unable to grow. These results suggest, that the cells
that have grown in the presence of 625 ng/ml aurantimycin A developed a resistance to
the antibiotic.
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Figure 3.17: Formation of aurantimycin-resistant suppressors.
Growth of wild type and ∆lftS (LMKK26) cells without (top) or with
(bottom) previous contact to a lytic aurantimycin A concentration (625
ng/ml). The immediate growth of the re-inoculated cultures indicated the
development of suppressors resistant to the antibiotic. Average values and
standard deviations of three replicates are shown.
To clarify if the resistance was a transient or heritable, single wild type and ∆lftS colonies
grown from resistant liquid cultures were isolated on BHI agar without aurantimycin.
After growth on agar and in liquid medium without the antibiotic, the isolated bacteria
were still resistant to aurantimycin (data not shown). It therefore seemed possible that
hertiable mutations in the genome were the cause of the resistance.
It is known that inactivation of lftR leads to the overproduction of the LieAB transporter
(Kaval et al. 2015) and that the LieAB transporter protects the cells from lysis in the
presence of aurantimycin (see figure 3.15). It was therefore likely that the mutations
impacted LftR. To test whether lftR did mutate in the resistant cells, the genomic region of
lftR including its promoter was amplified by PCR from 20 single putative suppressors of
the wild type (LMSH121-140) or the ∆lftS strain (LMSH141-160), grown in 20 separate
cultures in the presence of 750 ng/ml aurantimycin. The PCR product was sequenced to
find potential mutations.
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Table 3.10: Aurantimycin suppressor mutations. Mutations found in
wild type and ∆lftS cells grown in the presence of 750 ng/ml aurantimycin.
Each suppressor was grown in a separate well of a 96-well plate. The
base exchanges detected are indicated together with their position in the
genome and the resulting effect they have on the LftR protein.
Strain Background Mutation Effect
LMSH121 WT G750063A LftR: G27S
LMSH122 WT A750155 deletion LftR: frame shift
LMSH123 WT G749972T lftR RBS mutation
LMSH124 WT G750063A LftR: G27S
LMSH125 WT A750080 deletion LftR: frame shift
LMSH126 WT A750155 deletion LftR: frame shift
LMSH127 WT A750080 deletion LftR: frame shift
LMSH128 WT G749973T lftR RBS mutation
LMSH129 WT C750039T LftR: premature stop
LMSH130 WT A750182 deletion LftR: frame shift
LMSH131 WT A750155 deletion LftR: frame shift
LMSH132 WT C750121T LftR: T46M
LMSH133 WT C750062A LftR: premature stop
LMSH134 WT A insertion afterA750155 LftR: frame shift
LMSH135 WT A750080 deletion LftR: frame shift
LMSH136 WT A749939G PlftR -10 box mutation
LMSH137 WT T750252 deletion LftR: frame shift
LMSH138 WT A750155 deletion LftR: frame shift
LMSH139 WT A750155 deletion LftR: frame shift
LMSH140 WT A750155 deletion LftR: frame shift
LMSH141 ∆lftS G750193A LftR: G70D
LMSH142 ∆lftS C750141T LftR: R53C
LMSH143 ∆lftS C750141T LftR: R53C
LMSH144 ∆lftS C750141T LftR: R53C
LMSH145 ∆lftS C749998T LftR: T5I
LMSH146 ∆lftS G750237T LftR: premature stop
LMSH147 ∆lftS C750141T LftR: R53C
LMSH148 ∆lftS C750141T LftR: R53C
LMSH149 ∆lftS T750252 deletion LftR: frame shift
LMSH150 ∆lftS G750253A LftR: premature stop
LMSH151 ∆lftS G750165T LftR: premature stop
LMSH152 ∆lftS T750252 deletion LftR: frame shift
LMSH153 ∆lftS T750252 deletion LftR: frame shift
LMSH154 ∆lftS G750237T LftR: premature stop
LMSH155 ∆lftS C750141T LftR: R53C
LMSH156 ∆lftS C750141T LftR: R53C
LMSH157 ∆lftS T750252 deletion LftR: frame shift
LMSH158 ∆lftS T750252 deletion LftR: frame shift
LMSH159 ∆lftS C750141T LftR: R53C
LMSH160 ∆lftS C750141T LftR: R53C
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As expected, mutations in the lftR gene could be found in all suppressors. A complete list
of all mutations that were identified is given in table 4.2. The inactivation of the repressor
in some cells led to the observation that the ∆lftS strain has the same MIC as the wild
type. Interestingly, when the same procedure to select suppressors was done for the wild
type, suppressors were also isolated. From 20 colonies grown separately at 750 ng/ml
aurantimycin (highest concentration yielding growth), all 20 were suppressors with mu-
tations in lftR or its promoter (see table 4.2). Besides mutations that obviously inactivate
LftR, like premature stop codons or frame shifts, five single amino acid substitutions in
LftR were found (G27S, T46M, G70D, R53C and T5I). These might causally link the
de-repression to the structure and function of LftR (see discussion).
3.4 Identification of the LftR operator site
3.4.1 Determination of the minimal PlieA promoter
To identify the region of the DNA containing the regulatory elements required for the pro-
moter activity, the 266 bp long PlieA-lacZ reporter (LMSH5) used in the induction screens
described above was consecutively shortened to 193 bp, 152 bp, 122 bp and 97 bp up-
stream of the lieAB start codon. The resulting reporter strains were LMSH30, LMSH31,
LMSH32 and LMSH33. The activity of the shortened PlieA-lacZ reporter constructs was
determined by spotting 2 µl aurantimycin (2.5 mg/ml) onto the respective reporter strains
in the agar based induction assay also described above. Panel B in figure 3.18 shows that
the shortest promoter retaining inducability by aurantimycin is 122 bp long. An in silico
promoter prediction using the bprom online tool indicates that the next shortest region (97
bp in length) has lost the -35 box of the promoter (Solovyev and Salamov 2011). Without
the -35 box, transcription initiation is no longer possible. This explains the observation
that the 97 bp long fragment is no longer showing inducability. The 122bp long PlieA
promoter retained promoter activity, but was inactive unless induced by aurantimycin.
This indicated that this fragment must contain all elements necessary for initiation of
transcription as well as the LftR operator site.
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Figure 3.18: Defining the minimal PlieA promoter. The initially con-
structed PlieA-lacZ reporter (LMSH5) contained a 266 bp long fragment
upstream of lieA. Shown in panel A is the consecutive shortening of this
region to 193 bp (LMSH30), 152 bp (LMSH31), 122 bp (LMSH32) and
97 bp (LMSH33) upstream of lieA. Black boxes indicate the promoter
boxes and arrows an inverted repeat present in the sequence. Panel B
shows a loss of LacZ-activity for the 97 bp long fragment when induced
by 2 µl aurantimycin A (2.5 mg/ml).
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3.4.2 Identification of the PlieA promoter region important for LftR
binding
The previous results indicated that the 122 bp long promoter fragment contains the LftR
operator. The next step in the identification of the LftR operator was to find DNA bases
important for the binding by LftR. Based on the shortest active fragment identified, 10
bp long stretches of the promoter were mutated. Here, transversions of A to T, T to A,
G to C, or C to G were made in order to prevent significant changes in DNA melting
behaviour. These mutations were carried out in the region between base pair 69 and
base pair 21 before the lieA start codon. Residues 122-69 were not mutated, because
they contain the -35 and -10 box. Residues after base pair 21 were also not mutated,
because they containd the ribosome binding site. The five mutants versions of the PlieA-
lacZ reporter made resulted in the strains LMSH44, LMSH45, LMSH46, LMSH47, and
LMSH48. The DNA sequence of the resulting promoter fragments is shown in figure
3.19 (panel A). The ribosome binding site is also indicated in gray. When these strains
were investigated for promoter activity and inducability by aurantimycin, the first two
(containing mutations between the base pairs 69 and 51) showed high β -galactosidase
activity (blue color) even in the absence of aurantimycin (see figure 3.19, panel B). The
de-repression observed suggests that the region between base pair 69 and 51 contains the
sought after LftR binding motif.
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Figure 3.19: Identification of DNA regions important for LftR bind-
ing. Mutations in 10 bp long stretches of the PlieA-lacZ reporter were
made resulting in the strains LMSH44, LMSH45, LMSH46, LMSH47,
and LMSH48. The resulting DNA sequences are shown with mutations
having an effect on the promoter activity highlighted in blue and muta-
tions without a visible effect highlighted in yellow. The ribosome binding
site is indicated in gray (see panel A). The β -galactosidase activity, as
measured in the agar-based assay, shows that mutations in the region be-
tween 69 bp and 51 bp before the lieAB start codon result in a visible
constitutive expression from PlieA as indicated by the blue background
(see panel B).
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3.4.3 Systematic mutagenesis of the 69-51 bp region of the PlieA pro-
moter to identify the LftR binding motif
With the information obtained, the region between base pair 69 and 51 upstream of the
lieAB start codon should contain the putative LftR binding site. The next step was a more
targeted mutational analysis of 2 base pairs at a time in this region. Like before, the
mutations made were transversions (A to T, T to A, G to C, or C to G). The ten resulting
strains (LMSH51 to LMSH61) were screened in the agar-based and the β -galactosidase
assay for their promoter activity and inducability by aurantimycin. The wild type and
∆lftR mutant were used as controls. The modified promoter sequences are shown in figure
3.20, panel A, with mutations impacting LftR binding highlighted in blue and mutations
without a significant impact highlighted in yellow. The results of the agar based assay
indicate that starting from the duplet of base pairs 69-68 to the duplet 57-56 every second
duplet has a significant effect on the strength of repression. This can be seen in the
strongly blue background in the agar-based assay (figure 3.20, panel B). The promoter
activity was measured by quantifying the resulting β -galactosidase activity (figure 3.20,
panel C). These results confirmed the agar-based experiments and suggest that the base
pairs GT-NN-TA-NN-GA-NN-AC are important for the LftR-DNA interaction.
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Figure 3.20: Identification of base pairs important for the LftR-DNA
interaction. Mutations in 2 bp long stretches (duplets) of the 69-51 bp
region were made resulting in the ten strains LMSH51 to LMSH61. The
resulting DNA sequences are shown in panel A, with mutations impact-
ing LftR binding highlighted in blue and mutations without a significant
impact highlighted in yellow. Panel B: Results of the agar-based assay for
PlieA activity and inducability. The wild type and ∆lftR mutant are shown
for reference. Panel C: β -galactosidase activity measurements for PlieA
activity of the mutated reporters. Shown are average values and standard
deviations from three independent experiments.
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3.4.4 Confirmation of the LftR operator in PlftRS
It was shown by RNA sequencing that LftR regulates both the lieAB and the lftRS oper-
ons. Therefore, the LftR binding motif must be present in the promoter region of both
genes. Comparing the 14 bp long stretch identified in the lieA promoter to the lftR pro-
moter, a shared motif could be identified (see figure 3.21). This motif is located 13 bp
downstream of the -10 box of the PlieA promoter, but it overlaps with the -10 box in the
PlftR promoter. It should thus be impossible to modify without disrupting the promoter
activity. Interestingly, a second putative binding site in the PlieA promoter became obvious
at this stage (underlined in red in figure 3.21). Mutations in this region did not result in
altered promoter activity or inducibility, though (data not shown).
Figure 3.21: A sequence comparison of the lieA and lftR promoters.
A common motif (high-lighted in blue with light blue indicating an AT
wobble position) could be identified in both the lieA and the lftR promot-
ers. Arrows further indicate the inverted repeat at the beginning and the
end of the proposed binding site. Underlined in red is a second putative
binding site in the lieA promoter. The overlapping -10 box of the lftR
promoter is underlined by a dashed line.
Three mutants with inverted base pairs at the beginning (LMSH69 = mutant 1), end
(LMSH70 = mutant 2) and middle (LMSH71 = mutant 3) of the proposed binding site
in the lftR promoter were constructed and tested for promoter activity in the agar-based
assay with the wild type promoter as a control (see figure 3.22, panel B). The promoters
of mutants 1 and 3 showed no activity even in the presence of the inducer aurantimycin A,
because the mutations introduced alter the -10 box (dashed underline in panel A of figure
3.22). When the end of the putative binding motif was mutated though, a strong blue
background color resulted (see mutant 2 in figure 3.22, panel B). The fact that the mu-
tation of the second part of the inverted repeat constitutively activates the PlftR promoter
confirmed the binding site identified in the lieA promoter.
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Figure 3.22: Mutations confirming the LftR binding motif in the lftR
promoter. The reporter strains LMSH69 (mutant 1), LMSH70 (mutant
2) and LMSH71 (mutant 3) were created to confirm the putative LftR
binding motif (highlighted in blue) in the lftR promoter. The mutations
introduced in the three mutants are shown in red print (panel A). The
inactivation of the downstream part of the inverted repeat (indicated by
black arrows) in mutant 2 resulted in strong activity of the PlftR promoter
(panel B). The promoters of mutant 1 and 3, mutating the beginning or
middle of the binding motif, show no activity even in the presence of the
inducer aurantimycin (panel B).
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3.5 Effect of the genes sigC, lstR and lmo0421 on the re-
sistance against the inducing macrolides josamycin
and tylosin
In previous sections, it was shown that LstR mainly controls the expression of its own
operon (sigC-lstR-lmo0421) and that expression of this operon is notably induced by the
16-membered macrolide antibiotics josamycin and tylosin. Following the results obtained
with aurantimycin in the case of LftR, the MIC values of the inducing antibiotics were
determined by the broth dilution method for different mutants lacking individual genes
of the sigC operon or combinations thereof. The strains LMSH39 (lstR*), LMSH40
(lstR*∆lmo0421), LMSH89 (sigC*), LMMSH90 (lstR* sigC*) were investigated for al-
tered resistance levels compared to the wild type. In contrast to the LftR case though,
the MICs were identical for nearly all strains tested (see table 3.11). Here, the induction
of lmo0421 expression in the lstR* mutant did not lead to detectable resistance against
josamycin or tylosin, nor did the deletion of lmo0421 affect the resistance against these
antibiotics.
Table 3.11: Macrolide MIC values. MIC values of the strains LMSH39
(lstR*), LMSH40 (lstR*∆lmo0421), LMSH89 (sigC*), LMMSH90 (lstR*
sigC*) exposed to the inducing macrolides josamycin and tylosin. Aver-
age values of three independent experiments are shown and the wild type
MIC is listed for reference.
Genotype MIC MIC
josamycin [µg/ml] tylosin [µg/ml]
wild type 2 4
lstR* 2 4
lstR* ∆lmo0421 1.8 4
∆lmo0421 2 4
∆sigC 2 4
∆sigC lstR* 2 4
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3.6 Effect of lstR and lmo0421 on the resistance against
cell wall targeting antibiotics
The sigC-lstR-lmo0421 operon consists of two genes modulating transcription (sigC as an
activator and lstR as an repressor), the gene regulated in this operon should be lmo0421.
Lmo0421 contains streches of significant sequence homology to the RodA/FtsW fam-
ily of cell division proteins involved in peptidoglycan polymerization (Emami et al. 2017,
Rismondo et al. 2019). L. monocytogenes encodes 6 proteins belonging to the FtsW/RodA
family based on sequence homology (Rismondo et al. 2019). Visualizing the sequence
similarity of those proteins allows conclusions on their relationships to be drawn (Ga-
baldo´n 2005). Figure 3.23 shows a phylogenetic tree visualizing the sequence similarity
between the 6 proteins. Using the well described B. subtilis RodA and FtsW proteins
as a reference, it is possible to assign an approximate function to the listerial proteins
(Henriques et al. 1998, Emami et al. 2017) and most of the enzymes have recently been
characterized (Rismondo et al. 2019). As shown in figure 3.23, Lmo0421 is grouped out-
side both groups and might thus not be a typical FtsW- or RodA-like protein. The major
difference seems to be a nearly 70 amino acid long region at the N-terminus of Lmo0421
that is mainly composed of hydrophilic amino acid and absent in the other FtsW/RodA-
like proteins.
Figure 3.23: Phylogenetic tree visualizing the relationships between
the 6 listerial proteins belonging to the RodA/FtsW family. The lis-
terial proteins form two distinct clusters with the RodA/FtsW proteins
BsRodA, BsFtsW and BsSpoVE from B. subtilis. The B. subtilis proteins
are shown as a reference, because their functions are well defined and
seem to be identical to listerial proteins in the same cluster (Henriques
et al. 1998, Emami et al. 2017, Rismondo et al. 2019).
The deletion of RodA/FtsW proteins usually leads to an alteration of the resistance to
the antibiotic moenomycin that targets cell wall biosynthesis step mediated by these pro-
teins (vanHeijenoort et al. 1987, Emami et al. 2017, Rismondo et al. 2019). In order to
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determine the resistance level against moenomycin as well as other cell wall targeting
antibiotics like penicillin and vancomycin, the strains lstR* and lstR*∆lmo0421 mutants
were tested in diffusion assays. The results are shown in figure 3.24 and indicate that
Lmo0421 does not act like a typical RodA/FtsW protein, because no differences in re-
sistance could be observed for moenomycin. As none of the other cell wall targeting
antibiotics causes any measurable effect, Lmo0421 also does not seem to have a role in
the biosynthesis of the cell wall in general, at least under the conditions investigated.
Figure 3.24: Resistance against cell wall biosynthesis inhibiting an-
tibiotics. Disk diffusion assays were performed to determine the suscep-
tibility of the wild type, lstR* (LMSH39) and lstR* ∆lmo0421 (LMSH40)
mutants to different antibiotics targeting the cell wall biosynthesis. Filter
discs (6 mm diameter) soaked with antibiotic solution (10 µl of 1 mg/ml
penicillin G, 20 mg/ml vancomycin, 1.6 mg/ml moenomycin, 40 mg/ml
bacitracin, 20 mg/ml fosfomycin, or 30 mg/ml cycloserine) were placed
onto a BHI plate inoculated with a lawn of one bacterial strain. Three
independent experiments were performed and the average diameter of the
inhibition zone resulting after over night incubation at 37°C is shown with
the standard deviation.
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3.7 Determining if Lmo0421 has RodA- or FtsW-like func-
tionality
The genome of L. monocytogenes encodes a high numer of RodA- or FtsW-like proteins
that could mask the enzymatic activity of Lmo0421. The genomic location of all the
rodA- and ftsW-like genes is shown in figure 3.25, panel A. Another attempt to deter-
mine whether Lmo0421 has RodA/FtsW functionality was made. The gene lmo0421 was
strongly over-expressed in the lstR* background (this strain was shown to have the same
PsigC activity as the ∆lstR mutant in figure 3.14). When Lmo0421 has the same function as
a RodA or FtsW enzyme, it should be able to take over their role in cell wall biosynthesis.
To test this hypothesis, the unessential lmo2427-lmo2428 operon encoding two of the
RodA homologs (Rismondo et al. 2019) was deleted first. This deletion reduced the
number of proteins with proven RodA-functionality to one. This last gene (rodA3) is
essential for survival under standard conditions (Rismondo et al. 2019). It could then
be tested whether Lmo0421 has RodA activity by inactivation of the rodA3 gene in a
strain expressing lmo0421. In the case that Lmo0421 has RodA activity, the essential
rodA3 gene should become dispensable. Similarly, inactivation of the ftsW genes in the
lmo0421 expressing lstR* mutant should show whether Lmo0421 has FtsW activity.
Using the wild type, the lstR* (LMSH39), ∆rodA1-rodA2 (LMSH67) and the ∆rodA1-
rodA2 lstR* (LMSH68) mutants, we attempted to inactivate the remaining RodA- or
FtsW-like proteins by insertion of a plasmid that disrupts the genes. To do so, pMAD
derivatives containing an internal part of the genes lmo1071 (ftsW1), lmo2688 (ftsW2)
and lmo2687 (rodA3) followed by a TAA stop codon were constructed. These plasmids
can be integrated into the genome at 42°C, because they possess an temperature-sensitive
origin of replication. Integration of the plasmid into the target gene would result in two
disrupted gene fragments, thereby inactivating the gene product (see figure 3.25, panel
B).
The results of the inactivation experiments are shown in figure 3.25, panel C. In the wild
type and lstR* background only ftsW1 was essential. When rodA1 and rodA2 have been
deleted, rodA3 and ftsW2 also become essential. This observation is in agreement with
other results on the function of these genes (Rismondo et al. 2019). The lmo0421 overex-
pressing strains (lstR*) are unable to compensate for the loss of the rodA or ftsW genes.
When over-produced, Lmo0421 should have been able substitute for the loss of the other
genes. As this is not the case, Lmo0421 does not exhibit a RodA/FtsW functionality
under the conditions tested.
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Figure 3.25: Disruption of the rodA- and ftsW-like genes. Panel A:
Genomic location of the rodA and ftsW homologous genes of L. mono-
cytogenes. Panel B: Plasmids constructed to inactivate the RodA/FtsW
homologs lmo1071 (ftsW1), lmo2688 (ftsW2) and lmo2687 (rodA3) con-
tained an internal fragment of the respective genes followed by a stop
codon, as well as an erythromycin resistance marker (ermR) and a heat-
sensitive origin of replication (orits). Panel C: Results of the inacti-
vation experiments in the wild type, lstR* (LMSH39), ∆lmo2427-2428
(LMSH67) and ∆lmo2427-2428 lstR* (LMSH68) backgrounds.
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3.8 Cold-sensitive growth phenotype of the lltR* mutant
The genes of the lltR-lmo0600-lmo0601 operon have not been characterized in the scien-
tific literature. Our screen of the natural compound collection performed here to identify
conditions leading to gene expression also failed to identify substances that induce the
lltR-lmo0600-lmo0601 operon, which therefore remains enigmatic. In order to identify
phenotypes that might be associated with the PadR-like repressor LltR, standard experi-
ments to phenotypically describe listerial strains were performed. These included growth
in BHI at 30, 37 and 42°C, lysozyme induced lysis and intra-cellular replication in murine
macrophages, but non yielded significant differences (data not shown). Interestingly,
when the lltR* mutant was kept on agar plates at 6°C for prolonged periods of time,
the colonies did not seem to grow larger. The ability of L. monocytogenes to grow at low
temperature was used in the past to enrich cultures for Listeria (Lewis and Corry 1991).
To test if the growth of the lltR* mutant is impaired at refrigeration temperatures, liquid
cultures were inoculated and incubated statically at 6°C. A clear growth inhibition could
be observed at 6°C, while the mutant behaves like the wild type at 37°C (see figure 3.26).
The ladR and lstR mutants are shown for reference, but do not exhibit any difference to
the wild type at both temperatures.
Figure 3.26: Cold-sensitive growth phenotype of the lltR* mutant.
Strains LMSH1 (∆ladR), LMSH2 (∆lstR) and LMSH3 (lltR*) behave like
the wild type when grown in BHI at 37°C (panel A). When the same
strains are grown at 6°C though, the lltR* mutant shows a pronounced
growth deficit (panel B).
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To confirm that the growth defect at low temperature is caused by the inactivation of
LltR in the lltR* mutant, a plasmid carrying a copy of the original gene under the control
of an IPTG-inducible promoter was constructed. This plasmid was introduced into the
lltR* mutant and the growth of the resulting strain (LMSH42) was monitored on BHI
plates with and without IPTG at 6°C. In the presence of an intact copy of the lltR gene,
the lltR* mutant was again able to grow at refrigeration temperature (see figure 3.27).
The presence or absence of the inducer IPTG was not important, presumably because a
very low transcription level is sufficient for the strong repressor LltR to fulfil its function.
These observations are in accordance with the low expression level and autoregulatory
nature of the lltR gene that have been shown in the RNA sequencing experiments. It can
thus be concluded, that active LltR is important for the growth of L. monocytogenes on
BHI at low temperatures.
Figure 3.27: Complementation of the cold-sensitive phenotype. After
6 weeks of incubation at 6°C on BHI agar containing 1 mM IPTG, the
wild type grew into big colonies (left), while the strain LMSH3 (lltR*)
formed only small colonies (top). The introduction of a plasmid carrying
an intact copy of lltR into the lltR* mutant (strain LMSH42) complements
the growth defect.
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3.9 Effect of the genes lmo0600 and lmo0601 on growth
at refrigeration temperature
According to the RNA sequencing results, the two genes lmo0600 and lmo0601 are
strongly up-regulated in the lltR* mutant when compared to the wild type. To deter-
mine if the growth deficit of the lltR* mutant is caused by the over-expression of one
of those genes, lmo0600 and lmo0601 were deleted in the lltR* background resulting in
the strains LMSH50 (lltR* ∆lmo0600) and LMSH51 (lltR* ∆lmo0601). The deletion of
lmo0600 restored the growth of the lltR* mutant at 6°C. The lltR* ∆lmo0601 strain on the
other hand, did not grow at refrigeration termperature (see figure 3.28).
Figure 3.28: lmo0600 is responsible for the growth defect 6°C. The
over-expression of lmo0600 causes the growth deficit of the lltR* mu-
tant at 6°C. The strains LMSH3 (lltR*), LMSH50 (lltR* ∆lmo0600) and
LMSH51 (lltR* ∆lmo0601) were grown for 6 weeks at 6°C on BHI agar
with the wild type as a reference.
The deletion of lmo0601 in the lmo0599 mutant background seemed to change the colony
morphology when grown at 6°C (data not shown). It appeared as though the colonies
became translucent or started to lyse when compared to the parental lltR* mutant. If
this impression was true and lysis actually occured, then it should become more apparent
after longer incubation times. To investigate this hypothesis, the plate shown in figure
3.28 was incubated for another 6 months at 6°C. After this long incubation period, it
became obvious that the mutant lltR*∆lmo0601 did indeed lyse (see figure 3.29).
The fact that the deletion of lmo0600 in the lltR* background re-enables growth at low
temperatures, while the deletion of lmo0601 aggravates the phenotype by leading to lysis
suggests that both proteins are important for growth at low temperatures and might be
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Figure 3.29: The gene lmo0601 seems to protect the cells from lysis
at low termperature. The same plate as shown in figure 3.28 after an
incubation period totalling 7.5 months at 6°C. The lltR*∆lmo0601 mutant
(LMSH51 in the bottom right section) did lyse nearly completely.
functionally related. The exact biological function of the lltR-lmo0600-lmo0601 operon
and conditions leading to its expression still need to be clarified in future experiments.
3.10 Characterization of lltR* suppressor mutants that
are able to grow at 6°C
When the lltR* mutant LMSH3 was grown on BHI agar plates at 6°C for prolonged
periods of time, some colonies grew much larger in size than all the rest (data not shown).
To determine if the bacteria in these colonies had regained the ability to grow under
refrigeration, they were streaked to single cells and grown over night at 37°C. A single
colony was then transferred into liquid medium and after incubation at 37°C the resulting
culture was stored at -80°C. Material from these cultures was again streaked onto BHI
and incubated at 6°C for 6 weeks to confirm the ability to grow at low temperature. The
parental strain LMSH3 (showing only weak growth) and the wild type (showing growth)
were used as controls. The results (not shown) confirmed that all the isolated suppressor
grew like the wild type. The same procedure was repeated for the lltR* ∆lmo0601 mutant
(LMSH51), which was also unable to grow at 6°C. Suppressors could be easily isolated
in this mutant as well.
The overexpression of lmo0600 caused the inability of the lltR* and the lltR* ∆lmo0601
mutants to grow at low temperatures (see figure 3.28). The possibility that the suppressors
that were again able to grow had acquired mutations in lmo0600 was investigated next.
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The genomic region of lltR-lmo0600 and the PlltR promoter were amplified by PCR and
sequenced. The results confirmed that most mutants did indeed inactivate lmo0600 (see
Table 3.12). A disruption of Lmo0600 by insertion of a premature stop codon or a frame
shift was most commonly observed. There were also three single amino acid exchanges
in Lmo0600 that could have occurred at positions important for the protein function.
Interestingly, one mutation seemed to affect the repressor LltR instead of Lmo0600. The
exchange C16F at the beginning of LltR affected a cysteine residue in the α-1 helix.
This position is not conserved among the PadR-like transcriptions factors (see figure 1.4)
and the role of this position is so far unclear. One possible explanation why this exchange
leads to growth at 6°C could be that LltR* with the C16F exchange is again able to repress
its operon.
Table 3.12: Suppressor mutations of the cold-sensitive phenotype.
Mutations found in suppressors isolated from the lltR* (LMSH3) and the
lltR* ∆lmo0601 mutants grown at 6°C. The base exchanges detected are
indicated together with their position in the genome and the resulting ef-
fect they have on the Lmo0600 protein or on LltR.
Strain Background Mutation Effect
LMSH104 lltR* A640221G PlltR -35 box mutation
LMSH105 lltR* A640869 deletion Lmo0600: frame shift
LMSH106 lltR* A640758C Lmo0600: Q45P
LMSH107 lltR* A640221G PlltR -35 box mutation
LMSH108 lltR* A640869 deletion Lmo0600: frame shift
LMSH109 lltR* G640611T Lmo0600: RBS mutated,
LltR: E104D
LMSH110 lltR* ∆lmo0601 C640782A Lmo0600: P53Q
LMSH111 lltR* ∆lmo0601 C640871T Lmo0600: Q83 stop
LMSH112 lltR* ∆lmo0601 C640757T Lmo0600: Q45 stop
LMSH113 lltR* ∆lmo0601 G640346T LltR: C16F
LMSH114 lltR* ∆lmo0601 insertion after T641002 Lmo0600: frame shift
LMSH115 lltR* ∆lmo0601 C640757T Lmo0600: Q45 stop
LMSH116 lltR* ∆lmo0601 insertion after A640656 Lmo0600: frame shift
LMSH117 lltR* ∆lmo0601 G640731A Lmo0600: G36E
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Chapter 4
Discussion
4.1 PadR-like repressors strongly regulate a small set of
genes
The RNA sequencing data obtained for the ∆lftR mutant fit well to the previous knowl-
edge of tight regulation of the lieAB operon. The strong overproduction of LieAB in a
∆lftR mutant was first shown using crude protein extracts (Kaval et al. 2015). The high
amount of lieAB mRNA detected using RNA sequencing (nearly 500-fold more in the
∆lftR mutant than in the wild type) supports this observation. Besides confirming existing
knowledge, RNA sequencing also revealed the autoregulation of the lftRS operon (see
table 3.2). Northern blotting to detect lftS mRNA (see figure 3.6) and LacZ-assays (see
figure 3.5) verified the autoregulation and lend overall confidence to the results.
The two genes lmo0981 and lmo0982 located immediately downstream of lieAB are also
up-regulated significantly in the ∆lftR mutant. A closer look at how the sequencing reads
map to this region of the genome revealed that transcription is not properly terminated
after lieB, so that longer transcripts spanning the entire region form lmo0979 to lmo0982
are formed. This effect is probably due to the complete absence of LftR, a constella-
tion unlikely to occur under natural conditions. Under natural conditions, LftR will be
gradually inactivated at contact with the inducer, allowing expression of lieAB and lftRS
operons. New repressor molecules will be produced together with the LieAB transporter
and these additional LftR molecules can then repress transcription as soon as the antibi-
otic concentration drops due to the activity of the LieAB transporter. The auto-regulatory
nature of LftR (the more LftR is inactivated, the more new LftR will be synthesized) thus
prevents constantly high transcription levels and the induction rate is rather determined by
the dynamic equilibrium between the concentration of the repressor LftR and its effector.
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Smaller regulatory effects were also observed in the RNA sequencing data for the ∆lftR
mutant. The data revealed the down-regulation of SigB-controlled genes (see table 3.3).
The down-regulation ranged from around 2.4-fold to around 30-fold. An explanation
for all of the down-regulated genes was found in a second mutation that abolished RsbT
activity (see figure 3.3). Mutations in rsbT are known to lead to a sigB null phenotype
(Chaturongakul and Boor 2004), so the rsbTC10T mutation probably caused the inactiva-
tion of SigB in the strain LMKK42. Overall, the data for the ∆lftR mutant is in accordance
with existing knowledge, as well as extending the regulon of LftR by the lftRS operon.
In the case of LadR, the regulation of the multi-drug-efflux pump encoding gene mdrL is
well known (Huillet et al. 2006). Also, the induction of mdrL expression in a ladR mutant
was measured as being around 30-fold in a previous study (Crimmins et al. 2008). This
latter study also showed a three-fold induction of the multi-drug-transporter gene mdrM
in the ∆ladR mutant background (Crimmins et al. 2008). In perfect agreement with these
results, RNA sequencing data showed a more than 150-fold induction of mdrL. The two
other genes significantly regulated in the ∆ladR mutant were the 3-fold up-regulated efflux
pump lmo1617 (mdrM) and its transcriptional regulator lmo1618 (marR). These genes
are transcribed together as one operon (Toledo-Arana et al. 2009) and mdrM is known
to be LadR-regulated (Crimmins et al. 2008). Thus, even the relatively weak three-fold
induction of mdrM and marR expression was reliably detected using RNA sequencing and
confirmed the previous result. A ∆marR mutant induced mdrM around 70-fold (Crimmins
et al. 2008). It thus seems like mdrM is not a primary target of LadR, but is regulated due
to weak interaction effects.
The lineage-specific thermal regulator LstR showed a more complex regulatory behavior
than LadR. In total there were six up- and four down-regulated genes (see table 3.5 and
3.6). Of these genes, the most strongly regulated were lmo0421 and lmo0423 (sigC). Both
are located in the same operon as lstR (Toledo-Arana et al. 2009). Other up-regulated
genes (lmo0420 and lmo0419) are located directly downstream of the sigC-lstR-lmo0421
operon. The function of lmo0419 and lmo0420 remains unclear. In the absence of LstR,
the strong transcription from the sigC promoter might not be properly terminated. This
leads to the production of transcripts from genes located downstream of this operon, for
example lmo0420. In the case of lmo0420, these transcripts are in anti-sense orientation
and might interfere with the expression and regulation of this gene (Thomason and Storz
2010). The gene lmo0419 has the same orientation as the sigC operon and is therefore up-
regulated by incomplete termination of sigC-lstR-lmo0421 transcripts. This is a similar
situation as was observed with up-regulated lieAB transcripts in the ∆lftR mutant, where
incomplete termination of transcription after lieAB lead to transcription of the down-
stream genes lmo0981 and lmo0982. Similar effects occur in the ∆lstR mutant, but are
most likely irrelevant under natural conditions.
The genes up-regulated in the lltR* (lmo0599) mutant show the same general pattern as
observed for other PadR-like repressors. The lltR-0600-0601 operon is strongly repressed
by LltR. The next most strongly regulated gene lmo0602 is located immediately down-
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stream and in the same orientation. It is annotated as a transcriptional regulator and might
be responsible for the weak up-regulation observed for a small number of other genes. It
could also be the case that LltR itself has small effects on their expression. This behavior
could be similar to the weak regulation of the marR-mdrM operon by LadR.
In conclusion it can be said, that the PadR-like repressors investigated strongly regulate
a small set of genes and most of them are auto-regulatory. Strongly repressed genes are
up-regulated around 150-fold in the mutants lacking the cognate repressor. The auto-
regulation could not be shown for ladR, as a ∆ladR mutant was used. Still, the ladR
and mdrL genes are transcribed from promoters located in the same intergenic region (see
figure 1.5). Therefore, the control of both promoters by one LadR-binding operator seems
possible.
Smaller regulatory effects on a limited number of genes could also be observed in the
RNA sequencing data. Incomplete termination of transcription (in the case of lftR, lstR
and lltR) or weak recognition of other operators (as is likely for ladR) could be factors
resulting in minor up-regulation of secondary genes. Such effects are unlikely to manifest
under natural circumstances, because the induction of auto-regulatory systems can never
lead to the same expression level as the deletion of the repressor. The negative feedback
loop integrated in the regulation will prevent constantly high expression levels and might
serve to limit gene expression to the lowest level still resulting in an efficient response.
Over all, the RNA sequencing results proved to be very reliable, because they could be
confirmed using LacZ assays and Northern blotting. Further, previously published results
could be confirmed as well. However, it was impossible to draw conclusions on the
biological function of the PadR-like repressors from the pattern of deregulated genes
observed by RNA-Seq. The conditions leading to induction of PadR-dependent genes as
well as their function need to be determined in separate experiments.
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4.2 Conditions leading to the activation of PadR-dependent
promoters
It was shown by RNA sequencing that the genes controlled by PadR-like repressors are
not significantly expressed in L. monocytogenes EGD-e under standard conditions. Such
tight regulation indicates that the target genes are beneficial only under very specific cir-
cumstances. The expression is normally switched off by the PadR-like repressors, be-
cause it would result in a waste of energy and could also be detrimental to growth and
survival of L. monocytogenes. This becomes especially clear in the case of LltR where
the over-expression of its target gene lmo0600 prevents growth at refrigeration tempera-
ture (see figure 3.28). The same could be the case with LadR-controlled mdrL expression
under infection conditions, because the inactivation of the repressor leads to an increased
interferon response (Crimmins et al. 2008). An increased interferon response on the other
hand has been shown to decrease the capacity of the bacteria to grow in vivo (Crimmins
et al. 2008). LftR also switches of the production of the ABC-type transporter LieAB that
could import toxic substances like ethidium bromide (Kaval et al. 2015).
Knowledge of conditions leading to the induction of normally silent genes could help
to identify the function of those genes. In literature, several conditions and substances
have been described to induce expression of genes controlled by PadR-like transcription
factors (Ahmed et al. 1994, Morita et al. 2003, Zhang et al. 2005, Huillet et al. 2006, Tran
et al. 2008). An initial screen of these conditions identified rhodamine 6G and rhodamine
B as inducers of LftR-controlled gene expression (see figure 3.7). Rhodamine dyes do
not occur in nature (Cooksey 2016), so they are unlikely to be natural effectors of LftR.
Still, even artificial substrates allow the study of the underlying mechanisms regulating
gene expression. For example, it was possible to identify the essentiality of LftS for lieAB
induction using the rhodamine dyes (see figure 3.10).
For the repressor LadR, no inducing conditions could be found, despite previous studies
indicating that it reacts to rhodamine 6G in a different L. monocytogenes strain (Huillet
et al. 2006, Crimmins et al. 2008). The RNA sequencing data showed that the absolute
expression of lmo1409 (mdrL) in the ∆ladR mutant is relatively low, when compared to
the other PadR-type repressors (see figure 3.1 or figure 3.5). The expression from the
LadR-controlled mdrL promoter was also low in the β -galactosidase assay, compared to
the promoters controlled by LftR, LstR and LltR (see figure 3.5). It could therefore be the
case that the expression level under inducing conditions is not high enough to be detected
in the agar based screen. The induction by rhodamine 6G has not been quantified in this
work. The quantification could be used as a control to confirm whether in the EGD-e
background there is a weak induction or no induction at all.
The tight repression of mdrL might be essential under some conditions, for example dur-
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ing infection so as to not induce host defenses. This makes sense in the light of the fact
that lmo1409 influences the interferon response in eukaryotic host cells (Crimmins et al.
2008). Using qPCR it has been shown that in the presence of rhodamine 6G mdrL is
up-regulated, but expression remains at a fairly low absolute level (Crimmins et al. 2008).
Under the same conditions, the expression levels observed for other pumps (mdrT and
mdrM) reached much higher levels than for mdrL (Crimmins et al. 2008). This corrob-
orates the hypothesis that the low absolute expression is the reason why the agar based
assay failed to detect induction. In the case of lieAB, induction by aurantimycin A was
easily detectable due to the very strong activity of the lieAB promoter (see figure 3.1 or
figure 3.5). When L. monocytogenes comes into contact with this compound, a high ex-
pression level is absolutely essential for survival, because without quick production of
the LieAB transporter the cell would lyse and die. If MdrL is transporting a less toxic
substance, a low absolute expression level under inducing conditions might be sufficient.
A very high transport efficiency or low membrane permeability of the target compound
could also compensate for low expression levels.
Even if rhodamine 6G is an effector of LadR, it is of synthetic origin (Cooksey 2016)
and therefore unlikely to be the original target molecule of the naturally evolved LadR-
MdrL system. A natural effector might give a much clearer induction signal no matter
if measured by qPCR or the agar based screen. Taken together, the data suggest that
the natural effector of LadR and the substrate of MdrL have not yet been identified. The
LacZ-based reporter assay may also not have been suitable to detect induction of the PsigC
promoter by heat, because of LacZ stability or expression issues at elevated temperatures
(Schro¨gel and Allmansberger 1997).
An unbiased screen of a natural compound collection was performed, because the initial
testing of conditions and substrates mentioned in the literature only identified rhodamine
dyes as artificial substrates. The screen of the DZIF natural compound library contain-
ing 681 secondary metabolites from streptomycetes, myxobacteria and fungi revealed
one substance that induced LftR-controlled genes and two substances that induced LstR-
controlled genes. Transcription of the LftR-controlled lieAB genes encoding an ABC-type
transporter was induced by the depsipeptide antibiotic aurantimycin A and the lstR operon
was induced by the 16-membered macrolide antibiotics niddamycin and josamycin. No
substances that induce expression of the lltR operon or of the mdrL gene were found.
This suggests that the observed induction of lieAB by aurantimycin and the lstR operon
by josamycin and niddamycin is specific for the respective repressor-effector combina-
tions.
125
4.3 LftR-controlled aurantimycin-resistance genes might
be important for the survival of L. monocytogenes in
the environment
When antibiotics specifically induce gene expression, the regulated genes often confer
some kind of resistance to the antibiotic (Ohki et al. 2003, Lai et al. 2007, Chancey
et al. 2011, Nawrocki et al. 2014). This was also the case for LftR, which controlled
the production of the ABC-type transporter LieAB. The exposure L. monocytogenes to
aurantimycin induced lieAB expression and the LieAB transporter conferred resistance to
aurantimycin-induced lysis (see figure 3.15).
Aurantimycin A is a secondary metabolite synthesized by the soil bacterium Streptomyces
aurantiacus (Graefe et al. 1995). The antibiotic is very toxic to Gram-positive bacteria
with MICs below 0.01-0.1 µg/ml reported for B. subtilis, Staphylococcus aureus and
streptococci. Gram-negative bacteria are intrinsically resistant to aurantimycins (Graefe
et al. 1995). The biosynthetic gene cluster needed for aurantimycin synthesis contains 36
open reading frames encoding different enzymes involved in the synthesis and tailoring
of the antibiotic as well as an ABC transporter (Zhao et al. 2016). This particular ABC
transporter, ArtJK, shows around 50 % similarity to LieAB from L. monocytogenes and
could be responsible for the export aurantimycin from S. aurantiacus cells. Based on the
similarity between ArtJK and LieAB the hypothesis that LieAB exports aurantimycin A
becomes more likely.
The importance of LieAB for the resistance of L. monocytogenes against aurantimycin
was shown by determining the MIC of aurantimycin against lftRS and/or lieAB mutants
(see Table 2.8). Compared to other Gram-positive bacteria (Graefe et al. 1995), the L.
monocytogenes EGD-e wild type is highly resistant against aurantimycin. The ∆lftR mu-
tant overexpressing LieAB had a MIC even higher than the wild type. Mutants lacking
lieAB on the other hand were very sensitive to the antibiotic, even at low concentrations
(see table 3.9). The MIC values of the ∆lieAB mutants were in the same range as the
values observed for other Gram-positive bacteria (Graefe et al. 1995). Putting everything
together, the data suggest that the LftR-controlled lieAB operon becomes active in the
presence of aurantimycin and the LieAB transporter exports the antibiotic from the cell
(an/or the cell membrane).
Taking all results into consideration, the working model of LftR-controlled aurantimycin-
resistance looks as depicted in figure 4.1. In the absence of an effector, basal amounts
(light color) of LftR and LftS are produced due to background activity of PlftRS. This
basal activity results from incomplete repression of PlftRS by LftR (see the higher activity
of PlftR compared to PlieA in figure 3.8). The presence of basal amounts of the two proteins
allows for efficient repression of lieAB (no expression implied by gray color in figure 4.1),
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as well as effector recognition.
In the presence of aurantimycin, LftR is no longer able to bind to the DNA. The PlieAB
and PlftRS promoters are now accessible to RNA polymerase and become active (saturated
color). The high activity of the de-repressed PlieAB promoter allows the cell to synthesize
large amounts of LieAB (Kaval et al. 2015). This is necessary in order to protect the cell
from death by lysis (see figure 3.15).
Figure 4.1: Working model of the LftR-controlled resistance to au-
rantimycin. In the absence of the antibiotic (left), the lieAB operon is
strongly repressed, while a basal amount of LftR and LftS are being pro-
duced from a leaky lftR promoter. In the presence of aurantimycin, LftR
is unable to bind the promoters and large amounts of LieAB are produced
to protect the cell from lysis. The role of LftS in the induction process is
still unclear.
The role of LftR clearly is the repression of the lieAB operon in the absence of effector
molecules like aurantimycin A. The role of LftS in this scheme is not yet understood. LftS
is essential for the induction by aurantimycin (see figures 3.10 and 3.11), but whether it is
involved in sensing or binding of the antibiotic or in the removal of LftR from the operator
under inducing conditions remains to be determined.
It is also unclear if aurantimycin interacts with LftR or LftS. In the PadR-like repres-
sor LmrR, a hydrophobic cavity was suggested to bind planar polycyclic compounds
(Madoori et al. 2009). The binding of effector could in turn cause structural rearrange-
ments that prevent binding of the repressor to the DNA. A similar cavity exists in the
structure of LftR (Lee et al. 2019). Binding of aurantimycin to this pore could result
in structural rearrangements that regulate the LftR-DNA interaction. This needs to be
proven in further experiments, for example by co-crystallization or in EMSA studies us-
ing purified protein and effector. Unfortunately, such a regulatory mechanism would not
explain the essentiality of LftS for the induction process, so the true mechanism might
be more complex. LftS could for example bind the effector and then interact with LftR
to prevent repression. Other regulatory modes like complex formation between LftR and
LftS are also possible. LftS contains the domain of unknown function DUF1048. To-
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date no protein with such a domain has been described in the scientific literature. The
function of LftS in LftR-mediated gene regulation has been identified in this work. This
might offer the chance to assign a biological role to a whole class of proteins, if the same
regulatory pattern could be confirmed in other proteins containing DUF1048.
The presence of aurantimycin-resistance genes in the genome of L. monocytogenes sug-
gests that under natural conditions an interaction between aurantimycin producing bac-
teria and L. monocytogenes could take place. Additionally, the high sensitivity of Gram-
positiv bacteria that do not carry aurantimycin-resistance genes (Graefe et al. 1995) sug-
gests that L. monocytogenes is better able to survive in environments where the antibiotic
is present. Both, L. monocytogenes and aurantimycin-producing S. aurantiacus have been
isolated from soil (Vijayabharathi et al. 2011, Linke et al. 2014), supporting the hypothe-
sis that the two species might somehow interact or compete with each other in this habitat.
Another open question is, whether the LftRS-LieAB system is specific for aurantimycin
or whether other depsipeptides will also be detoxified. If the latter is true, LieAB might
be a more broadly relevant resistance mechanism against depsipeptides.
4.4 Mutations found in aurantimycin-resistant suppres-
sors
In liquid culture, aurantimycin-resistant suppressors could be readily selected when the
wild type or the ∆lftS mutant were grown in the presence of toxic aurantimycin concen-
trations. Both of these strains do not express the lieAB transporter genes under normal
conditions. When induced, the wild type will produce the transporter, but the ∆lftS mu-
tant is unable to do so (see figures 3.10 and 3.11). Nevertheless, both strains grew in
over night cultures containing aurantimycin at concentrations that were toxic to ∆lieAB
mutants (see figure 3.16).
When single cells were isolated from these over night cultures, sequencing of the lftRS
operon and its promoter revealed that all cells had acquired mutations in lftR or its pro-
moter (see table 3.10). The promoter mutations effected the -10 box or the RBS of lftR,
most likely leading to the inactivation of the lftRS operon. Mutations in lftR, which result
in a non-functional lftR gene, lead to constitutive expression of the lieAB transporter genes
and to aurantimycin-resistance as an end result. The observation that strains lacking the
lieAB genes did not develop resistance is in good agreement with this hypothesis, because
the resistance determinant is absent these strains (see figure 3.16). The ∆lftR strain on the
other hand is always resistant.
The formation of aurantimycin-resistant suppressors is the reason that both the wild type
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and the ∆lftS mutant showed identical MICs (see table 3.9). MIC values are usually deter-
mined after over night incubation, but this time was long enough for the resistant mutants
to over-grow the culture. It must therefore be concluded that the mutations inactivat-
ing LftR could form very easily or could already be present in a sub-population of the
inoculum.
Most suppressor mutations found in aurantimycin-resistant mutants inactivated LftR by
disrupting the lftR gene or its promoter via frame shifts and premature stop codons (see
table 3.10). The few single amino acid substitutions identified could be a valuable tool
for the characterization of the function and DNA interaction of LftR. The crystal structure
of LftR has been published recently (Lee et al. 2019). Based on this information, it is
possible to link the suppressor mutations to the structure of the protein (see figure 4.2).
Figure 4.2 shows the single amino acid exchanges found in the wild type and the ∆lftS
mutant. At the bottom of the figure, the secondary structural elements of LftR according
to its crystal structure are shown (Lee et al. 2019). The two mutations T46M and R53C
map in the putative DNA binding helix and could therefore prevent binding or recognition
of the operator by LftR. The arginine in position 53 belongs to a positively charged patch
(K9, R53, K56, K64, K66, R73, and K74) that was identified in the structure of LftR (Lee
et al. 2019). This patch could facilitate interactions with the negatively charged phosphate
backbone of the DNA helix (Lee et al. 2019). Although the threonine in position 46 is
not highly conserved, this position might be an important determinant of the sequence
specificity of LftR. The mutation T5I is located in the first helix α0 that together with
helix α4 is involved in LftR dimer formation (Lee et al. 2019). This mutation could pre-
vent the formation of a functional LftR dimer and thereby prevent LftR-mediated lieAB
repression. The two glycine replacements G27S and G70D are located at the beginning
of the α-helix 2 and beta-sheet 2. Glycine is known to be important for the formation
of secondary structures (Imai and Mitaku 2005). For example, it might work as a helix
breaker creating helices of a defined length. In LftR, nearly all secondary structural ele-
ments are flanked by glycine residues (see figure 4.2). The protein could adopt a different
secondary structure when these residues are mutated, thereby disrupting its function.
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Localizing the amino acid exchanges found in aurantimycin-resistant suppressors in the
3D-structure of LftR gives a more detailed impression of the impact they might have
(see figure 4.3). The superposition of the LftR dimer with a DNA double helix shown
in figure 4.3 revealed that all the exchanges (colored in red) occurred in parts of LftR
that are in close contact with the DNA. Additionally, the glycine exchanges affect areas
that are in close contact with the phosphate backbone of the DNA (see figure 4.3 or 4.4).
Exchange of the small glycine residues for bulkier amino acids might therefore lead to
steric clashes that prevent LftR from binding to the DNA. The exchange of glycine for
negatively charged glutamate at position 70 will also lead to repelling electrostatic effects
between the negatively charged phosphate backbone and the protein. This position is also
part of the loop structure in the beta-wing of LftR. It has been shown that the beta-wing
is essential for binding of PadR and LftR (Park et al. 2017, Lee et al. 2019). Mutations
that impact the structure in this part of LftR should therefore also impact the binding to
the DNA.
Figure 4.3: Location of the suppressor mutations in the 3 dimensional
structure of LftR. A superposition of the crystal structure of LftR (PDB:
6ABQ) with a DNA double helix (blue) shows how all single amino acid
mutations found in aurantimycin-resistant suppressors (colored in red) are
located at the interface with the DNA.
The other amino acid exchanges that did not affect glycine residues changed positions that
might be directly involved in interactions of LftR with DNA bases. Threonine at position
46 and arginine at position 53 are part of the DNA-binding helix and might interact with
base pairs in the major groove, while the threonine at position 5 could interact with the
DNA in the minor groove (see figure 4.4). It is interesting to note, that the R53C mutation
was found in 9 independent ∆lftS suppressors, but not a single time among 20 wild type
suppressors (see table 3.10). Besides being part of a positively charged patch that could
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stabilize protein-DNA interactions (Lee et al. 2019), this position might somehow be
important for the interaction of LftR and LftS, because the mutation was only found in
the ∆lftS background. It could for example play a role in the LftS-dependent induction of
gene expression upon exposure to effector molecules. Isolation and sequencing of more
suppressor mutants could yield more mutations that allow for further characterization of
the LftR protein.
Figure 4.4: Close-up look at the suppressor mutations in chain A of
the LftR dimer. The superposition of chain A of LftR (PDB: 6ABQ) with
a DNA double helix shows that the mutations T5I, T46M and R53C alter
amino acids that could directly interact with specific DNA bases, while
the glycine exchanges G27S and G70D are located in areas that are close
to the phosphate backbone of the DNA.
4.5 The LftR operator sequence
In accordance with the RNA sequencing results which showed that only the genes lftRS
and lieAB are strongly regulated by LftR (see table 3.2), the putative LftR operator motif
GTAW-TACNNN-ATAC (see figure 3.21) can only be found twice in the genome of L.
monocytogenes EGD-e. It consists of an imperfect inverted repeat separated by a 6 nu-
cleotide spacer region (GTAW-N6-ATAC). The inverted repeat alone can be found 192
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times in the genome of L. monocytogenes EGD-e. This shows that the conserved bases
in the spacer region must also be important for the recognition of the motif. The repeat
identified also differs from the suggested canonical PadR ATGT/ACAT repeat (Fibriansah
et al. 2012), but is of the same length.
The fact that the inverted repeat is imperfect in the lieA promoter while a perfect repeat
can be found in the lftR promoter is somewhat surprising, especially when considering
that the lieA promoter is strongly repressed, while the lftR promoter shows a detectable
background activity in Northern blots (see figure 3.6). A potential reason for this obser-
vation could be that there are other motifs, beside the primary operator, that play a role
in the total repression of the respective promoters. The lieA promoter with the 69-68 ex-
change is the lieA promoter variant with the highest activity in vivo (see figure 3.20), but
its activity only reached between 10 or 20 % of the maximal promoter activity measured
in the absence of LftR. The result that the maximum de-repression obtained by mutation
of the proposed binding site did not reach the same level as in the ∆lftR mutant indicates
residual binding of LftR outside of its core operator region.
Another possible explanation for residual binding could be that LftR is able to bind DNA
as a monomer. In the experiments performed, a defined set of bases was mutated at
any one time. Inactivation of both ends of the operator has yet to be tested. Therefore,
it is possible that one LftR monomer could bind one side of the operator and partially
repress transcription. Full repression is achieved by another monomer also binding to the
other side of the operator or by binding of the dimerized protein. Further, it can not be
excluded that elements further upstream of the investigated region are also important for
LftR binding. DNAse protection assays could help clarify this point.
LmrR, which like LftR is a PadR-type transcription factor of subfamily-2 (Park et al.
2017), has been shown to protect two sites in promoter of its target gene lmrCD from
DNase digestion experiments (Agustiandari et al. 2008). Of the two sites protected from
DNase degradation only one contains the inverted repeat motif that is thought to be the
primary binding site of LmrR (Agustiandari et al. 2008). LmrR thus seems to also bind
to DNA sequences that do not contain a classical operator sequence including an inverted
repeat. The classical operator has therefore been proposed to act as a nucleation site for
repressor molecules that enables bigger DNA-protein complexes to form (Agustiandari
et al. 2011).
Another model of LmrR-dependent regulation suggests that LmrR exhibits non-specific
DNA absorption and specific operator interaction states (Takeuchi et al. 2017). Effector
binding to LmrR is believed to shift this equilibrium towards the non-specifically DNA-
bound state leading to relief of repression (Takeuchi et al. 2017). It would be much more
difficult to determine the exact role of the operator, when the proteins exhibits unspecific-
DNA interaction as proposed by this model. However, such a model could explain why
complete de-repression was not achieved by the introduction of mutations in the LftR
operator.
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A motif very similar, but less conserved than the original LftR binding site is present in the
lieAB promoter. This motif (GTAATAA-N3-ATAC, underlined in figure 3.21) overlaps
with the consensus LftR operator. To test if this secondary motif is also involved in the
repression of the lieA promoter, it was mutated in addition to the 69-68 exchange, but
no additional de-repression was observed (data not shown). We were able to identify the
sequence GTAW-TACNNN-ATAC as the main DNA binding motif recognized by LftR
using base permutations and promoter-lacZ reporter constructs. Still, the exact regulatory
mechanism on which the lieAB repression by LftR is based remains to be determined.
4.6 The function of LstR remains unclear
The sigC-lstR-lmo0421 operon is not present in all strains of L. monocytogenes. Only
strains belonging to lineage II (serotypes: 1/2a, 1/2c, 3a) carry these genes (Zhang et al.
2003). Members of lineage II are commonly isolated from foods, but are found less fre-
quently in human clinical cases than lineage I strains (Gray et al. 2004). Natural selection
seems to have favored the presences of these genes in lineage II, while it was favorable
for lineage I strains to lose them. The specific conditions that underlie the selection pres-
sure will probably be understood once the biological function of the operon has been
determined.
The results obtained in this study allow the generation of a simple regulatory model of
the sigC-lstR-lmo0421 operon as shown in figure 4.5. Expression from the LstR operon
is regulated by two proteins: SigC and LstR. The data suggest that SigC is essential
for the transcription from PsigC (see figure 3.14). While SigC has an activating effect,
LstR negatively controls the expression of the operon (see figure 3.14). The function
of Lmo0421 is still unclear, but it does not seem to perform the same function as the
homologous RodA/FtsW proteins (see figure 3.25).
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Figure 4.5: Model of the regulation of the sigC-lstR-lmo0421 operon.
SigC is needed for the activity of the PsigC promoter, while LstR nega-
tively controls the expression of the operon. The role of Lmo0421 still
needs to be determined.
The natural compound screen revealed that the LstR-controlled genes were induced by
the 16-membered macrolide antibiotics niddamycin and josamycin. The induction by
josamycin and other macrolide antibiotics (tylosin and erythromycin) was confirmed us-
ing commercially available preparations of both compounds (see figure 3.13). Surpris-
ingly, no effect on the resistance against these antibiotics could be detected in mutant
strains lacking lmo0421, the effector gene of this operon (see table 3.11).
There are several possible explanations for this observation. First, the induction by the
macrolides could be unrelated to the biological function as was the case for LftR and
rhodamine 6G. Second, it could be the case that under the investigated conditions insuf-
ficient amounts of protein accumulated to show a measurable effect. Induction has only
been shown on the level of RNA, so the actual protein overproduction needs to be proven
in future experiments. Third, the effect of Lmo0421 could be masked by other proteins;
for example by the other RodA/FtsW proteins.
Having Lmo0421, a protein showing homology to RodA or FtsW proteins involved in cell
wall synthesis, under the control of a PadR-like repressor and an alternative sigma factor
is a unique constellation. The sigma factor and the repressor could integrate different
signals so that lmo0421 will only be transcribed when the two signals are registered at the
same time. The RodA/FtsW paralog Lmo0421 might thus only be activated under very
specific conditions. The negative and positive feedback loops enmeshed in the regulation
of the sigC-lstR-lmo0421 could also result in a variety of different expression patterns
depending on the strength of the feedback loops involved (Rodrigo et al. 2016). The
regulation could be important for the quick production of protein upon induction or could
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result in behaviors such as bistability or oscillation (Rodrigo et al. 2016). It might be
helpful to monitor the response of the operon after addition of an inducer like josamycin
using a fluorescent reporter to determine what behavior actually occurs.
4.7 LltR-controlled genes are associated with the ability
of L. monocytogenes to grow at low temperature
In contrast to many other bacteria, L. monocytogenes is able to grow at very low tempera-
tures (Junttila et al. 1988, Walker et al. 1990). This capacity is a major determinant in its
ability to infect humans and cause disease as shown by a risk assessment model developed
by the Food and Agriculture Organization of the United Nations (FAO 2004). In this re-
port the Food and Agriculture Organization of the United Nations suggested that ”nearly
all cases of listeriosis result from the consumption of high numbers of the pathogen. (FAO
2004)” Ready-to-eat and other foods stored in the fridge for prolonged periods of time are
especially prone to be infection sources, because long storage periods allow the pathogen
to grow to high densities necessary for infections to occur (FAO 2004).
Japan is a highly developed country, but to-date only a single outbreak of L. monocyto-
genes has been described in Japan (Makino et al. 2005). In this outbreak, the infection
vehicle was cheese, a food not part of a traditional Japanese diet. Interestingly, there is
also no mandatory notification system for listeriosis in Japan (Miya et al. 2016). For en-
terohemorrhagic E. coli (EHEC) a nationwide surveillance was established after a series
of outbreaks in 1996 involving more than 7,500 cases, while in more recent years around
3,000 cases, or roughly 24 EHEC cases/million person, are reported every year (Tera-
jima et al. 2014). It might be possible that without major outbreaks and only sporadic
cases, there has not been enough incentive to justify the establishment of an mandatory
surveillance system in Japan.
Estimations of the annual rate of listeriosis in Japan range from 83 up to 200 cases a year,
with a resulting rate of up to 1.4 cases/million persons (Okutani et al. 2004, Miya et al.
2016). This rate is indeed much below the 4 cases/million persons common in Europe
(Goulet et al. 2008), but without extensive national data from Japan a sound comparison
is impossible. An MLST-based analysis of some Japanese isolates came to the conclusion
that they came from sporadic cases (Miya et al. 2016).
Many of the milk or meat based ready-to-eat foods that are often sources of infection in
the west (Swaminathan and Gerner-Smidt 2007) are not part of a traditional Japanese diet.
The traditional Japanese diet could thus be a factor limiting the incidence of listeriosis by
reducing exposure to foods frequently associated with listeriosis in the west. On the other
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hand, raw seafood is often consumed in Japan and some products have been shown to
be frequently contaminated with low levels of L. monocytogenes (Miya et al. 2010). It is
tempting to speculate that the Japanese food culture focused on fresh foods is preventing
infections with L. monocytogenes, even when the food is consumed raw, because high
contamination levels are necessary for infections to occur (FAO 2004). The absence of
processed milk and meat products in the traditional diet and the focus on fresh food could
prevent L. monocytogenes from growing to the densities required for infections to occur,
because the products are not stored for extended periods of time under refrigeration.
The lltR gene is strongly expressed during growth at 10°C when compared to 37°C (Liu
et al. 2002). This supports the assumption that the regulator LltR is essential for growth
at low temperatures. The results obtained here show that the presence of an intact copy of
the lltR gene is indeed essential under refrigeration conditions (see figure 3.27). When the
repressor is inactivated, the genes lmo0600 and lmo0601 are over-expressed (see table 3.7)
and the over-expression of lmo0600 prevents L. monocytogenes from growing efficiently
at 6°C (see figure 3.28).
Studying the molecular mechanisms of how the lltR operon impacts growth at refrigera-
tion temperature might significantly enhance the understanding of growth of L. monocy-
togenes at low temperature. In order to gain a full understanding of the underlying mech-
anisms, it is important that the functions of LltR-controlled genes lmo0600 and lmo0601
will be determined. Based on sequence similarity, Lmo0600 might be an integral mem-
brane protein and Lmo0601 and internalin-like protein. Several potential functions of the
genes are suggested in figure 4.6. These could serve as an inspiration for future experi-
ments.
According to the in silico function prediction, both of the proteins might be associated
with the membrane. The fact that the lltr* ∆lmo0601 mutant lysed at 6°C, while the
lltr* mutant did not (see figure 3.29), suggests a functional link between lmo0600 and
lmo0601. The repression of lmo0600 is necessary for efficient growth at low temper-
atures. One valid conclusion is that induction of lmo0600 is unlikely to occur at 6°C,
because it would be detrimental for growth. It is therefore essential to find other phe-
notypes associated with the lltR operon in order to characterize its function. It would
be especially interesting to find natural conditions or substances that induce the expres-
sion of lmo0600. Adding an inducer to L. monocytogenes cultures at low temperature
should prevent growth, possibly providing a novel strategy to control L. monocytogenes
contamination of refrigerated food.
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Figure 4.6: Guesses about the function of Lmo0600 and Lmo0601.
Potential functions of the hypothetical proteins Lmo0600 and Lmo0601
are suggested here. The suggestions are based on the in silico notion
of Lmo0600 being an integral membrane protein and Lmo0600 showing
similarity to bacterial adhesins.
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